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Single-Component Optogenetic Tools Fo Cytoskeletal Rearrangements
Abstract
The Rho family of small GTPases coordinate actin cytoskeletal rearrangements underlying crucial cell
processes including migration and mechanotransduction. Dysregulation in these signaling pathways has
been associated with neurodegenerative disease and cancer. Rho GTPase signaling is tightly controlled in
space and time: GTPases are activated by guanine nucleotide exchange factors (GEFs) and inactivated by
GTPase accelerating proteins (GAPs) at the plasma membrane. To study Rho GTPase signaling, several
optogenetic tools have been developed, most of which use light to induce a protein-protein interaction,
recruiting a GTPase-activating GEF to the plasma membrane. Other optogenetic strategies involve the use
of single-chain photoswitches sterically occluding a constitutively active GTPase, which can result in
undesirable high dark-state activity of the tool. We sought to create single-component optogenetic tools
to perturb Rho GTPase signaling at the GTPase, GEF, and GAP level, resulting in lower dark state activity
and easier implementation in mammalian systems.In this work, we used BcLOV4, a fungal photoreceptor
which directly binds membrane lipids in response to blue light inputs, to recruit Rho signaling proteins to
the membrane, resulting in spatiotemporally precise signaling perturbation. We created BcLOV4
activation tools using the GTPase and GEF from the three best studied Rho GTPase pathways: RhoA,
which induces cell contraction through stress fiber formation; Rac1, which induces sheet-like
lamellipodial protrusions; and Cdc42, which induces spiky filopodial protrusions. Notably, we
demonstrated that the BcLOV4 system is compatible with wildtype GTPases, resulting in lower
unintended pathway activation in the dark state. We also report progress toward the creation of RhoA
termination tools using GAP domains and dominant-negative GTPases, allowing for the induction of
signaling activation and termination on the same optogenetic platform. Using structural knowledge we
gained from Rho GTPase tool development, we created a plasmid set and cloning workflow to simplify
BcLOV4 tool engineering for other signaling targets. Together, the BcLOV4 optogenetic toolbox will further
the study of Rho GTPase signaling and enable others to use this technology for single-component
optogenetic membrane recruitment.
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ABSTRACT

SINGLE-COMPONENT OPTOGENETIC TOOLS FOR CYTOSKELETAL
REARRANGEMENTS

Erin Berlew
Brian Y. Chow

The Rho family of small GTPases coordinate actin cytoskeletal rearrangements
underlying crucial cell processes including migration and mechanotransduction.
Dysregulation in these signaling pathways has been associated with neurodegenerative
disease and cancer. Rho GTPase signaling is tightly controlled in space and time:
GTPases are activated by guanine nucleotide exchange factors (GEFs) and inactivated
by GTPase accelerating proteins (GAPs) at the plasma membrane. To study Rho
GTPase signaling, several optogenetic tools have been developed, most of which use
light to induce a protein-protein interaction, recruiting a GTPase-activating GEF to the
plasma membrane. Other optogenetic strategies involve the use of single-chain
photoswitches sterically occluding a constitutively active GTPase, which can result in
undesirable high dark-state activity of the tool. We sought to create single-component
optogenetic tools to perturb Rho GTPase signaling at the GTPase, GEF, and GAP level,
resulting in lower dark state activity and easier implementation in mammalian systems.
In this work, we used BcLOV4, a fungal photoreceptor which directly binds
membrane lipids in response to blue light inputs, to recruit Rho signaling proteins to the
membrane, resulting in spatiotemporally precise signaling perturbation. We created
BcLOV4 activation tools using the GTPase and GEF from the three best studied Rho
v

GTPase pathways: RhoA, which induces cell contraction through stress fiber formation;
Rac1, which induces sheet-like lamellipodial protrusions; and Cdc42, which induces
spiky filopodial protrusions. Notably, we demonstrated that the BcLOV4 system is
compatible with wildtype GTPases, resulting in lower unintended pathway activation in
the dark state. We also report progress toward the creation of RhoA termination tools
using GAP domains and dominant-negative GTPases, allowing for the induction of
signaling activation and termination on the same optogenetic platform. Using structural
knowledge we gained from Rho GTPase tool development, we created a plasmid set
and cloning workflow to simplify BcLOV4 tool engineering for other signaling targets.
Together, the BcLOV4 optogenetic toolbox will further the study of Rho GTPase
signaling and enable others to use this technology for single-component optogenetic
membrane recruitment.
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CHAPTER ONE: Background and Motivations

1.1

Rho-family GTPase signaling

1.1.1

GTPases as mediators of cytoskeletal rearrangements
To maintain their shape, adhere to substrates, respond to external mechanical

stimuli, and migrate, cells must possess machinery to remodel the actin cytoskeleton
with spatiotemporal precision (227). GTPases, or GTP-hydrolyzing proteins, act as
molecular switches: in their active, GTP-bound state, they interact with downstream
effectors to induce cell signaling events; GTP hydrolysis yields an inactive, GDP-bound
state resulting in signaling termination (58). Two main types of GTPases exist in the cell.
Gα domains interact with transmembrane G protein-coupled receptors (GPCRs) which
associate

with

membrane

receptors

to

control

cyclic

AMP

(cAMP)

and

phosphatidylinositol signaling (257). Small GTPases, in contrast, are single-component
proteins; while they can associate with membranes, they are not integral membrane
proteins like their heterotrimeric counterparts. Five major families exist within the Ras
superfamily of small GTPases: Ras, which regulates gene expression; Rab, which
coordinates membrane trafficking; Arf, which is involved in vesicular transport; Ran,
which plays a role in nuclear protein shuttling and microtubule rearrangements; and Rho,
which regulates remodeling of the actin cytoskeleton (230). Rho GTPases play key roles
in critical cell processes including morphology maintenance, migration, and proliferation
(58). Accordingly, dysfunction or dysregulation in Rho GTPase signaling has been
associated with neurodegenerative disease (77) and cancer (57).
Rho GTPases contain three main structural features: the G domain, the helical
insert, and the C-terminal hypervariable region (213). The G domain is responsible for
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nucleotide (GTP or GDP) binding. It consists of a six-stranded mixed β-sheet surrounded
by five α-helices and contains five conserved structural motifs, designated G1 through
G5. G1, also referred to as the P-loop, coordinates the β-phosphate of the bound
nucleotide and a Mg2+ ion, which helps maintain the domain structure. G2 and G3
comprise two switch regions (switch I and switch II, respectively) which sense whether
the domain is bound to GDP or GTP. Based on this determination, the switches drive a
conformational change of the GTPase using a conserved “load-spring” mechanism,
allowing the active GTPase to interact with downstream signaling partners (258). The
insert region is located between the G4 and G5 motifs of the G domain and serves as a
binding site for associated guanine nucleotide exchange factors (GEFs) and pathway
effectors. Importantly, this insert determines which isoform-specific downstream binding
interactions can occur, preventing unintended inter-pathway crosstalk from occurring
(134). Finally, the variable C-terminus consists of about 10 amino acids which, with the
insert region, help determine downstream interactions. This region often contains
charged amino acids, allowing the GTPase to associate with charged lipid head groups,
and a terminal CAAX box which can be modified with lipids, allowing for membrane
association (236).
The best characterized members of the Rho GTPase family are RhoA, Cdc42,
and Rac1, due to their roles in diverse cell processes (197) and interactions with over 60
downstream effectors (58). RhoA activates Rho-associated protein kinase (ROCK) and
myosin light chain (MLC), leading to actin stress fiber formation and cell contraction
(241). Cdc42 and Rac1 both play important roles in cell motility through actin
polymerization and cell protrusion formation. Cdc42 activation results in the formation of
filopodia, spiky membrane protrusions, through Wiscott-Aldrich Syndrome protein
(WASp) and actin-related proteins complex (Arp2/3) (256). Rac1 induces the formation
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of larger, veil-like lamellipodia through WASp-family verprolin-homologous (WAVE) and
Arp2/3 (192). Together, these three Rho GTPases coordinate cell motility and
cytoskeletal remodeling through spatiotemporally precise activation and inactivation. A
variety of accessory proteins and mechanisms exist to maintain tight control over Rho
GTPase signaling at the plasma membrane.

1.1.2

Spatiotemporal regulation of Rho-family GTPases

1.1.2.1 Guanine nucleotide exchange factors (GEFs)
GTPase activation (Figure 1.1) requires dissociation of bound GDP from its
binding site so that a GTP molecule can replace it and induce an activity-conferring
conformational change (23). Once this dissociation occurs, GTP quickly re-binds the
GTPase due to its outnumbering of GDP in the cell by an order of magnitude (242),
making GDP dissociation the rate-limiting step. If left to its own devices, GDP
dissociation would occur too slowly for the rapid GTPase activation which is necessary
for robust responses to speed the GTPase turnover process. The general GEF
mechanism involves pulling GTPase switch I away the cellular environment. Thus,
accessory proteins called guanine nucleotide exchange factors (GEFs) are necessary to
speed the GTPase from the bound nucleotide, allowing it to undock from the protein.
Once GDP leaves the binding site, the GTPase is unstable, so the GEF binds the switch
II region, preventing the protein from unfolding and providing stability until a GTP
molecule can enter and bind (38).
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Figure 1.1

Overview of GTPase signaling

GTPases are inactive in their GDP-bound state. Guanine nucleotide exchange factors (GEFs)
catalyze GTP loading and GTPase activation. GTPase accelerating proteins (GAPs) catalyze
GTPase hydrolysis and inactivation. Guanine dissociation inhibitors (GDIs) bind the GTPase
prenylation motif, keeping them in the inactive state.

This mechanism varies slightly between Rho GTPase-associated GEF (RhoGEF)
families. For example, the PRONE (plant-specific ROP (Rho of plants) nucleotide
exchange factor) GEFs predominate RhoGEF signaling in plants (168) and interact with
two GTPases simultaneously. Mammalian GTPase signaling occurs with the help of two
GEF families: dedicator of cytokinesis (DOCK) GEFs and Dbl homology/pleckstrin
homology (DHPH) GEFs. In the DOCK family, each GEF contains two DOCK homology
regions (DHRs). DHR-1 interacts with phospholipids, allowing the GEF to stably localize
to the membrane, while DHR-2 acts as a GEF and interacts with the GTPase. DOCK
GEFs interact with both Cdc42 and Rac1, differentiating between the two based on the
identity of the fifty-sixth amino acid of the GTPases (129).
GEFs in the DHPH family, which is the focus of the GEF work in this thesis,
contain a Dbl homology (DH) domain followed by a pleckstrin homology (PH) domain.
Like the DOCK family, the DHPH family separates membrane association and GTPase
binding responsibilities between two protein domains. DH domains contain 10-15 helices
comprising three core (CR) regions. CR1 and CR3 interact with switch I of the
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associated GTPase, with switch II residing in the DH hydrophobic cleft. These
interactions allow the bound GDP to leave the GTPase core and stabilize the GTPase
until GTP binding can occur. PH domains interact with membrane lipids to serve as a
membrane anchor (207), keeping the GEF in the two-dimensional plane of the
membrane with which the GTPase is associated. For DHPH GEFs interacting with the
major Rho GTPases, some GEFs are specific to one GTPase, like Tiam1 (100) and
ARHGEF11 (108), which activate Rac1 and RhoA, respectively. Others exhibit broader
interactions, activating two or all three major Rho GTPases (170). GEF-GTPase
specificity is thought to be mediated by residues on DH domain helices 4 and 5;
mutation of these residues has been shown to alter GEF interaction profiles (37).

1.1.2.2 GTPase activating/accelerating proteins (GAPs)
GAPs, or GTPase activating/accelerating proteins, serve as the inactivation
counterparts to GEFs, catalyzing GTP hydrolysis resulting in GTPase signaling
termination (236). GAP domains function by stabilizing the transition state as GTP is
hydrolyzed by water in a nucleophilic attack. Specifically, a conserved arginine finger
found in all GAPs interacts with a conserved glutamine residue on switch II of the
GTPase, orienting the GTP so that its γ-phosphate can be hydrolyzed (38). Notably, this
GTPase glutamine residue can be mutated, resulting in a constitutively active (i.e.,
permanently GTP-bound) GTPase which is unresponsive to GAP-mediated inactivation.
Structurally, GAPs are less evolutionarily conserved than GEFs, with mechanistic
specifics varying from family to family (31). Like GEFs, GAPs also often contain
additional domains beyond the catalytic GAP domain to regulate protein interactions and
subcellular localization. For example, N-terminal BAR (Bin, Amphiphysen, Rvs) (8) and
CRAL-TRIO (cellular retinaldehyde-binding protein and TRIO-GEF) (183) domains found
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in RhoA-inactivating ARHGAP29 and ARHGAP1, respectively, allow the proteins to bind
membranes via lipid binding pockets.
Another similarity between RhoGEFs and Rho GTPase-associated GAPs
(RhoGAPs) lies in their specificity: some GAPs only interact with one GTPase, while
others can inactivate more than one. GAP specificity is thought to be mediated by their
co-localization with GTPases: expression of each GAP is not ubiquitous, with
preferential GAP expression varying across tissues, cells, and subcellular zones (235).
Thus, RhoGAPs may exhibit in vitro interactions with GTPases with which they do not
interact in a physiologically meaningful way. Mechanisms of GAP regulation are varied
and not fully understood. Crosstalk between Rho GTPase signaling pathways may allow
for persistent GTPase signaling by preventing premature termination by GAP inhibition
(266). Interestingly, an example of a mechanotransductive feedback loop was recently
discovered in which GAP expression is turned on in response to an increase in RhoAmediated stress fibers to prevent over-rigidification of the cytoskeleton (157). Recent
interactome analysis has also shown evidence for auto-inhibition by GAPs (170). Further
investigation into these various potential mechanisms of GAP regulation requires
additional methods for GTPase and GAP signaling perturbation within the cell.

1.1.2.3 Guanine dissociation inhibitors (GDIs)
In addition to activating GEFs and inactivating GAPs, GTPases also rely on
guanine dissociation inhibitors (GDIs) to keep GTPases in the off state, preventing
spurious signaling activation. The structure of GDIs allows them to accomplish this goal
through several mechanisms. First, GDIs contain a C-terminal domain with a
geranylgeranyl pocket lined with hydrophobic amino acids. The GTPase prenylation
motif can be inserted into this pocket, shielding the C-terminus from membrane
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incorporation and sequestering the GTPase in the cytosol (38). This process alters GDI
folding so that the GDI N-terminal regulatory domain can interact with GTPase switches I
and II, preventing the conformational change associated with GTP binding from
occurring (145). Thus, this binding event both removes the GTPase from its active
location in the cell and prevents re-activation through locking the protein in its off state.
In addition, GDIs have also been shown to prevent depletion of available Rho GTPase
populations in the cell by stabilizing inactive GTPases and preventing them from being
degraded by cytosolic protein complexes (24). When more GTPase is needed at the
membrane, GDI removal and GTPase membrane translocation can occur (65).
Several factors may play roles in GDI removal. Ezrin-Radixin-Moeisin (ERM)family proteins may bind to the GDI and act as GDI dissociation factors, causing the
GTPase to be released and insert into the membrane (153), where GEF activation can
occur. There is also evidence for cooperativity between membrane lipids and activating
GEFs (203) in removing the GDI from the prenylation motif, and of GDI phosphorylation
by Pak1 kinase (50), resulting in GTPase release. The Rho family of small GTPases
interacts with three RhoGDIs: RhoGDI1, which has high affinity for several Rho
GTPases, including RhoA, Rac1, and Cdc42 in most cell types (24); RhoGDI2, which
exhibits similar broad activity but is limited to expression in hematopoetic cells (80); and
RhoGDI3, predominantly interacts with lesser-studied Rho GTPases RhoB and RhoG
(26).

1.2

Optogenetic strategies for membrane recruitment of proteins

1.2.1

The plasma membrane as a signaling hub
Beyond cytoskeletal remodeling, many cellular phenomena are coordinated at

least in part at the plasma membrane, including cell-cell communication, vesicular
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transport, and cell growth and division (79). At the membrane, signaling events are
tightly controlled in space and time; thus, studying these pathways using global
approaches without spatial targeting is often sub-optimal. For example, pathway knockdown by drug treatment lacks temporal precision as the experiment relies upon the
timelines of cellular drug uptake and washout. Genetic targeting approaches like
overexpression of a protein of interest or gene knockout affect the whole cell, in contrast
to endogenous signaling events, which often occur asymmetrically (210). To establish
better spatiotemporal control over cell signaling, optogenetic tools have been engineered
to recruit proteins of interest (POIs) to the membrane in response to light inputs that can
be programmed precisely in space and time. Through the engineering of natural
photoreceptors which endogenously exhibit light-induced conformational changes,
several platforms have been developed to recruit POIs to the membrane to perturb cell
physiology and study cell signaling (87). Three well-studied approaches to optogenetic
membrane

recruitment

are

single-chain

heterodimerization, and light-induced protein clustering.
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photoswitching,

light-induced

Figure 1.2

Optogenetic tool mechanisms for membrane recruitment

a. Single-chain photoswitching. b. Photoinducible heterodimerization. c. Light-induced protein
clustering.

1.2.2

Single-chain photoswitching
One approach to membrane recruitment of POIs is to fuse the POI to a single-

chain photoreceptor and couple the light-induced conformational change to solvent
exposure of a POI site which binds a membrane partner. Thus, in the dark state, the POI
remains sequestered in the cytosol because its binding site is sterically occluded by the
photoreceptor; in the illuminated state, the binding site is exposed and the protein can
activate downstream signaling through diffusive contact with the membrane. While this
engineering strategy presents the genetic payload advantage of only needing to express
a single protein for pathway perturbation, single-component photoswitching tools can be
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difficult to engineer as total binding site occlusion is required to ensure no dark state
activity occurs, and more extreme measures may be required during experimentation to
prevent premature light exposure and pathway turn-on (262).

1.2.2.1 Dronpa
One class of single-chain optogenetic recruitment tools is based on Dronpa, a 29
kDa green fluorescent protein (GFP) with dual light responses: fluorescence turns on in
response to UV (390 nm) light and turns off in response to cyan (490 nm) light (5).
Mechanistic insight into Dronpa photoswitching suggests that UV light may induce a
structural rearrangement promoting multimerization of the protein and fluorescence via
endogenous amino acids rather than additional cofactors (274), while cyan light induces
monomerization and fluorescence extinction. Dronpa photoswitching is rapid, with
association and dissociation of monomers occurring within seconds of light exposure
(84). This protein can be engineered as an optogenetic tool by fusing POIs to Dronpa
monomers, which then aggregate and disaggregate in response to light cues (275). One
early use case involved the creation of a light-inducible protease, in which Dronpaprotease fusions were active in their monomeric, cyan-illuminated state and inactivated
upon UV-induced oligomerization. A membrane recruitment system was also engineered
by encoding a Cdc42 GEF sandwiched between two Dronpa monomers. Oligomerization
resulted in occlusion of the GTPase-interacting site on the GEF, while cyan-triggered
monomerization resulted in binding site exposure and Cdc42 activation at the membrane
(275).
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1.2.2.2 AsLOV2
Another class of single-chain tools was engineered from AsLOV2, the sensor
domain from Avena sativa phototropin I (209). Like other light-oxygen-voltage (LOV)
domains, AsLOV2 undergoes a blue light-induced conformational change in which the
interaction between its Jα helix and a β-sheet is disrupted. In LOV-containing proteins,
this conformational change is transmitted to a fused C-terminal effector domain, resulting
in signaling activation (88, 89). This natural signaling mechanism can be used to create
single-component optogenetic tools by fusing POIs to the LOV C-terminal Jα helix. With
engineering, the POI active site is occluded by the LOV in the dark state and exposed in
the lit state, allowing it to interact with downstream signaling partners. This technology
was used to engineer an optogenetic Rac1 tool in which a permanently GTP-bound
Rac1 GTPase was fused to AsLOV2; blue light induced membrane contact between
Rac1 and downstream effector WAVE, resulting in the formation of sheetlike lamellipodia
(261). AsLOV2 was also used to create a light-inducible nuclear export system, in which
the POI initially expressed in the cell nucleus due to an exposed nuclear localization
signal (NLS) in the photoreceptor dark state. Illumination resulted in exposure of a
previously occluded nuclear export signal (NES), resulting in POI export from the
nucleus to the cytosol (179). A similar platform was used to engineer an optogenetic
protease system using an analogous LOV domain from Arabidopsis thaliana (200).

1.2.3

Heterodimer association
As demonstrated with Dronpa and AsLOV2, a powerful strategy for optogenetic

membrane recruitment is to pair the light-induced conformational change of a natural
photoreceptor to a change in protein binding ability. Heterodimer association uses
similar logic: in its illuminated state, the photoreceptor can bind to a partner with much
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higher affinity than in its dark state. By fusing POIs to one or both components, one can
design a system in which proteins interact only in the presence of light (122). In the
context of membrane association and GTPase signaling, this technology can be used to
recruit POIs to a subcellular location like the plasma membrane by fusing one of the
heterodimerizers to the membrane by prenylation or fusion to a membrane-anchored
protein (208). The POI can then be fused to the cytosolic component; light-triggered
dimerization then results in membrane recruitment of the POI. As discussed in this
section, photoreceptors that heterodimerize can either be found in nature or engineered
by screening for protein-peptide interactions with known photoreceptors.
Though widely used, this membrane recruitment strategy presents issues in the
areas of genetic and optical bandwidth. Use of a heterodimerization pair requires
encoding two proteins for one functional tool system, an increased genetic payload for
the cell. Characterization of co-transfection conditions and system component
stoichiometry may also be required for optimal signal. In addition, this strategy also
requires the use of two optical channels to confirm plasmid transfection, limiting the
number of optical channels available to visualize other cellular proteins or structures.

1.2.3.1 Tunable light-induced dimerization tags (TULIPs)
Several heterodimerization systems have been created by engineering AsLOV2
(or another LOV domain) to bind a second protein only in its blue light-illuminated state.
In the tunable light-induced dimerization tag (TULIP) system, a peptide called LOVpep is
fused C-terminally to the Jα helix of AsLOV2. In the protein dark state, this epitope is
sterically caged within the LOV core; blue light triggers its release, allowing it to bind an
engineered Erbin PDZ (ePDZ) domain, which clamps onto the LOVpep like a clamshell.
This binding brings any proteins fused to AsLOV2 or ePDZ into close proximity (225).
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Advantages of this system include its relatively small protein size (AsLOV2 is 17 kDa;
ePDZ is 23 kDa) and its rapid kinetics (1.3 s association; 53 s dissociation) (85). As its
name suggests, the binding affinities in this system are tunable; LOVpep and ePDZ can
be modified to exhibit binding affinities over several orders of magnitude (225).
This system can be modified to target POIs to subcellular localizations by fusing
AsLOV2 to the membrane of interest using prenyl moieties and fusing the POI to be
recruited to the cytosolic ePDZ domain. Examples of this application include in the
recruitment of MAP kinase signaling proteins to the membrane in yeast cells, resulting in
inducible cell polarization and budding (225). A TULIP system was also developed to
control RhoA signaling by fusing a RhoGEF to the ePDZ domain and the LOVpep to the
plasma membrane (34). In addition, TULIPs were used to re-position organelles by
fusing system components to mitochondrial or endosomal membranes and motor
proteins (250). Though these examples demonstrate the versatility of this optogenetic
system, TULIPS are associated with higher dark-state activity (“leakiness”) and lower
light responsivity than other heterodimerization systems like Phy/PIF (discussed in
section 1.2.3.6) (185).

1.2.3.2 Improved light inducible dimerization system (iLID)
Like TULIPs, the improved light inducible dimerization (iLID) system uses an
AsLOV2-epitope sensor to bind an accessory protein in response to blue light. The
epitope in the iLID system is SsrA, a 7-amino acid peptide from E. coli which binds the
SsbP protein in the AsLOV2 lit state when it is not sterically occluded by the LOV (81).
This system also exhibits rapid association (τon = 5 s) and dissociation (τoff = 53 s)
kinetics (85) and has been used to control cell signaling at the membrane. Some salient
examples include GEF domain membrane recruitment to drive cell migration (81, 180)
13

and calcium signaling (104), induction of receptor tyrosine kinase (RTK) signaling (99),
and tracking the plus ends of microtubules (2). Further advancements have been
reported to limit the diffusion of iLID along the two-dimensional surface of the membrane
with the goal of improving resolution of iLID-based tools (174, 251).

1.2.3.3 FKF1:Gigantea
While TULIPs and iLID consist of a photoreceptor which has been engineered to
bind a second protein, the FKF1:Gigantea is comprised of two natural heterodimerizers.
FKF1 and Gigantea are dimerizing proteins from Arabidopsis thaliana whose interaction
plays a role in the plant circadian rhythms and day length measurement (212). The
photoreceptor in this system is FKF1, a LOV domain with an FMN cofactor whose blue
light-induced conformational change allows it to bind Gigantea. This system has been
used to control Rac1 signaling by recruiting a GEF to the membrane using a similar
membrane fusion strategy as discussed before (267) and to induce gene expression by
forming a transcription factor upon light-induced dimerization (29, 193). The
FKF1:Gigantea system has significant downsides. First, the proteins are large—FKF1 is
68 kDa and Gigantea is 129 kDa, which is a high genetic payload for the targeted cells.
This system also exhibits slow kinetics, with full association occurring within 30 minutes
and dissociation taking over an hour. Thus, the FKF1:Gigantea optogenetic system is
unsuitable for applications requiring fast on and off times, like cytoskeletal remodeling.

1.2.3.4 Magnets
Another LOV-based dimerization system uses two engineered isoforms of the
LOV photoreceptor Vivid called Magnets which heterodimerize in their blue lightilluminated state via an electrostatic interaction. Association and dissociation in this
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system are both rapid (τon = 1.5 s; τoff = 6.8 seconds) (116), though the speed of Magnet
dissociation could require higher light stimulation duty cycles to maintain protein-protein
interaction. This system was used to recruit an SH2 domain to the membrane to control
phosphoinositide production (116). Additionally, by fusing complementary protein pieces
to each Magnet monomer, it is possible to reconstitute a functional protein in response to
blue light, as demonstrated in light-inducible Cre recombinase (115) and CRISPR Cas-9
applications (178). While Magnets’ small size (17 kDa each) initially appears to be an
advantage from a genetic payload perspective, the initial reported system required
concatemerization of the encoding DNA sequences, in which the transfected plasmid
contained multiple Magnet genes in parallel, increasing the payload. This issue as well
as the requirement of a low-temperature incubation step of Magnet-expressing cells prior
to experimentation were resolved in a second-generation system, which was used for
subcellular POI recruitment to endomembrane organelles for transport and metabolism
applications (13).

1.2.3.5 Cryptochrome2
The optogenetic heterodimerization systems discussed up to this point have
been based on LOV domains. The Cry2 heterodimerization system capitalizes on a
natural light-induced binding interaction exhibited by cryptochrome2. Cryptochromes are
flavin adenine dinucleotide (FAD) binding photoreceptor domains from plants and
animals which play a physiological role in circadian rhythms (36). One of the
cryptochrome blue light-inducible signaling modalities is through protein-protein
interaction (277). As demonstrated in Arabidopsis thaliana cryptochrome AtCRY2, blue
light induces a tertiary structure change, causing AtCRY2 to bind the cryptochromeinteracting basic-helix-loop-helix (CIB1) protein (143). This Cry2-CIB interaction has
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been used to engineer optogenetic tools used to control protein dimerization and DNA
recombination using Cre (120), gene expression (95), and subcellular localization (102).
Advantages of this system include its rapid kinetics, with protein translocation in
membrane recruitment systems occurring in under 10 seconds and dissociation within 5
minutes after the light stimulus is removed (120), and, like the LOV-based systems, its
compatibility with heterologous expression in mammalian cells without the need for
exogenous cofactor supplementation (146). In addition to the protein stoichiometry issue
posed by all heterodimerization systems, cryptochromes also cluster in response to blue
light, potentially confounding the light-induced dimerization response (27). Further
engineering on Cry2 systems has been reported to improve the tool’s dynamic range
without significantly increasing protein size from the original 60 kDa and 20 kDa for Cry2
and CIB, respectively, as well as the creation of photocycle-tuned mutants for
customizable association and dissociation timescales (233).

1.2.3.6 Phytochrome/PIF
Like the Cry2 system, the phytochrome optogenetic system also utilizes a natural
light-induced photoreceptor binding interaction for subcellular recruitment of POIs.
Phytochromes are plant photoreceptors from Arabidopsis thaliana which link
environmental light input to physiological outputs including germination and flowering
(105). Phytochrome B (PhyB, 108 kDa) exhibits light-dependent binding to phytochromeinteracting factor 6 (PIF6, 12 kDa) (196). Unlike LOV and cryptochromes, which are
sensitive to one wavelength range of light for activation and rely on thermal reversion for
return to the dark state, Phy/PIF pairs are bistable and exhibit conformational changes in
response to two light colors: red (activation and onset of binding) and far-red
(inactivation and dissolution of binding) (205). This difference in light response is due to
16

the phytochrome cofactor; unlike LOV and cryptochromes, phytochromes bind bilin, a
linear tetrapyrrole. In response to red light (λ = 680 nm), a cis-trans isomerization event
occurs, resulting in a conformational change. This new form of the protein can either
thermally revert like LOV and cryptochromes back to its dark-adapted state or absorb
far-red (λ = 720 nm) light and rapidly revert on the seconds timescale (119, 177). In the
context of an optogenetic tool, this dual-state approach is incredibly powerful: by fusing
POIs to PhyB and PIF, protein interactions can be turned on and off with spatiotemporal
precision through the delivery of red or far-red light, respectively (139).
The PhyB optogenetic system has been used to control protein subcellular
localization to induce cytoskeletal rearrangements (139), PI3K, and MAPK signaling
events (238, 240). It has also been applied to the study of intracellular transport by
controlling organelle positioning (3), and in an extracellular setting to cross-link substrate
fibers and alter substrate stiffness (101). The PhyB system’s use of red and far-red light
makes it compatible with blue light-sensitive optogenetic tools, presenting the
opportunity for multiplexed tool use in the same cell without spectral overlap. However, a
downside lies in the system’s use of a bilin cofactor: since cells do not produce
phycocyanobilin (PCB) naturally, exogenous cofactor must either be added to cells prior
to experimentation, or a PCB biosynthetic pathway must be co-expressed with the PhyB
system (169, 244).

1.2.4

Clustering-based
As mentioned earlier, Cry2 exhibits two blue light responses: heterodimerization

with binding partner CIB and oligomerization with itself, particularly in the absence of CIB
(27). This oligomerization occurs rapidly (τon = 30 s), and clusters dissociate within 5
minutes. This clustering phenotype has been used to create optogenetic signaling tools
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in the Wnt/β-catenin and RhoA pathways, the latter of which led to the discovery that
GTPase clustering can result in activation (27) (see section 1.3.2). Later, this
methodology was used to disrupt clathrin-dependent endocytosis and induce actin
polymerization (232).

1.3

Existing optogenetic strategies for GTPase signaling perturbation

1.3.1

Activation by GEF recruitment
Because a major application of heterodimerization-based optogenetic tools is the

control of POI subcellular localization, it is unsurprising that this approach has been
applied to control GTPase signaling, whose activation relies upon membrane recruitment
of GTPases and activating GEFs. The main strategy for optogenetic GEF tool
engineering is to anchor one heterodimerizer to the plasma membrane through
prenylation and to fuse the pathway-activating GEF to the other, resulting in cytosolic,
inactive GEF in the dark state and GEF localized to the membrane in the illuminated
state, where it can activate endogenous GTPase. For RhoA, existing GEF tools include
LARG recruitment using an AsLOV2-derived heterodimerization system (90), PR_GEF
recruitment using TULIPs (254), and ARHGEF11 recruitment using Cry2/CIBN (249).
Notably, the ARHGEF11 system recruited only the DH domain of the GEF,
demonstrating that the PH domain is not necessary when another membrane
association

mechanism

(i.e.,

protein

heterodimerization-based

recruitment)

is

implemented. For Rac1, the DH and PH domains of GEF Tiam1 were used to create
tools using the iLID (81), Magnets (116), and Phy/Pif (139) platforms. For Cdc42,
recruitment tools were engineered using the DH and PH domains of Intersectin1 and
iLID (81), Phy/Pif (139), another phytochrome-derived system (113), and Cry2 (248).
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In addition to demonstration of pathway activation, these GEF-based optogenetic
tools also led to the development of Rho GTPase pathway quantification strategies
including the use of biosensors to quantify activated GTPase before and after
recruitment; the measurement of subcellular structures using actin visualization or
membrane markers; the measurement of changes in cell morphology (centroid position,
area, dimensions) or polarity; and demonstration of downstream pathway activation by
measuring cell migration or effector concentrations using mass spectrometry or pulldown
assays. While GEF recruitment is a well-characterized optogenetic strategy that results
in GTPase activation, all existing systems are heterodimerization-based, which presents
the implementation issues discussed earlier. In addition, recruiting a GEF to the
membrane may result in less robust activation compared with other activation methods
as it is inherently limited by GTPase concentration at the membrane.

1.3.2

Activation by GTPase clustering
As mentioned in section 1.2.4, the light-induced homo-oligomerization of Cry2

can be used to cluster and activate the GTPase RhoA. In this tool, Cry2 was fused to the
wildtype RhoA GTPase. Blue light then induced clustering of Cry2-RhoA, particularly
along the stress fibers of the actin cytoskeleton, leading to cell retraction. This clustering
was reversible, with dissolution occurring within minutes following light stimulus
withdrawal. Pathway activation was also confirmed with an ELISA assay to measure
RhoA-GTP levels following photoactivation as well as by stress fiber visualization and
intensity measurement (27). This engineering strategy was also used to create Cry2Rac1, also using a wildtype GTPase; membrane recruitment of this tool resulted in
lamellipodia formation and cell spreading. While this tool engineering strategy does not
require the stoichiometric tuning or take up two optical channels as discussed with
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heterodimerization systems, clusters can diffuse out of the stimulation region (as
discussed in Chapter 3), resulting in lower spatial precision of pathway activation.

1.3.3

Activation by GTPase recruitment
Evidence that some GTPases translocate from the cytosol to the plasma

membrane when activated or are constitutively localized near the plasma membrane
(162) suggests that membrane recruitment of a GTPase should result in its activation by
endogenous GEFs. Another strategy is to recruit a constitutively active (i.e., GEFindependent) GTPase whose activation does not rely upon endogenous GEFs. This
strategy was first demonstrated with the creation of photoactivatable Rac1 (PA-Rac1)
(261), using an engineered AsLOV2 bound to constitutively active Rac1. In the dark
state, the WAVE binding site of Rac1 was designed to be occluded by AsLOV2 to
prevent dark-state membrane association and downstream signaling activation by PARac1; the blue light-induced conformational change would allow for Rac1 diffusion to the
membrane and pathway activation. Light-induced activation of this tool was confirmed by
observed membrane extension and pharmacological Rac1 pathway inhibitors as
mechanistic controls; a biosensor-measured decrease in RhoA activation, suggesting
that Rac1-RhoA push-pull regulation (176) was indeed occurring as a consequence of
tool-mediated pathway activation. As discussed earlier, this system is associated with
dark-state leakiness and the requirement for stringent pre-experimentation dark
conditions to prevent transient pathway activation (262).
A Cry2-based Cdc42 recruitment system was later reported, with signaling
activation occurring with both wildtype and constitutively active Cdc42 tool variants.
Recruitment of either tool to the yeast membrane resulted in Cdc42-WASp interaction;
the system was used to measure the effects of different spatial signaling organization
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schemes in yeast (133). Tool function was characterized by measuring localizations and
intensities of downstream and interacting proteins, as well as measuring changes in cell
dimensions. This successful use of a wildtype GTPase in a membrane recruitment
system suggests that endogenous GEFs are sufficient to activate recruited GTPase and
that GTPase recruitment tools deserve further exploration and engineering.

1.3.4

Inactivation by GAP recruitment
To fully understand the dynamics of cell signaling, our optogenetic tool suite must

contain signaling termination tools in addition to activation tools. Thus, one strategy of
terminating GTPase signaling with spatiotemporal precision is the creation of
optogenetic GAP recruitment systems to terminate signaling for endogenous GTPases.
This strategy was used successfully in heterotrimeric G protein signaling by recruiting
the regulator of G protein signaling (RGS, a GAP subtype) domain to the membrane
(86). Termination of GPCR signaling was measured by quantifying cellular Ca2+
concentrations using a genetically encoded calcium sensor. Recently, a Cry2-based
system was reported for the recruitment of RhoGAP71E to the inner leaflet. This tool
was used to control actomyosin contractility in Drosophila embryogenesis (96), and tool
function was confirmed by quantifying the amount and distribution of myosin as a result
of downstream signaling, as well as cell morphology metrics like cell area and length.
This initial successful GAP tool report bodes well for future engineering efforts to expand
the repertoire of optogenetic GTPase termination tools.

1.4

Goal of the thesis
Optogenetic tools for perturbing Rho family GTPase signaling enable the study of

crucial cellular phenomena like motility and division, the elucidation of mechanisms
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underlying Rho dysfunction-associated disease, and the dissection of complex biological
pathways in space and time. Current approaches to Rho tool development rely
extensively on the use of heterodimerization pairs, which pose issues in implementation
related to the use of two system components and the requirement of more than one
optical channel to confirm tool expression; or on the use of constitutively active
GTPases, which are often plagued with high dark-state activity and poor resolution.
Additionally, there is a lack of focus on light-controlled signaling termination, a key piece
of the Rho signaling integration puzzle.
The overarching goal of this thesis is to create a Rho-family optogenetic tool
suite using a single-component membrane recruitment system to activate RhoA, Rac1,
and Cdc42 using GTPase and GEF tools, as well as terminate RhoA signaling using a
GAP or dominant negative GTPase tool. To accomplish this goal, I plan to use BcLOV4,
a newly discovered natural fungal photoreceptor which binds directly to membrane lipid
headgroups in response to blue light. Biophysical characterization of this protein is
presented in Chapter 2 and was published in 2018 in the Proceedings of the Natural
Academy of Sciences (69). Using BcLOV4, we engineered GTPase activation tools to
recruit wildtype GTPase and GEF to the membrane for the three major Rho family
GTPases. This work is presented in Chapters 3 and 4 and was published in Advanced
Biology (RhoA, 2021 (16)) and Photochemical and Photobiological Sciences (Rac1,
2020 (17)). Work toward the creation of a RhoA signaling termination tool is presented in
Chapter 5. Finally, to provide a workflow for future membrane pathway optogenetic tool
engineering work, we elucidated some structural principles underpinning BcLOV4-POI
fusion creation and created a plasmid set for facile fusion screening, presented in
Chapter 6 and published in ACS Synthetic Biology (18). Together, the Rho GTPase
toolbox and BcLOV4 characterization reported in this thesis will enable single22

component optogenetic control of important biological circuits and expand the utility of a
new optogenetic membrane recruitment platform.
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CHAPTER TWO: Biophysical characterization of BcLOV4 and CeRGS

This chapter adapts work from the following publication:
Glantz, S. T.; Berlew, E. E.; Jaber, Z.; Schuster, B. S.; Gardner, K. H.; Chow, B. Y.,
Directly light-regulated binding of RGS-LOV photoreceptors to anionic membrane
phospholipids. Proceedings of the National Academy of Sciences 2018, 115 (33),
E7720-E7727.

Author contributions: STG, EEB, ZJ, BSS, KHG, and BYC designed research; STG and
EEB conducted all experiments; KHG and BYC coordinated all research; ZJ conducted
in vitro experiments and bioinformatics; BSS conducted yeast and confocal imaging
experiments; STG, EEB, Z.J., BSS, KHG, and BYC analyzed data; and STG, EEB, ZJ,
BSS, KHG, and BYC wrote the paper.

2.1

Introduction

2.1.1

LOV proteins
LOV (light-oxygen-voltage-sensitive) protein domains play key roles in the ability

of organisms to sense and respond to light and have served as starting points for the
engineering of new optogenetic tools to perturb cellular physiology. LOVs are members
of the Per-aryl hydrocarbon receptor nuclear translocator (ARNT)-Sim (PAS) superfamily
of proteins and allow organisms in multiple kingdoms of life to sense blue light (45, 97,
127, 147, 277). Structurally, LOV proteins consist of a PAS fold made of a five-stranded
antiparallel β sheet and several α helices. The core of the protein contains a
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hydrophobic binding pocket which binds a flavin cofactor, either flavin mononucleotide
(FMN) or flavin adenine dinucleotide (FAD). This binding pocket contains a conserved
sequence GX(N/D)C(R/H)(F/I)L(Q/A), whose cysteine residue allows the LOV domain to
undergo a light-induced conformational change resulting in signal transmission (71).
In photoreceptor proteins, LOV domains are paired with effectors of a range of
functions, placing effector activity under light control. In the dark state, the flavin cofactor
is non-covalently bound to the LOV protein and fully oxidized, with an absorption peak at
450 nm with vibronic structure at 425 and 475 nm (277, 278). Blue light absorption by
the cofactor triggers the reversible formation of a covalent adduct between flavin and the
catalytic cysteine residue of the LOV hydrophobic core, diminishing blue light
absorbance and increasing UV absorbance at 390 nm. This photoadduct formation also
results in conformational change of the protein, which transmits light input to a change in
the biochemical activity of the paired effector (45, 60, 89, 97). Examples of LOVmediated phenomena include circadian rhythms (103), virulence (228), phototropism
(142), and stress responses (9).
In an engineering context, the modularity of LOV photoreceptors presents an
opportunity to develop new gain-of-function tools by customizing the LOV-paired effector
for light-inducible protein activity (165). Some examples of the utility of LOV proteins in
optogenetics include bacterial LOV EL222, which was adapted to control cellular
transcription (167); and photoswitchable AsLOV2 from Avena sativa, which has been
applied to manipulate Rho-family GTPase signaling (225, 261). Uncovering new LOVeffector pairs allows for greater insight into light-sensing mechanisms in living organisms
and for the development of new optogenetic tools.
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2.1.2

The RGS-LOV protein class
The structural and mechanistic diversity of LOV-effector pairs presents a great

opportunity to identify novel signal transmission mechanisms and new platforms for
optogenetic tool engineering. One method by which to identify new LOV-effector
combinations is through bioinformatic analysis of publicly available genomic sequence
data. A 2016 analysis cataloged over 6700 LOV domains with over 100 combinatorial
sensor-effector arrangements (69). Among the sensor-effector pairs identified were
regulator of G-protein signaling (RGS)-LOV proteins. RGS proteins function as the fast
terminators of heterotrimeric G-protein coupled receptor (GPCR) signaling, acting as the
GTPase accelerating proteins (GAPs) for membrane-localized Gα protein partners (19,
98, 247). The existence of RGS-LOV proteins had previously been predicted by others
(60, 61, 127, 216, 273), and some experimental evidence had been reported: genetic
deletion of RGS-LOV proteins did not result in pronounced changes in phenotype or
physiology (273), and RGS-LOV gene transcription was not regulated by light (217).
Thus, experimental characterization of RGS-LOV light response in cells was required to
confirm photosensory activity of the predicted LOV domain and establish its signal
transduction mechanism.
Conserved domain analyses and secondary structure prediction (61, 127, 216,
273) of the 66 identified RGS-LOV proteins showed a low-complexity region and RGS
domain located N-terminal to a single LOV domain, followed by a C-terminal domain of
unknown function (DUF), connected to the LOV by a Jα-helical linker and an
amphipathic helix (Figure 2.1). The Jα-helix linker and amphipathic helix have been
identified as mediators of signal transmission in other LOV proteins (88, 89, 163). Initial
screening experiments focused on five putative RGS-LOV proteins chosen for their short
length (for ease of cell transfection and transduction) and/or previous research by others
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into their hypothesized roles in the cell. Of these screened candidates, BcLOV4 from
noble rot fungus Botrytis cinerea could be expressed and purified in the highest yield
from E. coli and was subsequently used for further analysis.

Figure 2.1

Bioinformatics annotation of RGS-LOV proteins

a. Secondary-structure conservation across 66 candidate RGS-LOV-DUF proteins, where height
represents information content at a given position, in bits. Grayscale, bit score in fifths. b.
Consensus secondary-structure prediction and domain architecture of BcLOV4, from JPred,
phyre2, PSIPRED, and i-TASSER (secondary structures), IUPRED (disorder), Heliquest
(amphipathic helices), and Pfam hidden Markov models database (domains, HMM = match in
database).

2.1.3

BcLOV4 membrane translocation
Initial mammalian characterization experiments of BcLOV4 with a C-terminal

mCherry visualization tag in HEK293T cells showed an interesting phenomenon. We
observed that BcLOV4 was localized to the cytosol in its dark-adapted state and rapidly
and reversibly localized to the plasma membrane in response to blue light stimulation.
Membrane association and undocking kinetics measured by live-cell imaging were fast,
with τon = 1.11 s and τoff = 89.1 s, suggesting high affinity between BcLOV4 and its
membrane target (69) (Figure 2.2). This phenomenon was not limited to HEK cells and
has since been observed in HeLa, CHO, NIH 3T3, endothelial colony-forming cells,
neurons, yeast, and zebrafish cells. It was also observed when the mCherry tag was
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replaced with a 3xFLAG C-terminal peptide and protein was visualized by
immunostaining.

Figure 2.2

Light-activated membrane localization of BcLOV4 in HEK cells

a. Spinning-disk confocal fluorescence micrographs of BcLOV4 show it is cytosolic in the dark
and translocates to the plasma membrane in blue light. Cells were fixed with paraformaldehyde in
the dark or under blue light, and stained with Alexa Fluor 488-conjugated anti-3×FLAG antibody.
Scale = 10 μm. b. Example single cell for quantitative membrane localization analysis. pmGFP,
isoprenylated GFP marker. Line section for (c). Scale = 10 μm. c. Line section profiles of pmGFP
and BcLOV4-mCherry from cell in (b). Association, during 5-s illumination. d. Same as (c) for
dissociation (dissociation, dark after 5-s illumination). e. Population analysis of translocation
kinetics. Time constants were statistically determined by correlation analysis between the
membrane marker and BcLOV4 line section profiles, for similarity (τon = 1.11 s; 95% CI, 1.05–
1.18 s). N = 30 cells, (*) p < 0.05, (**) p < 0.01. f. Same as (e), for membrane dissociation. Time
constants were also statistically determined by correlation analysis, for dissimilarity (τ off = 89.1 s;
95% CI, 83.0–96.3 s).

Our hypothesis for why BcLOV4 bound the membrane in its lit state was that
BcLOV4 was interacting directly with membrane lipids via a polybasic amphipathic helix
(residues 403-416) fused to the signal-transmitting Jα helix. The helix’s high
concentration of positively charged amino acid residues (sequence TSFFKSFKKYK)
could bind the high concentration of negatively charged lipid head groups of the plasma
membrane via an electrostatic interaction. Implicating this helix in BcLOV4 membrane
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binding involved characterization of BcLOV4’s in vitro responses to light and its
interactions with membrane-like surfaces of controlled charge composition.

2.1.4

Problem statement
Light-inducible plasma membrane binding has not previously been reported in

natural LOV proteins, though engineered LOV-lipid binding was achieved using AsLOV2
and polybasic domains (91, 149). The novelty of this mechanism led us to attempt to
understand protein biophysics underlying protein-membrane association and determine
which protein substructure interacted with lipid in the lit state. Beyond the photobiological
insight this biophysical characterization could provide, there is also great bioengineering
potential. Inducible membrane translocation is an attractive property in optogenetic tool
development; several tool platforms exist using heterodimerization pairs to recruit
proteins of interest to the plasma membrane. Understanding the biophysical basis of
BcLOV4’s light induced lipid binding may enable us to use its natural light response to
engineer a new class of single-component optogenetic tools.

2.2

Results and discussion

2.2.1

BcLOV4 protein purification
Characterization of the biophysical properties of BcLOV4 requires the ability to

grow and purify high-yield recombinant protein from bacteria. Early purification efforts
demonstrated that BcLOV4 protein production is non-trivial; to maximize yield and
prevent protein from crashing out of solution, high salt concentration and glycerol must
be present from cell pellet lysis through elution of pure protein. We also found that a
second protein species is present in significant yield in the overexpression lysate, ~10
kDa shorter in length than BcLOV4, likely the result of a N-terminal truncation event.
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These observations led to the development of an expression and purification regimen for
BcLOV4 to maximize the yield of full-length protein from bacterial overexpression.
Full expression and purification conditions can be found in section 2.4.2. Briefly,
BL21(DE3) competent cells expressing His6-BcLOV4 were grown to mid-log phase and
protein expression was induced with IPTG. Temperature was reduced form 37°C to 18
°C and cells were grown for ~18 hours at 250 r.p.m. Cells were pelleted, frozen at -20 °C
for at least one hour, resuspended in high-salt lysis buffer, and lysed via sonication.
Clarified lysate was prepared for FPLC purification by pelleting the insoluble fraction
from the sonication mixture. Both wash and elution buffers contained high (0.5 M) NaCl
and 10% glycerol. Equilibration and wash steps were performed in 20 mM imidazole.
Clarified lysate was loaded onto a 5 mL Ni-NTA column and washed for 15 column
volumes. A gradient elution was then performed over 15 column volumes from 20-200
mM imidazole to elute the 10-kDa-truncated protein. Imidazole concentration was then
raised stepwise to 500 mM, and full-length protein was collected in 2.0 mL fractions.
Purified flavoprotein concentration was calculated using absorbance at 450 nm and the
FMN extinction coefficient (εFMN450 = 12,500 M-1 cm-1) and buffer-exchanged into
phosphate-buffered saline (PBS) for further characterization.

2.2.2

Cofactor identification
Bioinformatics analysis predicts that BcLOV4 contains a LOV domain, meaning it

would presumably bind flavin mononucleotide (FMN). Purified BcLOV4 had an optical
absorbance peak at λmax = 450 nm with triplet-peak fine structure indicative of a FMN
cofactor. To confirm that BcLOV4 binds FMN, we purified BcLOV4 and extracted its
cofactor by boiling it in 70% ethanol to precipitate the protein out of solution. The
extracted cofactor was then analyzed using thin-layer chromatography (TLC) against
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standard solutions of flavin family cofactors FMN, flavine adenine dinucleotide (FAD),
and riboflavin. The BcLOV4 cofactor had an Rf value of 0.26 (70, Figure S2), which
matched the Rf value for the FMN standard as well as the published FMN Rf value (41).
Thus, the LOV domain of BcLOV4 binds FMN.

2.2.3

BcLOV4 responses to blue light
In mammalian cells, we observed that BcLOV4 translocates from the cytosol to

the membrane in response to blue light stimulation. We sought to understand this
phenomenon by characterizing BcLOV4’s in vitro response to blue light. First, the time
constants associated with flavin adduct formation in BcLOV4 were measured using UVvis spectroscopy and exponential fitting. The triplet structure of the BcLOV4 spectrum
disappeared within one second of blue light stimulation; thermal reversion kinetics were
also rapid, with τoff = 18.5 s (Figure 2.3a-b). It should be noted that acquisition of stable
photocycle measurements for BcLOV4 required in vitro stabilization by high salinity in
the protein buffer (0.5-1.0 M NaCl), with or without 10% glycerol, or the use of solidphase supports like magnetic Ni-NTA beads to bind BcLOV4’s N-terminal His6 tag. In the
absence of these supports, such as in PBS, BcLOV4 quickly aggregated following blue
light exposure, forming a turbid solution. Dynamic light scattering (DLS) supported this
reversible observed light-induced change in solution particle size, indicating that
indicated that these protein aggregates were ~1 µm in diameter, compared to ~10 nm
diameter dark-adapted protein. In the presence of stabilizing salt and glycerol, no
significant change in particle size was observed by DLS in response to blue light (Figure
2.3c).
Mutating the cysteine residue (C292A) in the LOV domain of BcLOV4 canonically
responsible for forming the flavin photoadduct (42) resulted in loss of photocycling, with
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protein spectra resembling those of dark-adapted BcLOV4 even in the presence of blue
light. Similar to other LOV proteins, the C258I mutation (45) in BcLOV4 resulted in a
much longer in vitro tau off (586.5 sec), demonstrating that the thermal reversion of
BcLOV4 following blue light exposure is kinetically tunable.

Figure 2.3

Photochemical competence of purified BcLOV4

a. Representative flavin photocycling of BcLOV4 stabilized by 1 M NaCl and 10% glycerol to
prevent photoinduced aggregation, measured by absorbance spectroscopy. Illumination, 15
mW/cm2; λ = 455 nm. Time indicates post-illumination recovery period. b. Recovery kinetics
monitored at λ = 450-nm absorbance (A450). Black, exponential fit. Gray, mean ± SD (N = 3). c.
In vitro aggregation of BcLOV4 in direct response to blue light. The C292A mutant is unable to
form a covalent cysteinyl-flavin photoadduct and is thus photochemically inactive. Illuminated
samples become turbid but can be stabilized by high-salinity and/or molecular crowding agents.
Illumination, 15 mW/cm2; λ = 455 nm. Particle size by DLS (mean ± SD).

2.2.4

BcLOV4 size estimation
SDS-PAGE and anti-His6 Western blotting confirmed that gradient followed by

step elution during FPLC purification resulted in only full-length BcLOV4 protein
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(predicted molecular weight 67 kDa) in collected fractions (Figure 2.4a-b). To determine
the oligomeric state of BcLOV4, size-exclusion chromatography with multi-angle light
scattering (SEC-MALS) was performed on purified His6-BcLOV4 (Figure 2.4c). The
resulting spectra showed a large peak at 170 kDa, suggesting that BcLOV4 is a
dimer/trimer mixture in its dark-adapted state.

Figure 2.4

Size estimation of purified BcLOV4

a. BcLOV4 purity analysis by SDS-PAGE denaturing gel (left: Mark12 ladder, right: protein). The
protein runs fast with respect to the Mark12 ladder. b. Molecular weight characterization by
Western blot of His6-BcLOV4 (left: Magic Mark ladder, right: protein). Calculated molecular
weight = 67 kDa including tag (left: Magic Mark XP ladder, right: protein). c. SEC-MALS analysis
of FPLC-purified His6-tagged BcLOV4 is a dark-adapted oligomer (dimer/trimer mixture).

2.2.5

Characterization of protein-lipid interaction
To understand the mechanism of BcLOV4’s light-induced membrane binding,

protein-lipid overlay assays were first conducted to determine the specificity of BcLOV4’s
lipid binding. Initial screening with commercially available lipid strips showed that
BcLOV4 bound anionic but not zwitterionic head groups. However, these strips present
only immobilized lipid head groups rather than realistic membrane surfaces. To test for
protein-lipid interaction with a more membrane-like target, we created droplets of waterin-oil emulsions to emulate the cytosol and plasma membrane inner leaflet and observed
the localization pattern of BcLOV4 in response to blue light stimulation. Droplets
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consisted of BcLOV4-mCherry in PBS in the dispersed/aqueous phase and phospholipid
monolayers composed of zwitterionic phosphatidylcholine (PC, net charge 0) mixed with
anionic phospholipids of varying concentration and headgroup charge density (Figure
2.5a).
We observed that in droplets containing 20% phosphatidylserine (PS, net charge
-1), illuminated BcLOV4 was primarily localized to the phospholipid interface. This
droplet composition mimics the mammalian cell inner leaflet, in which patches of anionic
lipid head groups give the membrane a negative charge (121). In contrast, illuminated
BcLOV4 droplets with 100% PC membranes aggregated in the aqueous phase, similar
to the turbidity imaging of purified, lipid-free BcLOV4 following blue light exposure
(Figure 2.5b-c). These results suggested that BcLOV4’s light-induced membrane
binding is the result of electrostatic interactions between the positively charged
amphipathic helix and negatively charged membrane lipid head groups. Bolstering this
electrostatic hypothesis is the observation that both protein aggregation and protein-lipid
association diminished as salinity increased and Na+ and Cl- ions could interact with
charged system components.
The photochemically inactive C292A mutant of BcLOV4 did not localize to the
lipid monolayer in response to blue light stimulation, while the constitutively active
Q355N mutant (63, 72, 173) persistently localizes to the lipid interface even prior to blue
light stimulation when anionic phospholipids were present (Figure 2.5d). These results
confirm that the LOV domain, rather than some unknown blue light-induced mechanism,
mediates BcLOV4 lipid binding. Dissociation constants for BcLOV4 binding to
immobilized liposomal bilayers were next measured by surface plasmon resonance
(SPR). The measurements were made with the photochemically inactive C292A and
constitutively active Q355N mutants since controlled illumination within the instrument
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was not possible. BcLOV4-mCherry variants were used for SPR assays both to maintain
consistency with droplet assays, and for improved solubility and protein yield. The
BcLOV4 constitutively active mutant affinity for 20% PS liposomal bilayers was KdQ355N =
130 nM, or > 20-fold enhanced versus the photochemically inactive mutant KdC292A = 3.2
μM (Figure 2.5d-e). Thus, consistent with biophysical inferences from cellular kinetics,
BcLOV4 indeed possesses a high-affinity light-switched interaction with anionic
phospholipids. Binding increased with total anionic content (with PS), but there were
minimal differences between phospholipids of different headgroup charge density under
conditions of matching total charge (Figure 2.5f-g). Thus, BcLOV4 membrane binding is
charge dependent but nonspecific to headgroup identity, unlike the well-established
preference of pleckstrin homology (PH) domains for certain phosphatidylinositol
phosphates (PIPs) (114) or similar lactadherin-C2 domain-specificity for PS’s lipid
binding (268).

2.2.6

BcLOV4 truncations and mutations

2.2.6.1 Amphipathic helix mutant
Having

identified

the

light-switched

interaction

partner

as

an

anionic

phospholipid, we next sought to determine the protein binding site and focused on the
polybasic amphipathic helix in the linker region that is largely conserved among the
fungal homologs (AH1) (Figure 2.6a). In BcLOV4, this helix possesses a conserved
“FKK” motif (residues 412–414) found in membrane-interacting amphipathic helices of
Bcl-2–associated death promoter (BAD) (93), kinase suppressor of RAS (KSR) (6), and
cecropin anti-microbial peptides (211), and a “FFK” sequence (residues 408–410) found
at the membrane interface of the M2 proton channel of influenza A [Protein Data Bank
ID code 2rlf]. In such motifs, aromatic side chains putatively insert into the phospholipid
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bilayer, while the proximal lysine side chains electrostatically bind anionic lipids enriched
in the inner leaflet without great headgroup specificity (54) (Figure 2.6b).

Figure 2.5

In vitro binding of BcLOV4 to anionic membrane lipids

a. Schematic of BcLOV4 in lipid-stabilized w/o emulsions. b. Fluorescence micrographs of wildtype BcLOV4 fused to mCherry. Translocation to the inner leaflet-like interface is observed with
increasing anionic PS content, but not with purely zwitterionic PC interfaces. Scale = 25 μm. c.
Phospholipid interface binding curves, calculated as the membrane interface:dispersed phase
ratio (normalized) of BcLOV4 in the light and dark. N = 20-75 droplets; error, std err. d.
Constitutively active BcLOV4 Q355N structurally mimics the photoactivated signaling state, is
localized to the interface in the dark, and retains its preference for net anionic phospholipids over
zwitterionic ones. The photochemically inactive C292A mutant cannot form a covalent cysteinylflavin photoadduct and remains in the aqueous dispersed phase even upon illumination. Scale =
25 μm. e. Affinity measures by SPR to 80% PC/20% PS mixed liposomal bilayers. The interaction
with constitutively active BcLOV4 is high affinity (KdQ355N = 130 ± 75 nM) and > 20-fold enhanced
over the photochemically inactive mutant (KdC292A = 3.2 ± 1.2 μM). (i) The 0–20 μM range, with fit
only for constitutively active mutant for clarity, and (ii) 0–2 μM range. N = 2-7; mean ± SEM. f.
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SPR measures of constitutively active mutant binding to mixed PC/PS liposomes of varying total
anionic charge density. N = 3; mean ± SD. g. SPR binding assessments of constitutively active
mutant to lipids of different headgroup charge density, in liposomes of matching total anionic
charge density of 20% (N = 3; mean ± SD). (f) and (g): CL, cardiolipin; PC, phosphatidylcholine;
PIP2, phosphatidylinositol-(4,5)-biphosphate; PIP3, phosphatidylinositol-(3,4,5)-triphosphate; PS,
phosphatidylserine.

Figure 2.6

Structure-function determinants of BcLOV4-lipid interaction

a. Sequence logo of amphipathic helix (AH1) conserved among 66 RGS-LOV homologs (top) and
the specific sequence for BcLOV4, which includes known lipid binding motifs (underlined)
(bottom). b. Schematized membrane insertion mechanism of the AH1, where hydrophobic
residues embed into the hydrophobic bilayer and basic residues electrostatically bind anionic
phospholipids. c. SPR-determined affinity of AH1 mutant for 20% PS bilayers, with hydrophobic
residues mutated to alanine, is reduced ∼10-fold from wild-type BcLOV4. SPR data are of
constitutively active Q355N mutant (N = 2; mean ± SD). d. Phospholipid interface binding curves,
calculated as the membrane interface/dispersed phase ratio (normalized) of the AH1 mutant (no
Q355N) when dark-adapted or illuminated with blue light in w/o emulsions, normalized to wildtype saturation level under illumination (N = 20-200 droplets; mean ± SEM). Dotted fits for
perspective derived from Fig. 2.5. e. Representative fluorescence micrographs showing that the
AH1 mutant primarily remains in the aqueous dispersed phase upon illumination. Scale = 25 μm.

Thus, candidate phenylalanine and tyrosine residues within this region were
mutated to alanines. The BcLOV4-AH1 mutant (amphipathic helix mutant) photocycled
similarly to wild-type protein. In SPR assays, the BcLOV4-AH1 constitutively active
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mutant showed a 10-fold reduction in affinity, KdAH1-Q355N = 1.4 μM, for 20% PS liposomal
bilayers (Figure 2.6c), providing evidence that light-induced exposure of the specific
lipid-binding motifs drives membrane association. BcLOV4-AH1 also showed reduced
binding to anionic phospholipids in droplets of w/o emulsions, and largely remained in
the aqueous compartment/dispersed phase when illuminated with blue light (Figure
2.6d-e). The downward shift in the droplet-based phospholipid interface binding curves
of the AH1 mutant from wild-type levels confirmed the direct lipid-binding roles of the
aromatic side chains in the FKK and FFK motifs.

2.2.6.2 N-terminal truncations
In vitro truncation analyses were performed to establish the relative contributions
of the N-terminal and C-terminal domains in signal transmission from the LOV blue light
sensor to the lipid-binding regions (Figure 2.7a). mCherry-fused RGS-truncated
BcLOV4∆1–240, or “LOV-DUF,” aggregated in the absence of lipids in the dark (particle
size 32 ± 43 nm by DLS) and exhibited an upward shift in the phospholipid interface
binding curve versus full-length protein, both as photochemically inactive mutants.
Deletion of the unstructured N-terminus alone, BcLOV4∆1–96, had no such effects
(Figure 2.7b). These data suggest that, first, the RGS domain serves an inhibitory role
when dark-adapted and, second, that the LOV-DUF alone is sufficient for membrane
association.

2.2.6.3 C-terminal truncations
Removing the C-terminus of BcLOV4 proved more difficult. Several truncation
locations were attempted, all of which resulted in low yields of misfolded flavoprotein
with a spectral peak at 420 nm rather than the classical LOV λmax at 450 nm and fine
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triplet structure. Since attempts at purifying genetically encoded C-terminal truncations
were unsuccessful, we next attempted to truncate folded, purified full-length protein. A
factor Xa cleavage site (112) was inserted via site directed mutagenesis between the
LOV and DUF domains of BcLOV4 (residues 420-423, V420I, I422G) and protein
(BcLOV4-IEGR) was expressed, purified, and characterized to verify that the mutation
did not affect the normal properties of BcLOV4. Protein was treated with
ethylenediamine tetraacetic acid (EDTA) to chelate any nickel eluted from the FPLC
column during protein purification, then buffer-exchanged into a lower-salt buffer (50 mM
sodium phosphate, 300 mM sodium chloride) without glycerol so as not to interfere with
the catalytic activity of Factor Xa. BcLOV4-IEGR was then bound to magnetic nickel
beads and treated with Factor Xa to cleave off the C-terminus, leaving the N-terminus
stabilized by solid-phase beads to prevent misfolding.
We next wanted to determine whether C-terminally truncated protein was able to
photocycle. Since the magnetic nickel beads are incompatible with measuring
absorbance, the on-bead fluorescence photocycle was then measured. In response to
blue light, LOV fluorescence initially dropped for the cleaved protein, followed by a
“runaway” fluorescence trace which continued to increase over several minutes (Figure
2.7c). This increase in fluorescence in response to blue light resembled the aggregation
response of full-length BcLOV4 in PBS following blue light exposure, suggesting protein
instability following removal of the C-terminus. Following the photocycle assay, truncated
protein was eluted from the beads with concentrated urea and fragment sizes were
analyzed via SDS-PAGE. Multiple bands were present at the expected molecular weight
of the truncated protein, which indicated that Factor Xa cleavage was non-specific and
incomplete. While no soluble C-terminal truncations of purified BcLOV4 could be
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stabilized, these results suggest that the C-terminus of BcLOV4 plays a role in the
stability of protein folding and flavin incorporation.
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Figure 2.7

BcLOV4 truncation characterization

a. Truncations created to probe domain contributions to light-switched membrane association.
HMM, existing hidden Markov model. b. Phospholipid interface binding curves, calculated as the
membrane interface/dispersed phase ratio (normalized) of BcLOV4, N-terminally truncated
protein, and RGS-truncated LOV-DUF, in w/o emulsions and in the absence of illumination.
Increased binding by deletion of the RGS suggests that the RGS domain inhibits the membrane
interaction in the absence of illumination. Normalized to wild-type saturation level under
illumination. N = 30-125 droplets; mean ± SEM. c. Recovery kinetics monitored by flavin
fluorescence of cleaved and un-cleaved BcLOV4-IEGR bound to magnetic anti-His beads.
Illumination, 15 mW/cm2; λ = 455 nm, 30 seconds prior to monitoring. Fluorescence is normalized
to pre-illumination measurement.

2.2.7

CeRGS characterization
To determine whether the light-induced lipid binding properties observed for

BcLOV4 were generalizable to the larger RGS-LOV class of proteins, we next performed
biophysical and mammalian characterization assays on CeRGS, a homolog from the
black yeast Cyphellophora europaea (GenBank accession number ETN36999.1). His6tagged CeRGS was purified using the same protocol as BcLOV4. SDS-PAGE showed a
molecular weight of ~70 kDa, consistent with the predicted protein size (Figure 2.8a).
Purified protein was yellow in color and UV-vis spectroscopy showed the characteristic
flavin triplet peak centered at 447 nm, confirming cofactor incorporation (Figure 2.8b). In
vitro photocycle was measured by recording the protein’s absorbance at 450 nm before
and after a 5-second pulse of blue light. Exponential fit gave a τoff value of 139.2 ± 19.0
s, much longer than the measured in vitro τoff for BcLOV4 of 18.5 s (Figure 2.8c). This
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longer observed thermal reversion timescale for purified CeRGS even in the absence of
a lipid binding partner suggests structural differences between CeRGS and BcLOV4
resulting in different photocycle kinetics. Dynamic light scattering in dark-adapted and
blue light-illuminated states were similar to those observed for BcLOV4: in phosphatebuffered saline, mean particle size for CeRGS in its dark state was 11.8 ± 1.1 nm, which
increased to 658 ± 11 nm under blue light. No appreciable increase in protein size was
observed when the assay was conducted in 1 M NaCl (Figure 2.8d).

Figure 2.8

Characterization of CeRGS in vitro and in mammalian cells
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CeRGS recapitulates the in vitro photo-aggregation and light-dependent membrane localization
observed with BcLOV4, confirming the generality of the phenomenon amongst RGS-LOV
proteins. a. SDS-PAGE denaturing gel of purified CeRGS (left: Mark 12 ladder, right: protein). b.
UV-Vis spectrum. c. Recovery kinetics of protein stabilized by 1M NaCl and 10% glycerol to
prevent photo-induced aggregation, monitored at λ = 450 nm absorbance (A450). Black =
Exponential fit. Gray = Mean ± SD (N = 3). d. Dynamic light scattering data with and without
electrostatic stabilization. Illuminated = Immediately after 5 second illumination (15 mW/cm 2, λ =
455 nm) (N = 2-3). e. Spinning disk confocal images of HEK cells expressing 3xFLAG-tagged
CeRGS, probed with Anti-FLAG M2 monoclonal antibody and stained with Anti-mouse IgG Alexa
Fluor 488 conjugated secondary antibody. Scale bar = 10 µm. Images are from separate fixed
samples.

CeRGS-3xFLAG was expressed in HEK293T cells, which were fixed in the darkadapted state, under blue light illumination, and ten minutes after light stimulation.
Protein was visualized by anti-FLAG immunostaining with Alexa Fluor 488-conjugated
secondary antibodies (Figure 2.8e). Similar to BcLOV4, we observed that CeRGS is
largely localized to the cytosol in its dark-adapted state, with a small population of cells
showing both cytosolic and nuclear protein localization. Under blue light, the protein is
membrane-localized, with normal cytosolic expression reappearing following a dark
recovery period. This protein localization pattern combined with biophysical data
suggests that light-induced lipid binding is not just a feature of BcLOV4 but perhaps a
shared feature among RGS-LOV family proteins.

2.3 Conclusions and future directions
The biophysical characterization of BcLOV4-lipid interaction, in combination with
data from mammalian cells, suggest a photosensory signal transmission mode by
BcLOV4 (and potentially the larger RGS-LOV class) of rapidly blue light-inducible, and
reversible, membrane association mediated by electrostatic interactions with anionic
phospholipids. While other membrane-binding proteins contain PAS domain sensors
(94, 164) related to LOV domains, such as PhoQ, Aer, and LuxQ (39, 175), these are
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ligand-regulated transmembrane proteins unlike the cytoplasmic RGS-LOV reported
here. De novo secondary-structure and Rosetta (206) structural predictions suggest that
the DUF in this region may adopt a PAS-like fold with antiparallel β-sheets (69), and thus
it is possible that the LOV–DUF interaction is an evolutionarily conserved PAS/PAS
interaction as observed in other systems. It should be noted that other lipid interaction
sites may exist beyond the critical amphipathic helix between the LOV and DUF
domains. A future high-resolution structure of the lipid-bound state will greatly inform the
proposed biophysical model, as well as conclusively determine whether the DUF is
indeed a PAS domain.
In an applied context, BcLOV4 also contributes a useful single-component
optogenetic system with rapid translocation kinetics for photoinducible membrane
localization that is compatible in yeast and mammalian expression systems. Unlike the
indirect membrane binding of optogenetic tools that rely on heterodimerization between
cytosolic and membrane-bound partners (85, 237), BcLOV4 as a single-component
system is insensitive to heterogeneity in relative expression level tuning of two
components and is more facile in transgene delivery. As a future direction, finite element
modeling will provide a better understanding of the parameters governing BcLOV4
aggregation and translocation.
In summary, biophysical characterization of BcLOV4 and CeRGS demonstrates
a signal transmission mechanism of RGS-LOV proteins, linking photosensory cues to
changes in protein localization through lipid binding. BcLOV4’s light-inducible protein
translocation is an attractive candidate for a new optogenetic platform, allowing the user
to fuse protein cargo to BcLOV4 and recruit it to the signaling hub of the plasma
membrane in response to spatiotemporally precise blue light inputs.
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2.4

Materials and methods

2.4.1

Genetic constructs
Gene fragments encoding BcLOV4 (GenBank ID CCD53251.1) and CeRGS

(GenBank ID ETN36999.1) were ordered from Integrated DNA Technologies (IDT) as
gBlocks® and assembled by Gibson cloning or PCR assembly. Transgenes were cloned
by restriction digest into a pET21/28-derived BamUK bacterial expression vector (a kind
gift from Dr. Ranganath Parthasarathy) with the high copy pUC origin of replication,
kanamycin resistance, a T7/lacO promoter, and a multiple cloning site for in-frame fusion
to an N-terminal His6 tag. C-terminal mCherry fusions in BamUK were generated by
Gibson cloning and feature a short, flexible (GGGS)2 linker. Truncation variants were
generated by PCR from the full-length template and subcloned into the mCherry-BamUK
vector. All constructs were transformed into competent E. coli (New England Biolabs,
C2984H).
Mutants were generated by laboratory methods based on QuickChange kits.
Overlapping forward and reverse primers encoding the mutation of interest were
designed with a melting temperature ≥ 78 ºC. The designed mutation was introduced
over 18 cycles of PCR with the high-fidelity Phusion polymerase (New England Biolabs,
M0531S), and template plasmid was digested with DpnI for 1 hour at 37 ºC prior to
transformation into competent E. coli (New England Biolabs, C2984H).
For mammalian expression, CeRGS was cloned into the pcDNA3.1 mammalian
expression vector under the CMV promoter (Invitrogen) with a C-terminal 3xFLAG tag.

2.4.2

Protein purification
Bacterial expression plasmids were transformed into BL21(DE3) E. coli cells by

mixing 10 ng of purified plasmid DNA into 10 µL of chemically competent cells (New
45

England Biolabs, C2527H), incubating at 4 ºC for 30 minutes, heat-shocking cells in a 42
ºC water bath for 30 seconds, placing heat shocked cells on ice for 2 minutes, and then
incubating for 1 hour at 37 ºC in 100 µL S.O.C. media. Transformed cells were grown on
Luria Broth (LB) plates with 50 µg/mL kanamycin overnight at 37 ºC, and single colonies
were picked and grown overnight to saturation in LB media with 50 µg/mL kanamycin.
Cultures for protein production were initiated by diluting saturated overnight cultures
1:200 into fresh LB-kanamycin media in 1-2 L baffled flasks, and subsequently grown at
37 ºC with 250 r.p.m. shaking to a mid-log phase of OD600 = 0.5-0.8. Protein production
was induced with 0.5 mM isopropyl-beta-D-thiogalactopyranoside (IPTG), and cells were
grown for 18-22 hours at 18 ºC with 250 r.p.m. shaking in a refrigerated incubator. Cells
were then harvested in 250 mL centrifuge bottles by spinning at 3000 x g for 20 minutes,
and subsequently frozen at -20 ºC for < 2 weeks prior to cell lysis and purification.
Frozen cells were thawed at room temperature for 5-10 minutes and then
resuspended in 50 mL ice-cold lysis buffer (50 mM sodium phosphate, 500 mM NaCl,
0.5% Triton-X-100, pH 6.5) per liter of harvested cell culture. All subsequent steps were
carried out on ice or in a 4 ºC cold room. Re-suspended cells were homogenized with 3
passes through a 21-gauge syringe needle. 10 mL aliquots of lysate were each
sonicated 5 times with a duty cycle of 15 seconds ON, 30 seconds OFF with a Fisher
Scientific Series 60 Sonic Dismembranator at 100% power (60W). Individual aliquots
were pooled and transferred to a 50 mL polycarbonate conical tube and clarified by
centrifugation at 25,000 x g for 30 minutes at 4 ºC to remove insoluble fractions. The
supernatant was decanted and kept at 4 ºC prior to further purification.
His6-tagged proteins were affinity-purified by fast protein liquid chromatogphy
(FPLC, AKTA Basic) on Ni-NTA (GE HisTrap FF) columns. All exposed samplecontaining FPLC segments were covered with aluminum foil to maintain darkness. After
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sample loading onto a 5 mL column at 1mL/min, the column was washed with 20 mM
imidazole in buffer (50 mM sodium phosphate, 500 mM NaCl, 10% glycerol, pH 6.5) for
15 column volumes, followed by a linear gradient, from 20 to 200 mM imidazole, over 15
column volumes at 5 mL/minute. Proteins were eluted with 500 mL imidazole and
collected in 10 x 2 mL fractions. Samples were pooled based on purity assessed by
SDS-PAGE and concentration assessed by absorbance spectroscopy (A280), and then
buffer exchanged into 1x PBS using PD-10 desalting columns with Sephadex G-25 resin
(GE, 17085101). Buffer exchanged material was centrifuged at 4 ºC at 25,000 x g for 30
minutes to pellet insoluble protein debris. Buffer exchange was repeated twice more,
and the column was re-equilibrated with 1x PBS prior to each usage. Purified protein
was stored for < 2 weeks at 4 ºC.

2.4.3

Thin-layer chromatography
Cofactor identification was performed according to standard flavoprotein cofactor

protocol (41). Protein (10 nmol) was boiled in 70% ethanol for 2 minutes, chilled on ice
for 2 minutes, and then centrifuged at 16,000 x g for 10 minutes. Standards were
dissolved in water at 1 μM (all from Millipore-Sigma; FMN, F6750; FAD, F6625;
Riboflavin, R4500). Thin-layer chromatography was performed on glass silica gel plates
(Millipore-Sigma, Z292974) using standard methods with n-butanol : acetic acid : water
(3:1:1 v:v). Plates were dried and imaged on a UV transilluminator. Rf values: BcLOV4
cofactor (0.26), FMN (0.26), FAD (0.14), Riboflavin (0.61).

2.4.4

UV-vis spectroscopy
Absorbance

scans

were

measured

on

an

Ocean

Optics

USB2000+

spectrophotometer with a deuterium/halogen light source. Full spectrum (λ = 250-700
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nm range) absorbance scans were measured in quartz cuvettes (Starna Cells, 16.100FQ-10/Z15). Photocycle kinetics were measured by monitoring the absorbance at 450 nm
(A450). After baseline measurements were made for 15 seconds at room temperature,
the samples were stimulated with blue-light (10 s, λ = 455 nm, 15 mW/cm2) delivered by
a collimated LED (Mightex), and then dark-state recovery was monitored every 0.5
seconds for an additional 2 minutes.
To make solid-phase fluorescence-based photocycling measurements, 40 ng of
His6-tagged protein was mixed with 0.5 mg of magnetic Ni-NTA beads (ThermoFisher
HIsPur Ni-NTA resin, 88221) in a total reaction volume of 400 µL in 1x PBS and nutated
at room temperature for 1 hour. After three x 5-minute-long washes with PBS + 20 mM
imidazole, protein-bound bead samples were re-suspended in 200 µL of 1x PBS.
Fluorescence scans were measured on a Tecan Infinite M200 plate reader and kinetics
were measured by monitoring the fluorescence (excitation 450 nm, emission 505 nm) for
200 µL of protein-bound beads in a 96-well plate. After baseline measurements were
made for 15 seconds at room temperature, the samples were stimulated with blue-light
(10 s, λ = 455 nm, 15 mW/cm2) delivered by a collimated LED (Mightex), and then
thermal reversion in the dark was monitored continuously for an additional 2 minutes.

2.4.5

Dynamic light scattering
Particle size analysis was performed using a Zetasizer Nano Series (Malvern

Instruments, λ = 633 nm) for 5 μM protein in 1x PBS buffer. Three 10 s-long scans were
averaged. After establishing baseline values in the dark, samples were illuminated by a
collimated LED (Mightex, 5 s, λ = 455 nm, 15 mW/cm2), and then returned to the dark
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DLS chamber for post-illumination measurements for up to 60 minutes. Macroscale
turbidity images were taken with a Canon G12 camera.

2.4.6

SDS-PAGE and Western blot
Protein samples in 1x NuPAGE® lithium dodecyl sulfate (LDS) sample buffer

(ThermoFisher Scientific, NP0007) were heated to 70 ºC for 10 minutes and loaded on
4-12% Bis-Tris NuPAGE® SDS-PAGE gels, along with Mark12 unstained standard
(ThermoFisher Scientific, LC5677). Gels were run in 1x MOPS running buffer for 45
minutes at 200 V. Gels were visualized by staining with InstantBlue Coomassie stain
(Expedeon, ISB1L) and imaging on a digital scanner. For Western blotting, proteins were
run with MagicMark XP Western Protein Standard (ThermoFisher Scientific, LC5602),
transferred to PVDF membranes (ThermoFisher Scientific, LC2005) at 30 V for 1 hour in
1x NuPAGE® transfer buffer (ThermoFisher Scientific, NP0006), probed with mouse
monoclonal antibodies to the antigen of interest, and then probed with IRDye 680RD
Goat anti-Mouse IgG (Li-Cor Biosciences, 925-68070). Western blots were imaged on
an Odyssey CLx Infrared Imaging System (Li-Cor Biosciences, Model 9140).

2.4.7

Size-Exclusion Chromatography with Multi-Angle Light Scattering (SEC-MALS)
FPLC-purified BcLOV4 was buffer-exchanged into a SEC-MALS-compatible

buffer (50 mM sodium phosphate, 500 mM sodium chloride) using PD-10 desalting
columns with Sephadex G-25 resin (GE, 17085101). The protein was analyzed by SECMALS using an in-line HPLC (Agilent Technologies 1200), and MALS system (Wyatt
DAWN HELEOS II and OPTILAB T-rEX). SEC-purified protein was loaded onto a
Superdex 75 agarose and dextran-based column (GE) in 50 mM sodium phosphate and
500 mM sodium chloride. A 100 μL sample of BcLOV4 at 0.4 mg/mL was injected at a
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flowrate of 0.5 mL/min, over a total 53-minute-long profile. Data was collected and
analyzed using Astra chromatography software (Wyatt).

2.4.8

Protein-lipid overlay assay
Phospholipids at 3 mM in 1:1 chloroform:methanol (with 0.1% HCl) were spotted

(1 µL) onto 0.2 µm pore size nitrocellulose blotting membranes (ThermoFisher Scientific,
LC2000). After drying for 1 hour at room temperature, blots were either stored at 4 ºC, or
blocked for 1-4 hours in PBS containing 3% BSA (no detergent). 0.5 μM of His6-tagged
BcLOV4 variants were then added to PBS / 3% BSA (GST-tagged positive control at
23.6 nM) and this solution was incubated with a BSA-blocked, lipid-spotted nitrocellulose
membrane for 1 hour at room temperature. Membranes were washed 4 times with PBST (PBS + 0.1% Tween20) and then probed with mouse anti-His primary antibody at
1:2000 dilution (Cell Signaling Technology, 2366) in PBS + 3% BSA for either 1 hour at
room temperature or overnight at 4 °C. After an additional 4 washes with PBS-T,
membranes were probed with IRDye 680RD Goat (polyclonal) Anti-Mouse IgG (Licor
Biosciences, 925-68070) at 1:15000 dilution in PBS-T + 3% BSA for 1 hour at room
temperature. Blots were washed an additional 4 times in PBS-T and then in 1x PBS.
Blots were imaged on an Odyssey Infrared Imaging System in the λ = 700 nm channel at
Intensity 5.

2.4.9

Water-in-oil emulsion assay (protocells)
Lipids (see section 2.4.10) were resuspended in chloroform in a glass test tube

or round-bottom flask. Chloroform was evaporated under a stream of nitrogen and the
remaining lipid film was dissolved into decane (Aldrich, D901) at 2.5-25 mg/mL, based
on the solubility of each individual phospholipid. To facilitate suspension in decane and
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to remove excess chloroform, solutions were heated at 50 ºC for 3 hours and sonicated
in a water bath for 30 minutes. Lipids were stored in glass vials with Teflon caps
(Thomas Scientific, 1234R80) at -20 ºC. In experiments, 30 µL of 20 mM lipids (total
molarity) was mixed vigorously with 1.28 µL of purified mCherry-tagged protein in PBS
by pipetting up and down until a cloudy suspension formed. 20 µL of the water-oil
emulsion was transferred to microwells and imaged at 20×.
Automated MATLAB scripts were used to identify droplets, segment either just
the outer ring interface or the aqueous dispersed phase and to calculate integrated
fluorescence intensity and area over these regions. The ratio of membrane inner leafletemulating interface fluorescence intensity per unit area to cytoplasm-emulating
dispersed phase fluorescence intensity per unit area was considered a measure of
membrane-binding and normalized to the max ratio for illuminated wildtype protein. More
detail on this protocol can be found in Appendix 1 (67).

2.4.10 Surface plasmon resonance
SPR measurements were performed using a Biacore T200 (GE Healthcare)
instrument at 25 °C. Small unilamellar vesicles (SUV) were generated by initially
hydrating 1.5 mM phospholipids (phosphatidylcholine, Aldrich, P3556 and Avanti,
840051C;

18:1

(∆9-Cis)

phosphatidylcholine

(DOPC),

Avanti,

850375;

phosphatidylserine, Aldrich, P7769 and Avanti, 840032C; 18:1 phosphatidylserine
(DOPS), Avanti, 840035; phosphatidylglycerol, Aldrich, P8318; phosphatidic acid,
Aldrich, P9511; cardiolipin, Aldrich, C0563; PIP2, Cell Signals, #902; PIP3, Cell Signals,
#908) of a given composition in HBS-N buffer (25 mM HEPES, 150 mM NaCl, pH 7.4),
then sonication followed by 8 freeze/thaw cycles in a dry ice/ethanol bath, and finally 15
passes through an Avanti Lipid extruder with a 0.05 µm membrane. SUVs were
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immobilized by flowing them over the surface of a carboxymethylated dextran chip with
covalently attached lipophilic groups (Sensor chip L1) at 2 µL/min for 30 minutes.
Typically, 4000-10000 RU (resonance units) of liposomes were immobilized. His6BcLOV4-mCherry variants were buffer exchanged three times into HBS-N and passed
over the chip surface at a flow rate of 30 µL/min for 10 minutes. The chip was
regenerated after each binding experiment by the injection of 100 mM NaOH at 50
µL/min for 1 minute. SUV coated chips were used for a maximum of ~12 hours before
they were stripped with 40 mM octyl-B-glucoside and 0.5% SDS and re-coated. Steadystate equilibrium binding values were fit and analyzed with the curve fitting toolbox in
MATLAB.

2.4.11 On-bead cleavage assay
Factor Xa cut sites were introduced to the C-terminus of BcLOV4 by site-directed
mutagenesis and His6-tagged protein was purified as described in 2.4.2. Purified protein
was treated with EDTA for a final concentration of 5 mM prior to buffer exchange to
remove any nickel eluted from the FPLC column. Protein was buffer exchanged to
remove imidazole (50 mM sodium phosphate, 500 mM NaCl, 10% glycerol, pH 6.5
buffer) via a PD-10 column. HisPur™ Ni-NTA magnetic beads (200 µL) were added to a
1.5 mL tube and w mL wash buffer (50 mM sodium phosphate, 500 mM NaCl, 20 mM
imidazole, 10% glycerol, pH 6.5 buffer) was added. Beads were vortexed gently for 10
seconds, then collected to the side of the tube with a magnetic rack as wash was
aspirated off. This process was repeated for a total of three washes.
Protein was diluted with wash buffer to a final concentration of 1 mL and added
to the washed beads. Protein and beads were vortexed to mix, then incubated at room
temperature on a rotating tube rack for 30 minutes. Following binding, beads were
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separated from solution and supernatant was aspirated and saved. Beads were washed
as above with wash buffer for a total of four washes, then washed three times with lowsalt buffer (1 mL, 50 mM sodium phosphate, 300 mM sodium chloride). Washes were
collected and saved. Following the final wash, Factor Xa (12 µL, 1 mg/mL stock, New
England Biolabs, P9010) was added, then the solution was vortexed and incubated
wrapped in foil to prevent light exposure on a rocking table overnight.
Following incubation, Factor Xa flowthrough was collected, and beads were
washed three times with wash buffer. On-bead fluorescence photocycle was measured
as described in section 2.4.4. For SDS-PAGE and Western blot analysis, protein was
eluted in two 150 µL fractions (50 mM sodium phosphate, 500 mM sodium chloride, 10%
glycerol, 500 mM imidazole, pH 6.5), incubating for 15 minutes with rocking per elution.

2.4.12 Cell culture and transient transfection
HEK293T (ATCC, CRL-3216) cells were cultured in D10 media composed of
Dulbecco’s

Modified

Eagle

Medium

with

Glutamax

(Invitrogen,

10566016),

supplemented with 10% heat-inactivated fetal bovine serum (FBS) and penicillinstreptomycin at 100 U/mL. Cells were maintained in a 5% CO2 water-jacketed incubator
(Thermo/Forma, 3110) at 37°C. Cells were seeded onto poly-D-lysine-treated glass
bottom dishes (MatTek, P35GC-1.5-14-C) or into 24-well glass bottom plates (Cellvis,
P24-1.5H-N), treated in-house with type I collagen, at 15-20% confluency. Cells were
transfected at ~30-40% confluency 24 hours later using the TransIT-293 transfection
reagent (Mirus Bio, MIR2700) according to manufacturer instructions and Opti-MEM™
reduced serum media (Thermo Fisher, 3195062). Cells were fixed and imaged 24-48 h
post-transfection.
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2.4.13 Fluorescence microscopy and hardware
Fluorescence microscopy was performed on an automated Leica DMI6000B
fluorescence microscope under Leica MetaMorph control, with a sCMOS camera
(pco.edge), an LED illuminator (Lumencor Spectra-X), and a 63× oil immersion objective
(for fixed HEK cells) or a 20× air objective (for protocells imaging). Excitation illumination
was filtered at the LED source (mCherry imaging λ = 575/25 nm; Alexa Fluor 488
imaging or widefield BcLOV4 stimulation λ = 470/24 nm). Fluorescent proteins were
imaged with Chroma filters: mCherry (T585lpxr dichroic, ET630/75 nm emission filter,
0.2-0.5 s exposure), GFP (T495lpxr dichroic, ET 525/50 nm emission filter, 0.2 s
exposure)

2.4.14 Cell fixation and immunostaining
Cells were fixed in 4% paraformaldehyde in 1x PBS for 15 minutes at room
temperature. Dark-adapted cells were fixed under a dim red light, while illuminated cells
were irradiated with strobed illumination (λ = 455 nm, at ≥ 15 mW/cm 2, 5 seconds ON /
25 seconds OFF duty cycle) from a collimated LED (Mightex) for 30 seconds prior to and
throughout the fixation. For immunocytochemistry analysis of 3xFLAG-tagged protein,
cells were seeded and grown on poly-D-lysine treated #1.5 cover glass (Cellvis, P241.5H-N), washed three times with 1x PBS + 0.1M glycine, and then blocked with 1%
BSA (Thermo Fisher Blocker BSA 37525), 2% normal goat serum and 0.4% saponin in
1x PBS for 30 minutes at room temperature. Blocked cells were incubated overnight at 4
ºC with mouse Alexa Fluor 488-conjugated anti-3xFLAG monoclonal antibody (Cell
Signaling Technology, 5407) at 1:250 dilution in blocking buffer, or with anti-3xFLAG
antibody (Cell Signaling Technology, 8146) followed by an Alexa Fluor-488 conjugated
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secondary antibody (Cell Signaling Technology, 4408). Cells were washed three times
with 1x PBS prior to imaging.
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CHAPTER THREE: Optogenetic tools for induction of cell contractility

This chapter adapts work from the following publication:
Berlew, E. E.; Kuznetsov, I. A.; Yamada, K.; Bugaj, L. J.; Boerckel, J. D.; Chow, B. Y.,
Single-Component Optogenetic Tools for Inducible RhoA GTPase Signaling. Adv Biol
(Weinh) 2021, e2100810.

Author contributions: EEB designed genetic constructs, designed all experiments, and
conducted all experiments. IAK created the patterned illumination system and assisted
with the automated data analysis pipeline development. KY assisted with genetic
construct design, engineering, and assays. BYC, JDB, and LJB coordinated all research.
All authors contributed to experiment design, data analysis, and manuscript preparation.

3.1

Introduction

3.1.1

The RhoA signaling pathway
The RhoA signaling pathway centrally regulates cellular actin organization and

contractility,

playing

key

regulatory

roles

in

cell

migration,

developmental

morphogenesis, and cell cycle maintenance (49, 58). RhoA signaling coordinates
cytoskeletal stress fiber formation that determines how cells transmit mechanical forces
within the cell, across cell-cell junctions, and to the extracellular matrix (ECM) (43);
consequently, activation and inactivation of the RhoA GTPase by GEFs and GAPs,
respectively, is tightly controlled in space and time (Figure 3.1). New tools for inducible
control over RhoA activity may greatly enhance understanding of cytoskeletal dynamics
and mechanotransduction (55, 156).
56

Figure 3.1

The RhoA signaling pathway

RhoA signaling is regulated by guanine nucleotide exchange factors (GEFs), GTPase
accelerating proteins (GAPs), and guanosine nucleotide dissociation inhibitors (GDIs). RhoA
activation at the membrane induces actin polymerization, contributing to diverse cell processes
including mechanotransduction via nuclear recruitment of transcriptional co-activator Yesassociated protein (YAP).

At the plasma membrane, wildtype RhoA is activated by GEFs and subsequently
activates Rho-associated kinase (ROCK), a serine-threonine kinase. ROCK regulates
both cell contractility and actin filament density. Following activation by RhoA, ROCK
phosphorylates myosin light chain (MLC) and simultaneously phosphorylates and
inhibits myosin light chain phosphatase (MLCP). Both these activities increase the
ATPase activity of myosin II and promote contraction of the cell. Activated ROCK can
also phosphorylate LIM kinase (LIMK), which in turn phosphorylates cofilin to stabilize
actin filaments, resulting in a denser actin network (241). Thus, activation of RhoA at the
plasma membrane and interaction with downstream ROCK has profound consequences
for cell motility and morphology.
RhoA-ROCK signaling also drives essential nervous system functions including
neuritogenesis, neuron migration, and polarization. In the leading edge of a neurite
growth cone, RhoA is activated by membrane receptor signals to regulate the duration of
the developing neuron’s growth and pause phases (56), likely by promoting the
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condensation of actin filaments into an arc which acts as a barrier for microtubule
forward projection. In addition, RhoA has been implicated in neurodegenerative diseases
and injuries to the central nervous system: elevated levels of active RhoA have been
found in injuries to the spinal cord and optic nerve as well as in stroke lesions (62),
underscoring the clinical importance of understanding RhoA signaling.
RhoA

also

plays

a

role

in

mechanotransduction,

converting

external

environmental cues to a change in cytoskeletal tension and transcriptional regulation. In
response to an increase in ECM stiffness, RhoA signaling increases cytoskeletal
tension, driving transcriptional co-activator Yes-associated protein (YAP) from the
cytosol to the nucleus (55, 172). YAP, lacking a DNA binding motif, binds TEAD family
transcription factors to alter gene expression (140, 141). This conversion of mechanical
input to transcriptional activity is crucial in regulating liver (269) and heart (264)
organogenesis and regeneration. The centrality of RhoA signaling to cellular programs of
growth and migration as well as its roles in the development of multiple organ systems
make it an important target for cell signaling interrogation and manipulation.

3.1.2

Existing tools for RhoA signaling perturbation
The

main

strategies

for

controlling

RhoA

signaling

are

the

use

of

pharmacological pathway activators and inhibitors, the introduction of genetic gain-offunction or loss-of-function mutations, the mechanical manipulation of the cytoskeleton,
and the use of optogenetic tools. Drug mechanisms of RhoA signaling inhibition include
sterically occluding the GEF-interacting interface on RhoA GTPase molecules as in
Rhosin (219, 220), or by impeding downstream interactions with RhoA pathway effectors
as in Y-27632, a small-molecule inhibitor of ROCK signaling (246). Activation of RhoA
signaling can be achieved by treatment with soluble serum components like
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lysophosphatidic acid (199) and calpeptin (215). These pharmacological strategies lack
spatial precision; the addition of activators or inhibitors to cell culture media is not
compatible with subcellular or even sub-regional targeting of plated cells. In addition, the
timescale of drug uptake and washout is incompatible with temporally precise pathway
control and has been shown to be too slow to be compatible with cellular differentiation
between sustained and pulsatile input (28, 194), a critical need for GTPase signaling
dynamics experiments.
RhoA signaling can also be perturbed through genetic mutations or gene
knockout. Point mutations to the wildtype RhoA GTPase result in loss or gain of function.
The G17V mutation, first identified in T cell lymphoma, results in loss of catalytic
GTPase activity, while the dominant negative T19N mutation exhibits RhoA
downregulation (66). RhoA can also be locked in its active GTP-bound state by a G14V
mutation, which results in increased stress fiber formation and reduced cytokinesis
(166). RhoA knockout has also been achieved in a fibroblast tumor model (4),
decreasing cell motility and tumor growth. As with pharmacological inhibition, these
genetic manipulations lack the spatiotemporal precision necessary to probe RhoA
signaling at the subcellular level or to activate RhoA at physiologically relevant
timescales. Mechanical approaches focus on altering the cell’s microenvironment to
induce cytoskeletal and signaling changes, often through the alteration of stiffness of
cross-linked substrates (22, 83, 135). These techniques present the advantage of
increased temporal precision over pharmacological and genetic techniques for the study
of processes like wound healing, but lack the spatial resolution afforded by optogenetic
systems (239).
Because small GTPases and their associated GEFs signal at the plasma
membrane (10), optogenetic membrane localization techniques are effective for
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inducible activation of GTPase signaling: cytosol-sequestered effector proteins are
inactive prior to light exposure which dynamically recruits them to the cytosol-facing
inner leaflet of the plasma membrane to upregulate effector signaling (87). For Rhofamily GTPase signaling, most optogenetic activation tools are two-component
heterodimerization systems between a photosensory protein and a binding partner, one
of which is membrane-anchored, usually by prenylation. Cryptochrome (110, 126, 249)
(Cry2) or light-oxygen-voltage (34, 90, 181, 254) (LOV)-derived systems have been used
to recruit the catalytic DHPH domains of RhoA-selective GEFs to the plasma membrane
for RhoA signaling activation and increased cytoskeletal tension. Heterodimerization
systems require careful tuning of binding partner stoichiometry and the use of two
fluorescent channels for imaging in addition to stimulatory blue light, decreasing the
optical bandwidth available for other desired visualizations (201). Chemically induced
dimerization (CID) approaches have also been reported, but inducer molecule
rapamycin has been found to directly regulate RhoA (73, 76, 107). Finally, a Cry2-based
system directly controls the GTPase itself through light-induced clustering of RhoA and
increasing the binding avidity for activating membrane GEFs, though cytosolic diffusion
of clustered protein decreases the system’s spatial resolution (27).

3.1.3

Problem statement
Tools capable of inducing spatiotemporally precise, robust RhoA activation in the

cell would enable the study of important cell processes like migration and cytokinesis
and give insight into how cells translate environmental cues into physiological behaviors.
Progress in tool development for RhoA induction shows that optogenetic approaches are
currently the best-suited technologies for this problem, but with room for improvement:
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most existing technologies require two protein components and focus on GEF
recruitment rather than controlling the GTPase itself.
BcLOV4’s direct lipid binding presents a promising opportunity to create singlecomponent membrane recruitment tools without the need for a second protein and the
associated stoichiometric tuning and genetic payload. We hypothesized that BcLOV4
could be used as a platform to activate RhoA contractile signaling at the plasma
membrane (Figure 3.2). By engineering tools to activate signaling at both the GTPase
and the GEF level, we aim to create a toolbox for shaping cytoskeletal dynamics with
light, investigating key questions in mechanobiology, and dissecting activation nodes in
RhoA signaling.

3.2

Results and discussion

3.2.1

Design and screening of opto-RhoA and opto-RhoGEF
We conducted initial screening studies in HEK293T cells due to their high protein

expression level and simple culturing requirements. For construction of opto-RhoA, we
followed the workflow described in Chapter 6 (18). Briefly, six arrangements of wildtype
RhoA, BcLOV4, and an mCherry tag for protein visualization were cloned into the
pcDNA3.1 backbone, with a flexible (GGGS)2 linker separating each protein pair (Figure
3.3). These constructs were transiently transfected into HEK293T cells and visualized 24
hours later to identify domain arrangements with uniform high cytosolic expression in the
dark state and intact blue light-induced translocation to the plasma membrane. BcLOV4RhoA-mCherry expressed preferentially in the nucleus with minimal membrane
association. Cells expressing mCherry-BcLOV4-RhoA appeared rounded and unhealthy,
suggesting cytotoxicity. Both RhoA-mCherry-BcLOV4 and mCherry-RhoA-BcLOV4 were
membrane-localized prior to blue light exposure. Both BcLOV4-mCherry-RhoA and
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RhoA-BcLOV4-mCherry exhibited cytosolic expression; the latter was designated “optoRhoA” based on its higher expression and the similarity of its membrane:cytosol
fluorescence ratio before and after blue light exposure to BcLOV4-mCherry.

Figure 3.2

Schematic of opto-RhoA and opto-RhoGEF tool function

Schematized induction of cytoskeletal changes and contractile signaling in response to (a) optoRhoA and (b) opto-RhoGEF activation by BcLOV4-mediated membrane translocation.

In choosing RhoA-activating GEF proteins for fusion tool development, we
focused on identifying GEFs previously used in optogenetic membrane recruitment
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systems to induce cell contraction, demonstrating that membrane recruitment of the GEF
was sufficient for RhoA signaling activation, with an eye toward GEFs that were smaller
in size to preserve membrane translocation efficiency and lower the genetic payload of
the system. We screened three candidates: ARHGEF11 (42 kDa), previously used in a
cryptochrome fusion tool (249); ARHGEF1 (29 kDa), which was used in a rapamycin
activation system to activate RhoA (90); and ARHGEF12 (26 kDa), which caused
formation of actin stress fibers in a TULIP tool (254). These GEFs were fused to
BcLOV4 and mCherry following the cloning procedure developed for RhoA. Screening of
domain arrangements with full-length ARHGEF11 did not result in suitable tool
constructs; while three domain arrangements expressed in the cytosol, light-induced
membrane association either did not occur or did not result in cell contraction. For further
study, we truncated the GEF genes to remove the pleckstrin homology (PH) domain, a
membrane lipid-binding region made redundant by BcLOV4’s amphipathic helix.
Screening of ARHGEF12 fusions yielded no functional tool constructs, with
membrane association failing to induce cell contraction. For ARHGEF1, both BcLOV4ARHGEF1DH-mCherry and BcLOV4-mCherry-ARHGEF1DH expressed highly and
induced modest cell contraction upon blue light stimulation. Because ARHGEF11’s
successful fusion induced much more rapid and pronounced cell contraction, we
proceeded with this GEF for tool development and characterization.
We screened ARHGEF11DH fusions with BcLOV4 and mCherry in HEK293T
cells and observed similar pre-illumination membrane binding of ARHGEF11DHmCherry-BcLOV4 and mCherry-ARHGEF11DH-BcLOV4 as we observed for the
analogous RhoA fusions. This phenomenon will be discussed in detail in Chapter 6.
ARHGEF11DH-BcLOV4-mCherry’s expression was non-uniform, with large bright spots
of protein in the lysosome. The remaining three constructs all exhibited uniform cytosolic
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expression; BcLOV4-ARHGEF11DH-mCherry was designated as “opto-RhoGEF” based
on its robust membrane localization upon blue light stimulation (Figure 3.4).

3.2.2

Membrane translocation kinetics of opto-RhoA and opto-RhoGEF
We measured the kinetics of dynamic membrane association for opto-RhoA and

opto-RhoGEF (Figure 3.5). Briefly, mCherry fluorescence of tool constructs was imaged
before, during, and after a 5-second pulse of blue light. To prevent cell contraction which
would introduce analytical confounds, we treated cells with RhoGEF inhibitor Rhosin and
RhoA-ROCK interaction inhibitor Y-27632 for 24 hours before imaging. Line sections of
the plasma membrane were drawn and Pearson’s correlation between mCherry intensity
along the line section and a GFP membrane marker was measured at each timepoint.
Exponential fits were applied to these association and dissociation measurements for N
= 20 cells per construct and 95% confidence intervals were calculated. For opto-RhoA,
membrane association τon was 1.27 s (95% CI 1.14-1.40 s) and membrane dissociation
τoff was 114.2 s (95% CI 106.6-121.8 s). For opto-RhoGEF, membrane association τon
was 1.13 s (95% CI 1.01-1.26 s) and membrane dissociation τoff was 108.4 s (95% CI
103.4-113.4 s). These values are similar to those measured for effector-less BcLOV4mCherry in HEK cells (τon = 1.15 s, τoff = 89.1 s), in yeast (τon = 1.20 s, τoff = 84.9 s), and
of purified recombinant BcLOV4 with in vitro lipid interfaces (τon ~ 1 s, τoff = 133 s).

64

Figure 3.3

Molecular engineering of opto-RhoA
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a. Domain arrangement combinations of BcLOV4, wildtype (GDP-bound) RhoA GTPase, and
mCherry visualization tag. Domains were separated by flexible (GGGS) 2 linkers. b. Fluorescence
micrographs showing representative expression patterns of the six domain arrangements in the
dark-adapted state in HEK293T cells. Scale = 10 μm. c. Relative expression level of genetic
constructs versus BcLOV4-mCherry control with no effector. N = 25-31 cells per condition. Mean
± SEM. d. Ratio of membrane-localized vs. cytosolic protein for each domain arrangement in the
dark-adapted and blue light-illuminated states, normalized to BcLOV4-mCherry control. N = 25-31
cells per condition. Mean ± SEM. e. Representative membrane localization of opto-RhoA
following blue light stimulation. (Top) Fluorescence micrograph; scale = 10 μm. (Bottom) Line
section pixel intensity.
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Figure 3.4

Molecular engineering of opto-RhoGEF
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a. Domain arrangement combinations of BcLOV4, the DH domain of ARHGEF11, and mCherry
visualization tag. Domains were separated by flexible (GGGS) 2 linkers. b. Fluorescence
micrographs showing representative expression patterns of the six domain arrangements in the
dark-adapted state in HEK293T cells. Scale = 10 μm. c. Relative expression level of genetic
constructs versus BcLOV4-mCherry control with no effector. N = 25-31 cells per condition. Mean
± SEM. d. Ratio of membrane-localized vs. cytosolic protein for each domain arrangement in the
dark-adapted and blue light-illuminated states, normalized to BcLOV4-mCherry control. N = 25-31
cells per condition. Mean ± SEM. e. Representative membrane localization of opto-RhoGEF
following blue light stimulation. (Top) Fluorescence micrograph; scale = 10 μm. (Bottom) Line
section pixel intensity.

3.2.3

Widefield stimulation-induced cell contraction
To our initial surprise, we observed that cells expressing opto-RhoA or

opto-RhoGEF contracted following a single pulse of widefield stimulation; spatially
confined, asymmetrical illumination is not necessary to induce RhoA activation and
observe morphological changes (Figure 3.6). This feature of our RhoA tools differs from
other GTPase and GEF tools (explored fully in Chapter 4), which required repeated
illumination pulses and region-of-interest stimulation to effect cytoskeletal remodeling.
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Figure 3.5
cells

Membrane translocation kinetics of opto-RhoA and opto-RhoGEF in HEK

Time constants were determined by correlation analysis between the membrane marker
(pmGFP) and line section profiles of the mCherry tag. RhoA signaling was pharmacologically
inhibited with Rhosin and Y-27632 to isolate the membrane association/dissociation time
constants attributable to the protein-lipid interaction. a. Membrane association of opto-RhoA: τon =
1.27 s, 95% CI 1.14-1.40 s. b. Membrane association of opto-RhoGEF: τon = 1.13 s; 95% CI,
1.01-1.26 s. c. Membrane dissociation of opto-RhoA: τoff = 114.2 s; 95% CI, 106.6-121.8 s. d.
Membrane dissociation of opto-RhoGEF: τoff = 108.4 s; 95% CI, 103.4-113.4 s. N = 20 cells per
condition. Mean ± SEM. Values are in line with those of effector-less BcLOV4 in HEK and yeast
cells, and of purified recombinant BcLOV4 with in vitro lipid interfaces.

To assess the morphological changes induced by activation of opto-RhoA and optoRhoGEF, we quantified the changes in cell area and cell length along the polarization
axis, the direction of cell centroid displacement, and the stress fiber levels visualized by
phalloidin staining of filamentous F-actin.
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Figure 3.6
stimulation

Optogenetic induction of contractility by a single pulse of unpatterned

Representative images of HEK cells expressing (a) opto-RhoA and (b) opto-RhoGEF, before and
after one 5-second pulse of whole-field blue light stimulation. Visualized by mCherry tag. “Mask
Overlay” shows the initial cell boundary in yellow. Scale = 10 μm.

3.2.3.1 Automated cell morphology analysis
The ability to use unpatterned stimulation to drive RhoA activation and
subsequent morphological changes over a whole field-of-view (FOV) facilitated higher
experimental throughput and statistical powering than if spatially confined stimulation
were required for characterization of optogenetic pathway induction. We also determined
that, for HEK293T cells, the polarization axis aligns with the long axis of the cell (Figure
3.7). We imaged cells co-transfected with miRFP703-tagged LifeAct and a BFP-tagged
nuclear marker and measured the angle between the long-axis of the cell and the vector
connecting the cell centroid and the centroid of the actin arc, the thickest portion of
filamentous actin which is indicative of the leading edge of the cell. In the overwhelming
majority of cells (93 of 108, 86%), this angle was between 0 and 30 degrees, confirming
that the nucleus position along the cell’s long-axis was a viable morphological marker to
define the cell’s leading edge during analysis.
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Figure 3.7

Actin imaging of HEK cell polarization axis

a. The angle α is defined as the angle between the long axis of the cell (when the nucleus is
positioned toward the top) and the line segment connecting the cell centroid to the centroid of the
brightest region of F-actin, imaged by LifeAct-miRFP703. b. The angle was overwhelmingly (in 93
of 108 cells, 86%) between 0 and 30 degrees, confirming nucleus position along the long axis as
a viable morphological marker to define the leading edge during automated analysis. c.
Representative images of HEK293T cells expressing LifeAct-miRFP702 (red) and a nuclear
marker (mTagBFP-nucleus-7, blue). Yellow dotted line = algorithm-identified polarization axis of
the cell. (*) = actin arc. Scale = 10 μm.

For data collection, we imaged mCherry fluorescence of cells transfected with
opto-RhoA, opto-RhoGEF, or BcLOV4-mCherry control at 63× magnification before and
for 10 minutes following a 5-second pulse of blue light stimulation. We manually cropped
these whole-FOV videos into smaller visual fields (10-12 per FOV) focusing on only one
cell, then randomly assigned each video a number so the analyst was blinded to
experimental condition. Cell and nucleus boundaries at initial and final timepoints were
manually drawn, and binary masks of these boundaries were rotated using Python
package imutils to align the cell’s leading edge (defined by the long axis and nuclear
position) with the vertical axis of the image. Python package OpenCV was used to
calculate cell area, length and width dimensions, and centroid position (Figure 3.8a).
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3.2.3.2 Change in stress fiber levels
We quantified changes in cellular stress fiber levels using fluorescent-tagged
phalloidin to stain filamentous actin in control and tool-expressing cells fixed in the dark
and following blue light stimulation (Figure 3.8b). All constructs exhibited similar levels
in dark-state phalloidin intensity (indicating basal stress fiber levels), suggesting little
leakiness in RhoA and GEF signaling from diffusive tool-membrane contact in the darkadapted state, even at the level of protein overexpression supported by HEK cells.
Untransfected and BcLOV4-mCherry-expressing cells exhibited no significant change in
stress fiber levels between dark and illuminated populations. Significant increases in
phalloidin intensity were observed for both opto-RhoA and opto-RhoGEF (p < 0.001, by
Mann-Whitney U test), verifying that optogenetic activation of RhoA signaling results in a
downstream increase in actin polymerization.

3.2.3.3 Change in cell area and length
Optogenetic activation by whole-field stimulation of both opto-RhoA and optoRhoGEF drove extensive morphological changes: most cells rapidly decreased in size in
the ten minutes following blue light stimulation (Mean ± SEM; opto-RhoA, -16.3 ± 1.16%;
opto-RhoGEF, -14.1 ± 1.28%). In contrast, cells expressing BcLOV4-mCherry largely
remained unchanged in size (3.14 ± 1.63%) (Figure 3.8c). We assessed the statistical
significance of the differences between these cell populations using the non-parametric
Mann-Whitney U test uncorrected for multiple comparisons and calculated effect sizes
using the Wilcoxon-Mann-Whitney rank sum test. The activation-induced change in cell
area for both tools was significant and of large effect compared to the BcLOV4 control
(BcLOV4 vs. opto-RhoA, p < 0.0001, effect = 0.692; BcLOV4 vs. opto-RhoGEF, p <
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0.0001, effect = 0.661). No significant difference was measured in the comparison of
opto-RhoA and opto-RhoGEF (p = 0.139, effect = 0.080).
Following alignment of the cell’s polarization axis with the vertical axis of the
image, we measured the differences in cell dimensions, calculated as the length and
width of the minimum-area rectangle bounding the cell. While dimensions of BcLOV4
control cells remained unchanged (Δlength = 0.57 ± 0.77%; Δwidth = 4.79 ± 1.15%), we
observed that tool-expressing cells decreased more in length than in width (opto-RhoA,
Δlength = -14.2 ± 1.05%, Δwidth = -9.60 ± 1.22%; opto-RhoGEF, Δlength = -12.7 ±
0.64%, Δwidth = -7.34 ± 1.13%), suggesting that contraction pattern depended upon the
cell’s underlying polarity (Figure 3.8d). For cell length, we again observed significant
differences between tools and BcLOV4, and no significant difference between optoRhoA and opto-RhoGEF (BcLOV4 vs. opto-RhoA, p < 0.0001, effect = 0.629; BcLOV4
vs. opto-RhoGEF, p < 0.0001, effect = 0.583; opto-RhoA vs. opto-RhoGEF, p = 0.0575,
effect = 0.117).

3.2.3.4 Angle of cell centroid displacement
Following our observation that change in cell length dominated the dimensional
response to optogenetic stimulation, we next examined the movement of the cell
centroid during contraction. We computationally identified the centroid of the binary cell
masks at initial and final timepoints and measured the angle of the vector connecting
them relative to the cell’s polarization axis (Figure 3.8e). Thus, a displacement angle of
0° corresponds to the cell’s trailing edge retracting toward the leading edge; an angle of
180° implies leading edge retraction toward the trailing edge. We tabulated displacement
angles for each condition in bins 30° in width. For BcLOV4, no clear trend in direction of
centroid displacement was observed. For both opto-RhoA and opto-RhoGEF, the cell
73

centroid displacement vector was highly preferential toward the 0-30° bin, meaning that
the cytoskeletal retraction was predominantly at the trailing edge and along the
polarization axis when the whole cell was stimulated (Figure 3.8f). This trend suggests
that the cell’s tensile asymmetry due to its underlying actin organization and polarization
drives

the

morphological

changes

we

observed

when

RhoA

signaling

was

optogenetically activated. This observation is also consistent with the fact that RhoA
signaling complexes are most abundantly active in the cell rear during cytoskeletal
retraction (21, 187, 259).

3.2.3.5 Differences in pathway activation between opto-RhoA and opto-RhoGEF
By all observed measures, GTPase-level signaling activation by opto-RhoA was
consistently but modestly more effective than GEF-level stimulation by opto-RhoGEF.
No differences were observed in initial tensile state or subcellular distribution between
the tools, although opto-RhoA expressed at slightly higher levels (Figure 3.9). Despite
this lack of observable difference, the existence of both tools on the same optogenetic
platform is useful in that it enables the nodal dissection of RhoA activation inputs in the
cell. For simplicity and experimental throughput, our subsequent characterization
focuses on opto-RhoA since it generally induces a more potent cytoskeletal response to
activation (including its ability to separate adherens junctions) and fewer tools exist to
control RhoA directly than for its activating GEFs.
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Figure 3.8
stimulation

Analysis of cell contractility in response to unpatterned wide-field

a. Image analysis workflow. (i) Whole-FOV video cropping (yellow) to contain one cell. (ii) Cell
contour (black) and bounding rectangle (purple) definition from the initial frame in OpenCV
(threshold function and imutils). (iii) Iterative cell rotation (5° increments) and calculation of
associated bounding rectangle. The angle that maximizes rectangle height and positions the
nucleus closer to the top (as a leading-edge marker) is applied to all frames to align the y-axis
with the cell polarity. Iv. Binary mask creation for initial and final timepoints for calculating cell
areas, centroids, and lengths. b. Phalloidin stain intensity in dark-adapted vs. stimulated cells.
Mean ± SEM. N = 40 cells per condition. c. Box-and-whisker plot of cell area change upon wholefield stimulation. d. Box-and-whisker plot of cell length change upon whole-field stimulation. N =
82-93 cells per condition. e. Schematized calculation of angle of cell movement. Centroids of the
initial (red) and final (blue) cell boundaries are calculated in OpenCV (moments function). The
angle of movement between the cell polarization vector (green, dashed) and the centroid
movement vector (red) is designated as β. f. Circumplex charts of the angle of movement relative
to the polarization vector in cells expressing (i) BcLOV4, (ii) opto-RhoA, and (iii) opto-RhoGEF. N
= 82-93 cells per condition. b-d. Mann-Whitney U test: (**) p < 0.01; (***) p < 0.001; (****) p <
0.0001; (n.s.) not significant. c-d. Center line, median; “X”, mean; box limits, upper and lower
quartiles; whiskers, 1.5x interquartile range; points, outliers.
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Figure 3.9
Expression level distribution of opto-RhoA and opto-RhoGEF for
transfected HEK cells
a. Expression level distribution for opto-RhoA-transfected HEK cells. b. Expression level
distribution for opto-RhoGEF-transfected HEK cells. N = 30-31 cells per construct.

3.2.4

DMD stimulation-induced cell contraction
Following characterization of the response of opto-RhoA to widefield blue light

stimulation, we next sought to examine the effects of digital micromirror device (DMD)delivered spatially confined blue light stimulation on tool activation and cell morphology.
We observed that region-of-interest (ROI) illumination induced localized contraction of
the cell and created membrane blebs, presumably from the transient delamination of the
membrane from the actomyosin network (Figure 3.10). We also observed that selective
activation of opto-RhoA at an adherens junction resulted in separation of multiple cell
contacts within a 10-minute timecourse. The stimulation of duty ratio (Φ) of 1.6% (i.e.,
one second of blue light stimulation per minute) was initially chosen to ensure that
optogenetic activity was not photochemically limited by providing one flavin
photochemistry-saturating pulse per BcLOV4 membrane association-dissociation cycle.
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Figure 3.10

Optogenetic induction of contractility by patterned stimulation

a. Epifluorescence micrographs of HEK cells expressing opto-RhoA, visualized by mCherry. i.
Trailing edge contraction in two adjacent cells. ii. Four-cell adherens junction separation. b.
Epifluorescence micrographs of HEK cells expressing opto-RhoA, visualized by mCherry. (i)
Leading edge contraction. (ii) Contraction and reversible bleb formation. White arrow = bleb
location. White box = spatially patterned blue light illumination field, stimulated at 1.6% duty ratio.
Dotted yellow line = cell boundary mask in the dark-adapted state. Scale = 10 μm.

3.2.5

Stimulation angle dependence of opto-RhoA-mediated contraction
Our observations of the direction of cell contraction when opto-RhoA was

activated by wholefield stimulation suggested that the cell’s underlying polarity spatially
determines how the cell contracts. We next wanted to explore the issue of polarity
further by measuring whether the extent of morphological changes depend upon the
orientation of blue light stimulation with respect to the cell polarization axis. With these
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experiments we sought both to gain insight into how RhoA activation intersects with cell
polarity in determining morphological outcomes, and to better understand how userspecified optical stimulation paradigms impacts experimental outcomes.
We defined the stimulation angle as the angle between the cell’s polarity axis and
the vector connecting the centroid of the whole cell to the centroid of the stimulated
region; thus, an angle of 0° implies stimulation of the leading edge, while an angle of
180° implies the trailing edge (Figure 3.11a). For each datapoint, one cell was
stimulated with DMD-guided blue light (Φ = 1.6%) in a ~25 µm square overlaying about
25% of the cell area. We varied the stimulation angle and measured the percent
changes in cell area and cell length as a function of stimulation angle bin (angles
spanning 0-180°, 30° bin width).
We observed that the magnitude of induced morphological changed with
stimulation angle alignment to the polarization axis: stimulation at the leading and trailing
edges led to the largest constrictions, which was again consistent with the organization
of the cell’s original stress fiber network and the endogenous subcellular distribution of
RhoA signaling complexes (Figure 3.11b-d). Statistical differences between bins were
measured using the Mann-Whitney U test. Interestingly, any stimulation angle we tested,
even those orthogonal to the polarization axis, still caused the contraction resulting in
decrease in cell area and length. Thus, while alignment of optical excitation to the
polarization enhances morphological changes induced by RhoA activation, it is not
required to observe dramatic morphological change. These experimentally determined
spatial relationships, between the input of optogenetic RhoA signaling induction and the
downstream output of cytoskeletal contractility, will be useful for guiding experimental
design and data interpretation across optical stimulation paradigms.
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Figure 3.11

Stimulation angle dependence of opto-RhoA driven contraction

a. Schematic of stimulation angle (θ) calculation from the polarization axis, cell centroid, and
centroid of the overlap region of the cell with the patterned stimulation field. b. Exemplar images
of focal contraction of the trailing edge of a HEK cell after 10 minutes of pulsatile patterned
stimulation (1.6% duty ratio). White box = illumination field. Scale = 10 μm. c. Box-and-whisker
plot of change in cell area (relative to initial area) for binned stimulation angles. d. Box-andwhisker plot of change in cell length (relative to initial length) for binned stimulation angles. c-d. N
= 10-35 independent videos per bin. Mann-Whitney U test: (*) p < 0.05; (**) p < 0.01; (***) p <
0.001; (n.s.) not significant. Top row = vs. 0-30° leading edge bin; bottom row = vs. 150-180°
trailing edge bin. Center line, median; “X”, mean; box limits, upper and lower quartiles; whiskers,
1.5x interquartile range.

3.2.6

Characterization of constitutively active opto-RhoA
For nodal dissection of RhoA signaling, opto-RhoA and opto-RhoGEF allow for

GTPase- and GEF-level pathway activation. We next modified opto-RhoA to create a
version in which the RhoA GTPase was constitutively active, or locked in the GTP bound
state, via a G17V mutation. In theory, opto-RhoA-G17V activity is not regulated by GEF
or GAP interaction. We initially hypothesized that, resulting from its lack of reliance on
GEFs for activation, opto-RhoA-G17V would result in more potent cell contraction than
opto-RhoA. In response to whole-field stimulation, however, the area and length
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changes (Figure 3.12a-b) we observed were less pronounced than those generated
with opto-RhoA and opto-RhoGEF (area, -8.79 ± 0.94%; length, -10.6 ± 0.72%), but still
statistically significant compared to BcLOV4 (area, p < 0.0001, effect = 0.570; length, p <
0.0001, effect = 0.629).
Phalloidin stain data of dark-adapted cells expressing opto-RhoA-G17V revealed
a significantly higher stress fiber level compared to BcLOV4 (p < 0.01 by Mann-Whitney
U test) (Figure 3.12c). This increased basal tensile state suggests some leakiness in the
constitutively active tool; its lack of reliance on GEF activation increases the probability
of RhoA signal transduction in the dark by diffusive membrane contact alone. Thus, the
diminished morphological changes observed relative to wildtype opto-RhoA are likely
due to a decreased dynamic range. We observed a similar outcome with constitutively
active Rac1, which will be discussed in Chapter 4. This finding underscores the utility of
wildtype GTPase tool fusions as potent actuators of cell signaling without perturbing
basal cytoskeletal states.

3.2.7

Inhibition of RhoA:RhoGEF interaction and ROCK:RhoA interaction
To confirm the dependence of observed morphological changes on RhoA

signaling, we treated cells with ROCK interaction inhibitor Y-27632. For both opto-RhoA
and opto-RhoGEF, cytoskeletal changes were largely abrogated, demonstrating that
membrane recruitment of both tools induces downstream signaling through RhoA-ROCK
interaction. Contraction was also diminished in cells treated with Rhosin, an inhibitor of
RhoA-activating GEFs including ARHGEF11, the effector in opto-RhoGEF (220).
Rhosin’s inhibition of opto-RhoA-mediated contraction further establishes that optoRhoA is GDP-bound in its cytosolic dark state (Figure 3.13).
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Figure 3.12
mutant

Basal and induced activity of constitutively active opto-RhoA-G17V

Box-and-whisker plots of (a) change in cell area normalized to initial area, and (b) change in cell
length, normalized to initial length, vs. BcLOV4-mCherry control. N = 82-90 cells each. c.
Quantification of basal actin stress fibers in transfected cells in the dark. Mean ± SEM. N = 40
cells per condition. a-c. Mann-Whitney U test: (**) p < 0.01; (****); p < 0.0001; (n.s.) not
significant.

3.2.8

Opto-RhoA-induced YAP nuclear recruitment and mechanotransduction
Having characterized opto-RhoA as a driver of RhoA-ROCK signaling and

cytoskeletal tension, we next explored its role in mechanotransduction. RhoA-controlled
stress fibers relay mechanical cues from the extracellular matrix to the transcriptional coactivator Yes-associated protein (YAP) and its paralog, TAZ. YAP/TAZ nuclear
translocation is followed by their regulation of TEAD-family transcription factors (140,
141), linking an increase in cytoskeletal tension to a change in gene expression (Figure
3.14a). Beyond expanding our optogenetic toolbox to include control of downstream
gene expression, controlling YAP activation with opto-RhoA could also prove useful in
the study of cell migration and tissue development, in which the RhoA-YAP relay is
particularly important (118, 157, 264).
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Figure 3.13

Pharmacological suppression of optogenetic RhoA pathway signaling

a. Inhibition of RhoA-GEF interaction with Rhosin in representative cells expressing (i) BcLOV4
control, (ii) opto-RhoA, (iii) opto-RhoGEF. Mask overlay shows the initial cell boundary (dotted
yellow line). Optogenetic induction of contractility is largely abrogated. b. Inhibition of ROCK
signaling by Y-27632 results in similar suppression. 1.6% stimulation duty ratio. Scale = 10 μm.

We stimulated serum-starved opto-RhoA-expressing cells co-transfected with
EGFP-tagged YAP with widefield blue light (Φ = 1.6%) and monitored YAP localization
over a time course of 10 minutes. We observed an influx of YAP to the nucleus (Figure
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3.14b-c) within ~3 minutes of tool activation, in line with previous work by others
showing that optogenetic activation of ARHGEF11 could drive rapid nuclear import of
YAP within ~5 minutes of increased cytoskeletal tension (249). In contrast,
photoactivation of effector-less BcLOV4-mCherry did not result in a change in nuclear
YAP. Differences in endpoint cytosolic YAP, nuclear YAP, and nuclear:cytosol YAP ratio
between opto-RhoA and BcLOV4 cells were statistically significant (p < 0.0001,
assessed by Mann-Whitney U test) (Figure 3.14d).
Beyond nuclear localization, we next sought to determine whether opto-RhoA
stimulation resulted in a change in transcriptional activity. Using a previously described
luciferase reporter system (55) in serum-starved cells of low initial cytoskeletal tension,
we measured transcriptional activity of a YAP-dependent promoter, 8XGTIIC (Figure
3.14e). For luciferase-only and BcLOV4 controls, no significant difference was observed
between dark and photoactivated cells; for opto-RhoA, photoactivation resulted in a
significant (p < 0.05) increase in YAP-TEAD transcriptional reporter output. Thus, we
demonstrated that opto-RhoA drives an increase in cytoskeletal tension sufficient to
induce YAP nuclear import and alter transcriptional activity, making it a valuable addition
to the recently reported optogenetic YAP toolbox (52, 255).
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Figure 3.14

Opto-RhoA induction of YAP-dependent mechanotransduction

a. Photoactivated opto-RhoA increases cytoskeletal tension to drive YAP nuclear import and
transcriptional co-activation. b. Exemplar images of YAP-GFP nuclear import following blue-light
photoactivation of opto-RhoA and effector-less BcLOV4 control. Scale bar = 10 μm. Arrows
indicate nucleus position. c. Nuclear:cytosolic YAP in response to 1.6% duty ratio stimulation of
opto-RhoA and BcLOV4 control. N = 30 cells each. d. Change in (i) nuclear YAP, (ii) cytosolic
YAP, and (iii) nuclear:cytosolic YAP, normalized to region area. N = 30 cells each. e. Dual
luciferase reporter assay showing increased YAP-coactivated TEAD-dependent transcription
driven by opto-RhoA but not BcLOV4-only control. Luminescence was measured from firefly
luciferase under a YAP-sensitive synthetic promoter (“8xGTIIC”), normalized to co-expressed
Renilla luciferase. N = 8 wells per condition. c-e. Mean ± SEM. Mann-Whitney U test: (*) p < 0.05;
(***) p < 0.001; (****) p < 0.0001; n.s. not significant.

3.2.9

Demonstration of opto-RhoA functionality in CHO, HeLa, and 3T3 cells
We tested opto-RhoA in other cell lines to better understand its potential for use

in cell migration and tissue morphogenesis studies (Figure 3.15). Photoactivation of
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opto-RhoA was sufficient to induce cell contraction in Chinese hamster ovary (CHO),
HeLa and 3T3 (mouse embryonic fibroblast) cells. In CHO and HeLa cells, a 20-40%
reduction in the mass of DNA transfected (versus HEK293T cells) was required to
reduce cytotoxicity. Preliminary studies in endothelial colony-forming cells (ECFCs) have
resulted in significant protein aggregation in the dark-state cytosol and poor cell health,
despite good tolerance of BcLOV4-mCherry expression; further optimization is required
to determine viability in this line.

Figure 3.15

Demonstration of opto-RhoA function in other cell lines

Epifluorescence micrographs of other cell lines expressing opto-RhoA, visualized by mCherry,
before and after a 5-second pulse of blue light stimulation. Dotted yellow line = cell boundary
mask in the dark-adapted state. Scale = 10 μm.

3.3

Conclusions and future directions
Here, we report the engineering of single-component optogenetic RhoA GTPase

and ARHGEF11 to potently drive actomyosin contractility, stress fiber formation, and
rapid activation of transcriptional mechanotransduction. Opto-RhoA demonstrates that
membrane recruitment of a wildtype GTPase is sufficient for pathway activation following
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nucleotide exchange catalyzed by endogenous GEFs. Because the GTPase in optoRhoA lacks a (“CAAX”) prenylation site (24, 65), it is less likely to be activated by the
external stimuli that activate the endogenous cellular RhoA residing at the membrane;
thus, the occlusion of the RhoA C-terminus in opto-RhoA also enhances its orthogonality
to the endogenous GTPase. In addition, opto-RhoA lacks a GDI (guanosine nucleotide
dissociation inhibitor) binding site because of the disrupted prenlyation, which we
hypothesize prevents the overexpressed opto-RhoA from destabilizing the endogenous
pool of Rho-family GTPases by otherwise outcompeting it for regulatory interactions with
the chaperone GDI. These features are useful for leaving the basal cytoskeletal
physiology intact when opto-RhoA is inactive in its dark-adapted state.
Opto-RhoA and opto-RhoGEF exhibit similar membrane association kinetics to
BcLOV4, which are favorable for manipulating cytoskeletal dynamics with high
spatiotemporal precision. Throughout the data herein, opto-RhoA accumulation is
observable in DMD-patterned illumination fields, even well after the induction period is
complete. Such gradual accumulation of activated Rho-family GTPase is also observed
with a heterodimerizing optogenetic Cdc42 created by others (12, 132). However, this
accumulation is not as readily observed in control cells treated with GEF- and ROCK
inhibitors, or in effector-less BcLOV4-mCherry controls, all of which exhibit similar
membrane dissociation kinetics to one another. Together, these photoactivated
distribution profiles and kinetics data suggest that the puncta originate de novo and
persist from interactions amongst activated RhoA/actomyosin signaling complexes (10,
11), as opposed to homo-oligomerization into large photobodies, which is the clustering
mechanism of Cry2-RhoA (27) (Figure 3.16).
In summary, we have created high-performance single-component tools for
optogenetic activation of RhoA GTPase and ARHGEF11 to control cell contractility and
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RhoA-driven transcriptional mechanotransduction. The accompanying characterization
of how cytoskeletal changes depend on spatial patterning of the optical stimulation
informs how tool performance should vary across different experimental setups and
designs, and will also advance the study of diverse cell behaviors by connecting
spatiotemporal patterns of focal RhoA signaling induction to the consequent cell-wide
cytoskeletal responses. These tools demonstrate the versatility of BcLOV4 technology
for single-component optogenetic control over peripheral membrane proteins.

Figure 3.16

Expression of Cry2-RhoA activation by photoinduced clustering

Epifluorescence micrographs of HEK cells expressing Cry2-RhoA, visualized by mCherry. White
box = spatially patterned blue light illumination field, stimulated at 1.6% duty ratio; two fields of
view (i and ii). Scale = 10 μm.

3.4

Materials and methods

3.4.1

Genetic constructs
Domain arrangement combinations of BcLOV4, mCherry, and the RhoA or

ARHGEF11 effector (with a flexible (GGGS)2 linker between each pair) were assembled
into the pcDNA3.1 mammalian expression vector under a CMV promoter by Gibson
cloning with HiFi DNA Assembly Master Mix (New England Biolabs, E2621). BcLOV4
and mCherry were amplified from their previously reported mammalian codon-optimized
fusion (Addgene plasmid 114595) (69). Wildtype RhoA GTPase was amplified from
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CLPIT Cry2PHR-mCherry-RhoA (Addgene plasmid 42959, a kind gift from Dr. Lukasz
Bugaj) without the C-terminal “CAAX” motif to prevent prenylation (27). The DNA
sequence of ARHGEF11 (Genbank ID XP_011508491.1) was human codon-optimized
using the Integrated DNA Technologies (IDT) Codon Optimization Tool and ordered as a
gBlock®. The DH domain of this GEF was identified using the PROSITE ExPASy
database and amplified from the full-length gene. The DH domain of ARHGEF12 was
amplified from PR_GEF (Addgene plasmid 80407). The DH domain of ARHGEF1 was
amplified from pCAG-mCherry-FKBP-GEF (Addgene plasmid 85152). All genetic
constructs were transformed into competent E. coli (New England Biolabs, C2984H). All
sequences were verified by Sanger sequencing.
The RhoA constitutively active G14V mutant was generated by QuikChange sitedirected mutagenesis according to manufacturer’s instructions. Briefly, overlapping
primers encoding the mutation with melting temperatures ≥ 78°C were designed using
Agilent’s

online

primer

design

tool

(https://www.agilent.com/store/primerDesignProgram.jsp). The mutation was introduced
over 18 PCR cycles with 8-minute elongation time using the Phusion® high-fidelity DNA
polymerase master mix (New England Biolabs, M0531). The opto-RhoA template
plasmid was digested with DpnI for one hour at 37°C before transformation into Turbo
competent cells.
The following plasmids were acquired from Addgene:
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Table 3.1: Plasmids acquired from Addgene
Plasmid
pCIBN(deltaNLS)-pmGFP
mTagBFP-Nucleus-7
pLifeAct-miRFP703
pEGFP-C3-hYAP1
8XGTIIC-luciferase

Assay
Membrane localization kinetics
Actin imaging
Actin imaging
YAP translocation
YAP mechanotransduction

Addgene #
26867
55265
79993
17843
34615

Renilla luciferase plasmid was a kind gift from Dr. Lukasz Bugaj.
For bacterial overexpression and purification, non-codon-optimized BcLOV4 and
mCherry were amplified from their previously reported fusion (Addgene plasmid 114596)
and Gibson assembled with RhoA into the BamUK backbone with HiFi DNA Assembly
Master Mix (New England Biolabs, E2621) and transformed into Turbo competent cells.

3.4.2

Cell culture and transient transfection
All mammalian cells were maintained in a 5% CO2 water-jacketed incubator

(Thermo/Forma, 3110) at 37°C. For imaging experiments, cells were seeded onto polyD-lysine-treated glass bottom dishes (MatTek, P35GC-1.5-14-C) or into 24-well glass
bottom plates (Cellvis, P24-1.5H-N), treated in-house with type I collagen, at 15-20%
confluency. Cells were transfected 24 hours after seeding at ~30-40% confluency, then
imaged 24-48 hours after transfection. All transfections were performed with OptiMEM™ reduced serum media (Thermo Fisher, 3195062).
HEK293T (ATCC, CRL-3216) were cultured in D10 media composed of
Dulbecco’s

Modified

Eagle

Medium

with

GlutaMAX

(Invitrogen,

10566016),

supplemented with 10% heat-inactivated fetal bovine serum (FBS) and penicillinstreptomycin at 100 U/mL. HEK cells were transfected using the TransIT-293
transfection reagent (Mirus Bio, MIR2700) according to manufacturer instructions.
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Chinese Hamster Ovary (CHO) cells (cDNA Resource Center, CEM3000000)
cells were cultured in Ham’s F-12 Nutrient Mixture with GlutaMAX (Invitrogen,
31765035) supplemented with 10% heat-inactivated fetal bovine serum (FBS) and
penicillin-streptomycin at 100 U/mL. CHO cells were transfected using TransIT-CHO
transfection reagent (Mirus Bio, MIR2170) according to manufacturer instructions. For
opto-RhoA, DNA transfection mass was reduced from 2.5 µg to 0.5-1.0 µg per 35 mm
cell culture dish.
HeLa cells (provided by the Arjun Raj Lab, UPenn) and 3T3 cells (provided by
the Lukasz Bugaj Lab, UPenn) were cultured in D10 medium as described above. Both
cell lines were transfected with Lipofectamine™ 3000 transfection reagent (Thermo
Fisher, L3000008) according to manufacturer instructions. For opto-RhoA in HeLa cells,
DNA transfection mass was reduced from 2.5 µg to 0.5-1.0 µg per 35 mm cell culture
dish.
Endothelial colony forming cells (ECFCs) (provided by the Joel Boerckel Lab,
UPenn) were maintained in Endothelial Cell Growth Medium (Lonza, CC-3162)
supplemented with 10% defined FBS (HyClone, SH30070.03) and penicillinstreptomycin-amphotericin B at 100 U/mL. Cells were seeded for imaging experiments
between passages 4 and 6 in antibiotic-free media. ECFCs were transfected with XTremeGENE HP (Millipore-Sigma, 6366244001) according to manufacturer instructions,
using 0.2-2.0 µg DNA per 35 mm dish.

3.4.3

Fluorescence microscopy and hardware
Fluorescence microscopy was performed on an automated Leica DMI6000B

fluorescence microscope under Leica MetaMorph control, with a sCMOS camera
(pco.edge), an LED illuminator (Lumencor Spectra-X), and a 63× oil immersion
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objective. Excitation source illumination was filtered at the LED source (mCherry imaging
λ = 575/25 nm; GFP or Alexa Fluor 488 imaging or widefield BcLOV4 stimulation λ =
470/24 nm; miRFP imaging λ = 632/32 nm; BFP imaging λ = 395/25 nm). Fluorescent
proteins were imaged with Chroma filters: mCherry (T585lpxr dichroic, ET630/75 nm
emission filter, 0.2-0.5 s exposure), GFP (T495lpxr dichroic, ET 525/50 nm emission
filter, 0.2 s exposure), miRFP703 (AT655dc dichroic, ET655 nm emission, 0.5 s
exposure), BFP (455 dichroic, 480/40 nm emission, 0.2 s exposure).
Cells were imaged at room temperature in CO2-independent media (phenol-free
HBSS supplemented with 1% l-glutamine, 1% penicillin-streptomycin, 2% essential
amino acids, 1% nonessential amino acids, 2.5% HEPES pH 7.0, and 10% serum).
The custom spatially patterned illuminator was (DMD) digital micromirror devicebased and constructed from a digital light processor (DLP, Digital Light Innovations,
CEL5500), based on a design by Trojanowski, et al. (243). All optics and optomechanics
were from ThorLabs unless stated otherwise. A liquid light guide-coupled source
(Mightex, LCS-0455-3-22) was collimated into the DLP. The DLP output was infinity
corrected with an additional lens, and the coupled through a side auxiliary port window of
the microscope to gain direct access to the back of the objective, by using a custom K
Type laser cube (Nuhsbaum, Inc.) with a shortpass dichroic mirror (λ < 900 nm). Digital
masks were drawn in the DLP Light Commander software (Figure 3.17).

3.4.4

Expression level and membrane:cytosol ratio measurement
HEK293T cells were co-transfected with a GFP membrane marker and mCherry-

tagged tool construct in a 1:10 ratio. Cells were imaged at 63× magnification for 3-5
fields of view per construct. mCherry fluorescence was imaged with a 0.5 s exposure
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time, followed by GFP fluorescence imaging (0.2 s exposure). mCherry fluorescence
was the imaged again after 5 seconds of blue light stimulation.

Figure 3.17

Structured illumination schematic

Light from a liquid light guide-coupled λ = 455 nm LED was collimated into the (DMD) digital
micromirror device-based DLP (digital light processor, Digital Light Innovations CEL5500) via an
air-spaced doublet collimator (ASDC, Thorlabs F810APC-405) and a plano-convex lens (L1, f =
200 mm). After the DLP the projected illumination pattern was infinity-corrected using another
plano-convex lens (L2, f = 150 mm). The light was then redirected to the objective (Obj, 63× /
1.40 NA, Leica #506187) using a shortpass dichroic (DC, λ < 900 nm, Thorlabs DMLP900R)
mounted in a custom K type laser cube (Nuhsbaum). The LED was from Mightex (LCS-0455-322).

To assess expression level, cells were manually segmented using the pmGFP
micrograph to identify cell boundaries, and background-subtracted fluorescence was
recorded for N = 25-31 cells per condition. Cell fluorescence was normalized to BcLOV4mCherry mean fluorescence. To measure membrane:cytosol fluorescence ratio, the
plasma membrane and cytosol were manually segmented using pmGFP localization as
a guide. The ratio of mean membrane to cytosol fluorescence was calculated for darkadapted and post-illumination states for N = 25-31 cells per condition.
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3.4.5

Membrane localization kinetics
For membrane recruitment quantification, pmGFP was co-transfected with tool

fusions as described in section 3.4.4. To prevent cell contraction, transfected cells were
incubated with RhoGEF inhibitor Rhosin (Millipore-Sigma 555460, 25 μM) and ROCK
inhibitor Y-27632 (Millipore-Sigma Y0503, 10 μM) for 24 hours prior to imaging, and
inhibitors were also added to CO2-independent media. A dark-state mCherry image was
captured (500 ms exposure), followed by a 5-second blue light pulse with simultaneous
mCherry imaging every 200 ms to monitor protein localization. The GFP membrane
marker was imaged immediately after blue light stimulation for correlation analysis (200
ms exposure). mCherry was then visualized every 5 seconds for 10-15 minutes in the
absence of blue light stimulation. Membrane localization and dissociation were
measured by line section analysis and correlation with pmGFP in ImageJ and MATLAB.
Briefly, line sections approximately 30 µm in length bisecting the plasma membrane
were drawn for N = 20 cells per condition. The Pearson’s correlation coefficient was
measured between the mCherry and pmGFP fluorescence intensity across this line
section for each frame. An exponential fit was applied to calculate τon and τoff values and
95% confidence intervals for each construct.

3.4.6

Widefield and DMD stimulation assays
For widefield stimulation assays, mCherry fluorescence was imaged before a 5-

second pulse of blue light. mCherry fluorescence was then imaged every 15-30 seconds
for 10 minutes following stimulation. For data analysis, each cell was treated as a
separate data point, with N = 82-93 cells from 10-12 field-of-view videos per condition, 68 cells per video.

93

For DMD stimulation assays, mCherry fluorescence was imaged every 15
seconds for 10 minutes. During this time, cells were stimulated for one second per
minute (1.6% duty cycle) patterned illumination (25 μm-wide square encompassing
∼25% of cell area). The stimulation angle was defined as the angle defined by the
polarization axis and the line segment between the cell centroid and the centroid of the
stimulated cell area. Each data point was derived from one cell in an independent video,
and cells were binned by angle of stimulation, with bin widths of 30 degrees spanning 0180 degrees, N = 10-35 videos per bin.
For widefield and DMD stimulation assays, statistical significance was assessed
by the two-sided non-parametric Mann-Whitney U test, uncorrected for multiple
comparisons.

3.4.7

Cell morphology analysis pipeline
Change in cell area, cell length, and centroid movement were computed via a

custom analysis Python script (Figure 3.8a). For whole-field stimulation assays, videos
of an entire field-of-view were cropped so that each contained only one cell. Contours of
the cell membrane and nucleus were identified using the threshold function in OpenCV.
Each video was rotated by increments of 5 degrees until the long polarization axis of the
cell aligned with the y-axis, and then a cell-bounding rectangle was calculated using the
Imutils package with the short edge aligned with the x-axis; the angle of rotation was
chosen such that the cell nucleus was closer to the top of the rectangle as a
morphological marker for the cell leading edge, as confirmed by LifeAct imaging. Binary
masks of the cell at initial (t = 0 min) and final (t = 10 min) timepoints were created for
each cell. The change in cell area was calculated by finding the percent change in the
area bounded by the cell contours at the final timepoint relative to its area at the initial
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timepoint. Change in cell length was calculated using the height of the bounding
rectangle at the final and initial timepoints.
For experiments with spatially patterned illumination, a similar imaging
processing workflow was followed. The angle of rotation was calculated as above, and
binary masks of the cell at the initial and final timepoints and the stimulation zone were
created and rotated such that the leading edge of the cell was positioned at the top of
the image. Masks of the cell regions inside (the overlap) and outside (the non-overlap)
the stimulation zone were created using the OpenCV bitwise operation functions “and”
and “xor”, respectively. The centroids of the whole cell and the overlap region were
computed at the initial and final timepoints. The angle of stimulation was defined as the
angle between (i) the vector connecting the initial cell centroid and overlap region
centroid and (ii) the vertical vector between the initial cell centroid and the leading edge
of the cell.
For analysis of morphological markers of cell polarization, HEK293T cells were
co-transfected with a nuclear marker (mTagBFP-Nucleus-7) and miRFP703-tagged
LifeAct. The data analysis pipeline was applied to align the long axis of the cell with the
y-axis, and to position the nucleus closer to the top of the cell as a putative marker of the
leading edge. The actin arc was then located by identifying the brightest LifeActmiRFP703 region of at least 5 μm2 in area. The angle between the long axis and the
vector connecting the cell centroid to the actin arc centroid was then calculated to verify
that the actin arc occurs at the computationally identified leading edge of the cell.

3.4.8

Phalloidin staining
Cells were plated in 24-well tissue culture treated plates (CytoOne, CC7682-

75240) and transfected as described in section 3.4.2. 24 hours after transfection, cells
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were washed with PBS and the media was replaced with DMEM supplemented with
penicillin-streptomycin and without FBS. Light-exposed 24-well tissue culture-treated
plates were incubated under Arduino-controlled blue strip LEDs (light intensity 15
mW/cm2) strobing at a 1.6% stimulation duty cycle in a 5% CO2 water-jacketed incubator
for two hours. Cells were fixed with 4% paraformaldehyde in PBS at room temperature
for 10 minutes, washed twice with PBS (5 min per wash), and then permeabilized with
0.1% Triton-x-100 in PBS for 15 minutes. Cells were blocked with 1% BSA in PBS for 30
minutes, then stained with Alexa Fluor 488 Phalloidin (Invitrogen, A12379) diluted 1:400
in PBS for 20 minutes at room temperature, protected from light. Plates were washed
twice prior to imaging. Total filamentous actin was quantified by normalizing total cell
Alexa Fluor 488 fluorescence to cell area, with N = 40 cells per condition.

3.4.9

Pharmacological inhibition assays
The GEF inhibitor Rhosin (Millipore-Sigma, 555460) was added to cells at 25 µM

final concentration upon transfection, 24 hours before imaging. ROCK inhibitor Y-27632
(Millipore-Sigma, Y0503) was similarly added to cells at 10 µM final concentration.
Inhibitors were also added at the same final concentration to the CO 2-independent
media in which the cells were imaged.

3.4.10 YAP nuclear localization assay
HEK293T cells were initially plated at 75% confluency in 10 cm dishes to drive
YAP to the cytosol. Cells were then passaged one day later and seeded at 25%
confluency in 35 mm poly-D-lysine-treated glass bottom dishes. The next day, dishes
were washed with PBS (5 min per wash) and media was replaced with DMEM
supplemented with 2% heat-inactivated FBS and penicillin-streptomycin.
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Cells were

then transfected with a 4:1 ratio of opto-RhoA-mCherry or BcLOV4-mCherry to EGFPYAP. EGFP-YAP was imaged every 15 seconds using a 250 msec excitation pulse that
also stimulated BcLOV4, and mCherry fluorescence was imaged every minute. Nuclear
and cytosolic fluorescence normalized to the area of each region was calculated every
minute by manual segmentation in ImageJ, with N = 20 cells per condition.
3.4.11 YAP-mediated mechanotransduction assay
YAP-TEAD-dependent transcriptional activity was quantified using a dual
luciferase reporter system (Promega, E1910). HEK293T cells were co-transfected with
plasmids encoding 8XGTIIC-luciferase, a YAP-sensitive promoter driving firefly
luciferase expression (500 ng); Renilla luciferase (500 ng); and BcLOV4-mCherry or
opto-RhoA-mCherry (1500 ng). At transfection, full media was replaced with DMEM
supplemented with 2% heat-inactivated FBS and penicillin-streptomycin. Half the cells
were incubated under pulsing blue light with a 1.6% stimulation duty cycle for 12 hours.
Cells were lysed according to manufacturer instructions. Luminescence was measured
in white 96-well plates (Corning, 3917) on a Tecan M200 spectrophotometer with a 10
second integration time. The firefly luminescence value for each sample was normalized
to its Renilla luciferase readout. N = 8 lysate samples per condition.
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CHAPTER FOUR: Optogenetic tools for induction of cell protrusion

This chapter adapts work from the following publications:
(1)

Berlew, E. E.; Kuznetsov, I. A.; Yamada, K.; Bugaj, L. J.; Chow, B. Y.,

Optogenetic Rac1 engineered from membrane lipid-binding RGS-LOV for inducible
lamellipodia formation. Photochem Photobiol Sci 2020.

Author contributions: EEB designed genetic constructs, designed experiments, and
conducted all experiments. IAK designed experiments, contributed to all experiments,
constructed the patterned illumination system, and performed the blinded data analysis.
KY assisted with molecular cloning and cellular assays. LJB and BYC coordinated all
research. All authors contributed to data analysis and manuscript preparation.

(2)

Berlew, E. E.; Yamada, K.; Kuznetsov, I. A.; Rand, E. A.; Ochs, C. C.; Jaber, Z.;

Gardner, K. H.; Chow, B. Y., Designing single-component optogenetic membrane
recruitment systems: the Rho-family GTPase signaling toolbox. ACS Syn Biol 2022.

Author contributions: EEB and KY designed genetic constructs, designed experiments,
conducted experiments, and analyzed data. IAK constructed the patterned illumination
system, conducted the FRAP measurement, and contributed to automated data analysis
development. EAR and CO assisted with genetic construct design, engineering, and
assays. BYC coordinated all research. All authors contributed to data analysis and
manuscript preparation.
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4.1

Introduction

4.1.1

Cell protrusions
The ability of cells to grow, change shape, and migrate depends on their ability to

generate a pushing force from actin polymerization (189, 227). In addition to the
contractile force-inducing RhoA, the Rho family of small GTPases also contains
protrusion-forming Rac1 and Cdc42; together with RhoA, these proteins are tightly
controlled in space and time to coordinate cytoskeletal changes enabling cell motility
(117), wound healing (1), and cytokinesis (131). Rac1 and Cdc42 signaling is essential
in the formation of tissues and organs; its dysregulation can result in tumorigenesis
(152). The precise spatiotemporal requirements of these signaling pathways make them
appealing candidates for optogenetic manipulation.

4.1.1.1 The Rac1 signaling pathway
The Rho-family GTPase Rac1 drives the formation of sheet-like cellular
protrusions called lamellipodia and plays an essential regulatory role in cell growth and
migration (46) (Figure 4.1a). Like other GTPases, Rac1 is GDP-bound in its inactive
state; activation occurs following membrane translocation by interaction with GEFs, the
best studied of which include Tiam1, P-Rex1, and Trio (154, 155). Active, GTP-bound
Rac1 initiates downstream actin polymerization through WAVE (WASp-family verprolinhomologous) protein-scaffolded interaction with the Arp2/3 (actin-regulated proteins)
regulatory complex (190, 191, 224). Overactivation of Rac1 can result in the formation of
solid tumors (48, 125), making it a promising therapeutic target (32). Beyond its
translational potential of new biological insights, the creation of new optogenetic tools for
Rac1 signaling perturbation will enable investigation of the many open questions remain
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in understanding Rac1 signaling, including how Rac1 and RhoA activation is temporally
controlled at the leading edge of the cell to coordinate directional migration (176).

4.1.1.2 The Cdc42 signaling pathway
Cdc42 signals through a mechanism similar to that of Rac1. Following membrane
recruitment and GEF-mediated activation, it also activates Arp2/3-mediated cytoskeletal
rearrangement, but Cdc42 interacts with WASp (Wiscott-Aldrich Syndrome protein)
instead of WAVE, resulting in a different actin polymerization paradigm that produces
shorter, spiky filopodia (47) (Figure 4.1b). Cdc42 plays a role in chemokine-driven tumor
cell invasion through its crosstalk with RhoA (226), with which it shares several
interacting GEFs and GAPs (170).

4.1.2

Existing tools for Rac1 and Cdc42 signaling perturbation

Like RhoA, Rac1 and Cdc42 signal at the plasma membrane, making light-induced
membrane recruitment a viable strategy for spatiotemporally precise pathway initiation.
For Rac1, most tools (81, 116, 139, 248) sequester RacGEF Tiam1 in the cytosol in the
off state by fusing it to a half of an optogenetic heterodimerizing protein pair, with the
other half anchored to the membrane. Light-induced conformational change drives
heterodimerization and membrane recruitment of Tiam1, where it can activate
endogenous membrane-localized Rac1 GTPase. Another approach involves fusing the
Rac1 GTPase to AsLOV2 (261, 262), with its downstream protein-interacting surface
sterically occluded by AsLOV2 in the protein’s dark, as in PA-Rac1. Blue light stimulation
induces AsLOV2 conformational change and uncaging of Rac1, allowing it to initiate the
lamellipodia formation pathway. However, tool function relies upon point mutations to
Rac1 to lock it in its active, GTP-bound state by Inhibiting interaction with guanine
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nucleotide dissociation inhibitors (Q61L) and GTPase accelerating proteins (E91H and
N92H), relieving the GTPase of the need for GEF activation. This feature results in a
propensity for spurious pathway activation following transient contact between PA-Rac1
and the plasma membrane, decreasing its spatiotemporal resolution and requiring
stringent experimental setups to prevent unintended illumination (262) which are not
feasible in all lab settings.
Existing systems for optogenetic perturbation of Cdc42 signaling are all twocomponent, using heterodimerization pairs to recruit either catalytic domains of the
Cdc42 GEF Intersectin1 (81, 113, 139, 225) or the GTPase itself (132). As discussed
earlier, two-protein systems occupy an increased genetic payload in the cell and require
the use of two optical channels for visualization of each protein component in addition to
the stimulation channel, significantly decreasing the available bandwidth for imaging
other wavelengths in the assay. The available tools for inducing the spatiotemporally
precise formation of cell protrusions are limited to GEF-level activation, two-component
systems, and/or low-resolution of using a constitutively active GTPase, leaving room for
improvement with the BcLOV4 system.

4.1.3

Problem statement
Optogenetic tools for the induction of Rac1 and Cdc42 signaling at the GTPase

and GEF level are needed to probe the spatiotemporal nuances of cell protrusion
formation and to study cell migration and morphogenesis. Given the limitations of
existing two-component or constitutively active systems, we sought to create BcLOV4
fusions of wildtype GTPases Rac1 and Cdc42 and two of their respective GEFs, Tiam1
and Intersectin1. For GTPase tools, blue light induces membrane localization of the
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Figure 4.1

The Rac1 and Cdc42 signaling pathways

Rac1 and Cdc42 signaling are regulated by guanine nucleotide exchange factors (GEFs),
GTPase accelerating proteins (GAPs), and guanosine nucleotide dissociation inhibitors (GDIs). a.
Following nucleotide exchange, Rac1 initiates actin polymerization and lamellipodia formation
through WAVE (WASP-family verprolin-homologous) and the Arp2/3 (actin regulatory protein)
complex. b. Cdc42 initiates actin polymerization and filopodia formation through WASP (WiscottAldrich Syndrome Protein) and Arp2/3.

wildtype GTPase fused to BcLOV4, where it undergoes nucleotide exchange and GTP
loading by endogenous pathway GEFs. In its active form, the GTPase can then interact
with downstream effectors for initiation of actin polymerization. At the membrane, GEF
tools catalyze activation of endogenous membrane-bound GTPases, which similarly
initiate downstream signaling (Figures 4.2-4.3). Development of these tools will also
complete the Rho-family BcLOV4 activation toolbox, allowing for the disentanglement of
RhoA-Rac1-Cdc42 interactions on the same optogenetic platform.
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Figure 4.2

Schematic of opto-Rac1 and opto-Tiam1 tool function

Schematized induction of cytoskeletal changes and contractile signaling in response to (a) optoRac1 and (b) opto-Tiam1 activation by BcLOV4-mediated membrane translocation.

Figure 4.3

Schematic of opto-Cdc42 and opto-Intersectin1 tool function

Schematized induction of cytoskeletal changes and contractile signaling in response to (a) optoCdc42 and (b) opto-Intersectin1 activation by BcLOV4-mediated membrane translocation.
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4.2

Results and discussion

4.2.1

Design and screening of opto-Rac1
To engineer opto-Rac1, we screened domain arrangement orderings of

mammalian codon-optimized BcLOV4, human Rac1, and a mCherry visualization tag,
with a glycine/serine-rich flexible linker, (GGGS)2, between the respective domain pairs.
To enable cytosolic sequestration of the Rac1 effector and limit membrane localization of
BcLOV4-fusion proteins in the dark-adapted state, a single leucine residue was
truncated from the Rac1 C-terminal prenylation site (“CLLL,” or more generally “CAAX”)
(204). These domain combinations were then screened in transfected HEK cells for
protein expression uniformity, relative expression level, and light-activated translocation
efficiency in response to whole-field illumination with blue light (Figure 4.4).
BcLOV4-Rac1-mCherry was chosen as opto-Rac1.

This particular domain

arrangement was uniformly distributed throughout the cytosol in the dark-adapted state,
retained its ability to be reversibly recruited to the membrane upon illumination with
similar efficiency to the BcLOV4-mCherry reference protein. Other domain arrangements
were not considered viable because their inducible membrane recruitment capabilities
were reduced and they displayed undesirable expression profiles, evidenced by poor cell
health (e.g. round morphology in domain arrangement mCherry-BcLOV4-Rac1),
permanent localization to membrane or trans-Golgi network in the dark, or nuclear
sequestration, the latter potentially from exposure of the Rac1 nuclear shuttling
sequence (136) that is possible with disrupted prenylation (161). The observed nuclear
sequestration was unlikely to depend on cell cycle phase (160), since it is the dominant
phenotype observed in an unsynchronized population for domain arrangements
BcLOV4-mCherry-Rac1 and Rac1-BcLOV4-mCherry (Figure 4.5).

104

The membrane localization in the dark-adapted state observed when BcLOV4 is
at the C-terminus of the chimera (domain arrangements Rac1-mCherry-BcLOV4 and
mCherry-Rac1-BcLOV4) suggests that such configurations are disfavored when
engineering fusion proteins. This phenomenon will be further explored in Chapter 6.

4.2.2

DMD stimulation-induced lamellipodia formation with opto-Rac1
To test optogenetic function for spatially precise induction of lamellipodia

formation, cells expressing opto-Rac1 were stimulated with spatially patterned blue light
using a digital micromirror device to emulate a sensory activation gradient. Because
BcLOV4 undocks from the membrane within approximately one minute in the dark (68,
70), cells were provided a brief stimulation pulse every 30-60 seconds. Sprawling sheetlike lamellipodial protrusions were rapidly and selectively initiated in the blue lightilluminated field and remained largely confined to the spatial field upon reaching the
boundary (Figure 4.6). Thus, opto-Rac1 induction of lamellipodia formation is spatially
restricted.
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Figure 4.4

Molecular engineering of opto-Rac1

a. Domain arrangement combinations of BcLOV4, wildtype human Rac1, and mCherry
visualization tag that were tested. Domains were separated by flexible (GGGS) 2 linkers.
Candidates were tested for relative expression level and translocation efficiency vs. BcLOV4mCherry in transfected HEK cells. BcLOV4-Rac1-mCherry was ultimately selected as opto-Rac1
based on its uniform localization profile in the dark-adapted state and similar translocation
efficiency to BcLOV4-mCherry. b. Fluorescence micrographs showing representative expression
patterns of the six arrangements in the dark-adapted state. c. Relative expression level vs.
BcLOV4-mCherry control with no effector. d. Ratio of membrane-localized vs. cytosolic protein for
the engineered arrangements (normalized vs. BcLOV4-mCherry control) in the dark-adapted and
blue light-illuminated state. N = 25-35 each. Mean ± SEM. e. Dynamic membrane localization of
opto-Rac1 is reversible under whole-field illumination. Top = Fluorescence micrograph, Scale =
10 µm. Bottom = Line section pixel intensity.
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Figure 4.5
cells

Representative distribution of Rac1 construct expression profile in HEK

Fluorescence micrographs of transfected HEK cells in the dark-adapted state. (Φ Nuc/Cyto) =
ratio of observed average fluorescence intensity in the nucleus vs. cytoplasm (N = 25-35 each).
The dominant preference for nuclear localization of genetic constructs ii. and iii., plus their lack of
plasma membrane localization, indicates that their nuclear localization is not a consequence of
cell cycle phase or sequestration by the plasma membrane. Scale = 10 µm.

107

We assessed the phenotypic response to different stimulation duty ratios to
gauge the functional efficiency of opto-Rac1 and guide experimental parameters for
future use. Duty ratio (Φ) was chosen as the “sensitivity” parameter because it is easier
to precisely control optical stimulation timing than intensity over time. The 15 mW/cm 2
irradiance was chosen as it is sufficient to saturate flavin photocycling, but this
photochemical threshold at the protein-level was not exceeded to avoid photobleaching
or compensating for inefficient optogenetic function at the cell signaling level. We
quantified the extent of induced lamellipodia formation as the average movement of the
stimulated cell boundary over the first two minutes, since protrusions were clearly
observable during this initial post-induction period and the spatial confinement of
lamellipodia induction to the illumination field decreases the average movement over
longer periods. Opto-Rac1 performed consistently at Φ = 1.6% duty ratio, which for
context is in the low end of the duty ratio range of Φ ~ 2.5 – 20% that has been reported
for related tools for small GTPase signaling with blue light photoreceptors (47, 180, 198,
252, 253). Cell border change for each opto-Rac1 duty cycle was statistically significant
compared to BcLOV4-mCherry expressing cells stimulated with a 5.0% duty cycle (p <
0.01) (Figure 4.7). Thus, the optogenetic efficiency of opto-Rac1 is sufficient to perform
reliably on commonplace microscopy setups without major photobleaching risks.
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Figure 4.6

Spatially precise induction of lamellipodia formation by opto-Rac1

a. Fluorescence micrographs of three different transfected HEK cells and a BcLOV4 control.
Protrusions are rapidly formed in the patterned illumination field for opto-Rac1, and remain largely
restricted to the field even many minutes after reaching the edge. Opto-Rac1 also accumulates
selectively within the field in an actin network-dependent manner. No protrusions are observed for
the effector-less control. Scale = 10 µm. b. Region of interest (ROI) selection around the
illumination field of view after 10 minutes of pulsatile stimulation show sheet-like protrusions.
Indices i-iv correspond to those in panel a, with auto-adjusted levels for the ROI. White box =
illumination field. Dotted yellow line = mask of original cell boundary. (a-b) λ = 455 nm at 15
mW/cm2, 1.6 – 5.0% duty ratio.
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Figure 4.7

Quantification of opto-Rac1 induction of lamellipodia formation

a. Stimulation epochs using a digital micromirror device to spatially pattern illumination fields. b.
Analysis methodology to determine distance moved by cell. The cell border was manually
segmented at 0 seconds post-illumination (black solid border) and at 120 seconds postillumination (red dashed line). The distance moved by the cell was defined as the mean length of
line segments (black dashed line) that were normal to the cell border at 120 seconds, with one
endpoint at the t = 0 border and the other endpoint at the t = 120 s border. Line segments were
spaced at 2.5 μm intervals along the t = 120 s border. c. Lamellipodia formation in response to
stimulation duty cycles, with irradiance fixed at the saturation threshold for flavin photocycling.
Phenotypic response was quantified by average distance of cell border movement in the
illumination field after two minutes. N = 19-37 independent videos each. Mann-Whitney U test: (*)
p < 0.05, (**) p < 0.01 vs. BcLOV4-mCherry control (no Rac1 effector). λ = 455 nm at 15 mW/cm2.

4.2.3

Inhibition of Rac1:RacGEF interaction and actin polymerization
To confirm that the wildtype Rac1 domain can be recruited to the membrane in

its inactive GDP-bound form as proposed, we performed the spatially patterned
induction experiments in the presence of a Rac1-GEF inhibitor NSC 23766 (25, 64), with
a high Φ = 5% to ensure robust photochemical activation. NSC 23766 inhibits the
interaction between Rac1 and two of its GEFs, Trio and Tiam1. Opto-Rac1 still
selectively bound the membrane in illumination field, but lamellipodia formation was
suppressed by this pharmacological inhibition monomers (p < 0.05 versus untreated,
DMD-stimulated opto-Rac1 cells). This finding confirms that its membrane recruitment is
GEF-independent and indicates that the wildtype effector domain is in its inactive or
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GDP-bound when opto-Rac1 is initially recruited to the membrane. This signaling mode
is consistent with single-molecule tracking studies showing that membrane localization
of Rac-GDP precedes GEF-activation in natural Rac1 signaling, and is sufficient for actin
polymerization (46) (Figure 4.8a).

Figure 4.8

Pharmacological inhibition of opto-Rac1 activity

Optogenetic signaling proceeds by GEF-activation of GDP-bound wildtype Rac1 upon membrane
localization, followed by downstream actin polymerization. a-b. Fluorescence micrographs of
transfected HEK cells expressing opto-Rac1, treated with the (a) Rac1- GEF inhibitor NSC 23766
and (b) the actin polymerization inhibitor cytochalasin D. Opto-Rac1 accumulates at the
membrane within the patterned illumination field (box) but does not induce lamellipodia formation.
λ = 455 nm at 15 mW/cm2, 5% duty ratio. Scale = 10 µm. c. Population level data to quantify
pharmacological suppression of opto-Rac1 activity. Mann Whitney U test (*) p < 0.05. N = 31 (+
NSC 23766), N = 30 (+ cytochalasin D) independent videos each.

Lamellipodia formation was also inhibited in the presence of the actin
polymerization inhibitor cytochalasin D (214), which binds the barbed end of growing
actin filaments to block the addition of new actin monomers (p < 0.05 versus untreated,
DMD-stimulated opto-Rac1 cells). This finding confirms that the cytoskeletal
rearrangements were actin-mediated and not a spurious byproduct of other Rac1
signaling pathways or protein accumulation at the inner leaflet. Opto-Rac1 did not
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accumulate strongly in the illumination field in the presence of either inhibitor, unlike
when actin polymerization is possible, and thus the latter observed accumulation stems
from opto-Rac1 binding to a polymerized actin network (Figure 4.8b).

4.2.4

Comparison of opto-Rac1 to PA-Rac1
The opto-Rac1 signaling mechanism is distinct from previously reported

genetically encoded approaches for inducible Rac1 activity, which have used Rac1activating GEFs or constitutively active (CA) proteins mutated to eliminate inhibitory
interactions with GDI (guanosine nucleotide dissociation inhibitor) and GAPs (GTPaseactivating protein) (33, 78, 106, 198, 260, 263). While membrane recruitment systems
have not yet been reported using wildtype Rac1 effector (vs. CA-Rac1 or indirect Rac1GEFs), its use clearly permits effective opto-Rac1 signaling and suggests that basal
GEF levels are sufficient to support signaling in response to rapid increases in
membrane concentration of GDP-bound Rac1. It should be noted that mutation of the
Rac1 domain in opto-Rac1 to CA-Rac1 (260) (corresponding to the GDI-interaction site,
Q61L, and the GAP-interaction sites, E91H and N92H) was toxic with evidence of basal
activity (Figure 4.9). Thus, the use of wildtype Rac1 effector contributes to the
optogenetic efficacy, possibly by reducing basal activity of opto-Rac1, which was
negligible under normal laboratory conditions (without precautions for blue lightexposure other than brief assay dark-adaptation period) that were less stringent than
reported precautions needed to limit basal activity of PA-Rac1, where all cell handling
and assays are conducted in darkness (including baffling electronic displays) (263).
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Figure 4.9

Expression of constitutively active Rac1 constructs in HEK cells

Multiple representative cells were imaged in the dark-adapted state. Constitutively active [CA]
Rac1 fused to BcLOV4 reduced cell health based on Trypan Blue live/dead cell count, and
compromised morphology with evidence of spurious activity in the dark-adapted state. The topcenter image, chosen to demonstrate permanent membrane localization in non-rounded cells,
shows high background after auto-contrast because of dimmer raw fluorescence. For reference,
photoactivatable Rac1 (PA-Rac1), a fusion of AsLOV2 and constitutively active Rac1, shows
spurious sheet-like protrusions in the dark-adapted state under similar laboratory conditions.
Scale bar = 10 µm.

4.2.5

Design and screening of opto-Tiam1
To engineer an optogenetic tool for induction of Rac1 signaling at the GEF level,

we chose to work with the 28 kDa DH domain of Tiam1 based on its previous use in
heterodimerization-based activation tools (47, 245). We followed a similar screening
workflow as for opto-Rac1, with the addition of two C-terminal FLAG-tagged domain
arrangements following our observation that domain arrangements with BcLOV4 at its Cterminus are generally unsuitable for tool engineering (see Chapter 6). With the
exception of Tiam1-mCherry-BcLOV4 and mCherry-Tiam1-BcLOV4, all screened
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constructs exhibited uniform cytosolic fluorescence in HEK293T cells and an increase in
membrane-localized protein following blue light stimulation (Figure 4.10a-c).
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Figure 4.10

Molecular engineering of opto-Tiam1

a. Representative images of Tiam1 domain arrangements. Scale = 10 µm. b. Expression levels of
domain arrangements measured by mCherry fluorescence. N = 75 cells per condition. c. Fold
change in membrane:cytosol mCherry fluorescence ratio between dark-adapted and post-blue
light illumination states. N = 30 cells pre condition. d. Box-and-whisker plot of percent change in
cell area within the stimulated region for viable domain arrangements. N = 6 independent videos
per condition.

To identify constructs capable of inducing cell protrusions when recruited to the
plasma membrane, all six candidate constructs were subjected to spatially confined blue
light stimulation, and the change in cell area within the stimulated region was measured
over a 10-minute time course. The greatest area change was observed for BcLOV4Tiam1-mCherry, which we designated as opto-Tiam1 (Figure 4.10d).

4.2.6

DMD stimulation- and serum starvation-induced lamellipodia formation with opto-

Tiam1
Upon screening opto-Tiam1 activity in serum-fed cells, we observed that
protrusion formation was inconsistent, with hybrid filopodia/lamellipodia forming within
the stimulated region. However, serum starvation of tool-expressing cells for 24 hours
prior to imaging resulted in consistent formation of sheetlike lamellipodia. We attribute
this difference in phenotype to the decreased cytoskeletal tension and focal adhesion
strength in serum-starved cells (199, 202), resulting in easier cytoskeletal remodeling
(Figure 4.11). We quantified lamellipodia formation by measuring the change in cell area
within the stimulated region and observed a statistically significant increase (p < 0.05 by
Mann-Whitney U test) in opto-Tiam1 area compared to BcLOV4-mCherry (Figure 4.12).
We also used inhibitors of Tiam1:Rac1 interaction (NSC 23766), Arp2/3 signaling (CK
666), and actin polymerization (cytochalasin D) to confirm the tool activation mechanism
(Figure 4.13). Thus, opto-Tiam1 can be used for reliable induction of Rac1 signaling and
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lamellipodia production, complementing opto-Rac1 two nodes of Rac1 signaling pathway
activation.

Figure 4.11
cells

Differences in opto-Tiam1 phenotype for serum-fed vs. serum-starved

a-b. Exemplar images of opto-Tiam1-induced filopodia formation in serum-fed cells (a) and
lamellipodia formation in serum starved cells (b) with pulsatile patterned stimulation (1.6% duty
ratio). White box = illumination field. Dotted yellow line = cell boundary mask in the dark-adapted
state. Scale = 10 µm. c. Box-and-whisker plot showing change in cell area within the stimulated
region for serum-starved vs. fed cells expressing opto-Tiam1. Mann-Whitney U test, uncorrected
for multiple comparisons. (*) = p < 0.05. N = 12 independent videos per condition.
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Figure 4.12

Optogenetic induction of lamellipodia formation with opto-Tiam1

a. Exemplar images of opto-Tiam1-induced lamellipodia formation with pulsatile patterned
stimulation (1.6% duty ratio). White box = illumination field. Scale = 10 µm.
b. Box-and-whisker plot showing percent change cell area within the stimulated region, compared
to effector-less BcLOV4 control. Mann-Whitney U test, uncorrected for multiple comparisons. (*) =
p < 0.05. N = 9 independent videos per condition.

4.2.7

Design and screening of opto-Cdc42
Domain arrangement combinations of BcLOV4, mCherry, and wildtype Cdc42

GTPase were screened following the same procedure as Tiam1 fusions. All constructs
except Cdc42-mCherry-BcLOV4 and mCherry-Cdc42-BcLOV4 expressed uniformly
throughout the cytosol and translocated to the plasma membrane in response to blue
light stimulation. We next tested whether any of these six candidate tool constructs could
activate Cdc42 signaling at the membrane. Because filopodia formation can be
subjective and difficult to discern with a membrane-associating protein, we instead
imaged actin polymerization with miRFP703-tagged LifeAct before and after pulsatile,
spatially confined blue light stimulation. We measured the percent change in LifeAct
intensity in the stimulated region of the cell (normalized to the non-stimulated region)
after five minutes of stimulation with a duty cycle of Φ = 1.6%; an increase in stimulated
region LifeAct intensity would suggest increased filamentous actin polymerization and
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filopodia formation. The best performing construct, mCherry-Cdc42-BcLOV4-3xFLAG,
was designated as opto-Cdc42 (Figure 4.14).

Figure 4.13

Pharmacological inhibition of opto-Tiam1

a. Representative images of BcLOV4 control, wildtype opto-Tiam1, and opto-Tiam1 inhibited with
Rac1 inhibitor NSC 23766, Arp2/3 inhibitor CK 666, and actin polymerization inhibitor
cytochalasin D. mCherry tag was imaged during pulsatile patterned stimulation (1.6% duty ratio).
White box = illumination field. Dotted yellow line = cell boundary mask in the dark-adapted state.
Scale = 10 µm. b. Quantification of percent change in cellular area within stimulated region.
Center line, median; “X”, mean; box limits, upper and lower quartiles; whiskers, 1.5x interquartile
ranges. N = 9 independent videos per condition. Mann-Whitney U test, uncorrected for multiple
comparisons. (*) = p < 0.05, (**) = p < 0.01, (n.s.) = not significant.
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Figure 4.14

Molecular engineering of opto-Cdc42

a. Representative images of Cdc42 domain arrangements. Scale = 10 µm. b. Expression levels
of domain arrangements measured by mCherry fluorescence. N = 75 cells per condition. c. Fold
change in membrane:cytosol mCherry fluorescence ratio between dark-adapted and post-blue
light illumination states. N = 30 cells pre condition. d. Schematic of opto-Cdc42 quantification
assay using miRFP703-LifeAct. e. Box-and-whisker plot of percent change in LifeAct
fluorescence within the stimulated region for viable domain arrangements. N = 6 independent
videos per condition.

4.2.8

DMD stimulation-induced filopodia formation and actin quantification with opto-

Cdc42
Opto-Cdc42 membrane recruitment via spatially confined stimulation induces
actin polymerization and filopodia formation. We measured the change in LifeAct
fluorescence intensity within the stimulated region and observed a statistically significant
increase in opto-Cdc42 cells compared to negative control BcLOV4-mCherry (p < 0.05
by Mann-Whitney U test) (Figure 4.15). We also used inhibitors of Cdc42:GEF
interaction (ZCL 278), Arp2/3 signaling (CK 666), and actin polymerization (cytochalasin
D) to confirm the opto-Cdc42 tool signaling mechanism (Figure 4.16). Because
cytochalasin D affects actin polymerization, we did not quantify LifeAct fluorescence for
this inhibition condition. For all inhibitors, we measured the change in cell boundary
length within the stimulated region, with an increase in boundary length corresponding to
the presence of small membrane protrusions.
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Figure 4.15

Optogenetic induction of filopodia formation with opto-Cdc42

a. Exemplar images of opto-Cdc42-induced filopodia formation with pulsatile patterned
stimulation (1.6% duty ratio). White box = illumination field. Scale = 10 µm. b. Box-and-whisker
plot showing percent change in miRFP703-LifeAct fluorescence intensity within the stimulated
region, compared to effector-less BcLOV4 control. Mann-Whitney U test, uncorrected for multiple
comparisons. (**) = p < 0.01. N = 18 independent videos per condition.

4.2.9

Design, screening, and characterization of opto-Intersectin1
To activate Cdc42 signaling at the GEF level, we used the 51 kDa Dbl-homology,

Pleckstrin-homology (DHPH) domain of the Intersectin1 GEF, which has previously been
used in other optogenetic heterodimerization systems (47, 113, 180).

All screened

domain arrangements, except those with BcLOV4 at the C-terminus of the protein which
were previously shown to be disfavored, exhibited cytosolic expression in the dark state.
Intersectin1-BcLOV4-mCherry was chosen as opto-Intersectin1 based on its robust
filopodia formation upon blue light stimulation (Figure 4.17).
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Figure 4.16

Pharmacological inhibition of opto-Cdc42

a. Representative images of BcLOV4 control, wildtype opto-Cdc42, and opto-Cdc42 inhibited with
Cdc42 inhibitor ZCL 278, Arp2/3 inhibitor CK 666, and actin polymerization inhibitor cytochalasin
D. mCherry tag was imaged during pulsatile patterned stimulation (1.6% duty ratio). White box =
illumination field. Dotted yellow line = cell boundary mask in the dark-adapted state. Scale = 10
µm. b. Quantification of change in cellular LifeAct-miRFP fluorescence observed within stimulated
region, corrected for photobleaching. LifeAct fluorescence was not calculated for cytochalasin D
condition due to disruption of LifeAct-actin binding by the inhibitor. c. Quantification of change in
cell border length observed within stimulated region, normalized to initial border length. (b-c)
Center line, median; “X”, mean; box limits, upper and lower quartiles; whiskers, 1.5x interquartile
ranges. N = 12 independent videos per condition. Mann-Whitney U test, uncorrected for multiple
comparisons. (*) = p < 0.05, (**) = p < 0.01, (***) = p < 0.001.
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Figure 4.17

Molecular engineering and tool function of opto-Intersectin1

a. Representative images of Tiam1 domain arrangements. Scale = 10 µm. b. Exemplar images of
opto-Intersectin1-induced filopodia formation with pulsatile patterned stimulation (1.6% duty ratio).
White box = illumination field. Scale = 10 µm.

4.2.10 Membrane translocation kinetics of protrusion tools
We measured the kinetics of dynamic membrane association for opto-Tiam1 and
opto-Cdc42 (Figure 4.18). Briefly, mCherry fluorescence of tool constructs was imaged
before, during, and after a 5-second pulse of blue light. Line sections of the plasma
membrane were drawn and Pearson’s correlation between mCherry intensity along the
line section and a GFP membrane marker was measured at each timepoint. Exponential
fits were applied to these association and dissociation measurements for N = 20 cells
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per construct and 95% confidence intervals were calculated. For opto-Tiam1, membrane
association τon was 1.34 s (95% CI 1.27-1.42 s) and membrane dissociation τoff was
155.1 s (95% CI 136.9-173.2 s). For opto-Cdc42, membrane association τon was 0.984 s
(95% CI 0.936-1.03 s) and membrane dissociation τoff was 98.7 s (95% CI 93.7-103.8 s).
The τon values are similar to those measured for effector-less BcLOV4-mCherry in HEK
cells. Opto-Tiam1’s τoff value is about a minute longer than that of BcLOV4-mCherry; this
longer membrane residence time may be due to Tiam1:Rac1 interactions at the
membrane.

4.3 Conclusions and future directions
Here, we present a set of optogenetic tools for the induction of filopodia and
lamellipodia formation at the GTPase and GEF level. Opto-Rac1 and opto-Cdc42 serve
as further examples that membrane recruitment of a wildtype GTPase is sufficient for
pathway activation. In the BcLOV4 system, mutations to lock the GTPase into its active
state are unnecessary; the use of a wildtype GTPase adds a requirement for GEF
interaction following membrane recruitment for signaling activation to occur, decreasing
the tool’s dark-state activity and reducing the chances of spurious pathway activation.
Like opto-RhoA, our opto-GTPase protrusion tools feature disrupted prenylation, making
them less likely to be activated by the cell signals that turn on endogenous GTPase
signaling and preventing their interaction with guanosine dissociation inhibitors,
increasing their orthogonality to cell GTPase populations (24, 65). Thus, opto-Cdc42 and
opto-Rac1 exhibit lower risk for disturbing basal cell physiology or outcompeting
endogenous GTPases than other systems.
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Figure 4.18

Membrane translocation kinetics of opto-Cdc42 and opto-Tiam1

Time constants were determined by correlation analysis between a membrane marker (pmGFP)
and line section profiles of the mCherry tag. N = 30 cells per construct. a. Membrane association
of opto-Cdc42: τon = 0.984 s, 95% CI 0.936-1.03 s. b. Membrane dissociation of opto-Cdc42: τoff =
98.7 s, 95% CI, 93.7-103.8 s. c. Membrane association of opto-Tiam1: τon = 1.34 s, 95% CI 1.271.42 s. d. Membrane dissociation of opto-Tiam1: τoff = 155.1 s, 95% CI, 136.9-173.2 s.

The GTPase and GEF tools we engineered for Rac1 and Cdc42 allow for two
levels of activation from a signal integration standpoint. The level of pathway activation
by an opto-GEF tool is limited by the endogenous cellular GTPase concentration, while
rapid turnover cycles by endogenous GEFs result in a more robust response by
overexpression of an opto-GTPase tool (78, 154, 155). Our characterization of the
effects of stimulation duty cycle can be used to guide use of opto-Rac1; similarly, the
finding that serum starvation is essential for robust lamellipodia formation with optoTiam1 may be useful to lower initial cytoskeletal tension for more effective pathway
induction using other tools. With the optogenetic tools presented in this chapter, we hope
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to explore their function in more migratory cell types and examine the connections
between the signaling pathways of Rho-family GTPases.

4.4

Materials and methods

4.4.1

Genetic constructs
Domain arrangement combinations of BcLOV4, mCherry, and its effector (Rac1,

Tiam1-DH, Cdc42, or Intersectin1-DH), with a flexible (GGGS)2 linker between each
protein pair were assembled into the pcDNA3.1 mammalian expression vector under a
CMV promoter by Gibson cloning with NEB HiFi DNA Assembly Master Mix (E2621).
BcLOV4 and mCherry were amplified from their previously reported mammalian codonoptimized fusion (Addgene plasmid 114595) (69). The DNA sequence of Rac1 (Genbank
ID AAH04247.1) was human codon-optimized using the Integrated DNA Technologies
(IDT) Codon Optimization Tool and ordered as a gBlock®, with a single C-terminal
leucine residue (of the “CAAX”-motif) removed to prevent prenylation and membrane
localization in dark-adapted fusions. The DH domain of Tiam1 was identified using the
PROSITE ExPASy database and amplified from pMXs3-TIAM1 (Addgene plasmid
86143). Wildtype Cdc42 GTPase was amplified from CLPIT Cry2PHR-mCherry-Cdc42
without the ‘CAAX’ motif to prevent prenylation, a kind gift from Lukasz Bugaj. The DH
domain of Intersectin1 was also identified using ExPASy and amplified from RpBphP1mCherry-Intersectin1-DHPH (Addgene plasmid 79839). For Tiam1 and Cdc42 tool
screening, mCherry-effector-BcLOV4 and effector-mCherry-BcLOV4 constructs were
also cloned with a C-terminal 3xFLAG tag following a GGGS linker.
The Rac1 constitutively active mutant was generated by QuikChange sitedirected mutagenesis (Q665L, E695H, and N696H) based on previously reported
mutations(260). Briefly, overlapping primers encoding the mutation with melting
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temperatures ≥ 78°C were designed using Agilent’s online primer design tool
(https://www.agilent.com/store/primerDesignProgram.jsp). The mutation was introduced
over 18 PCR cycles with 8-minute elongation time using the Phusion® high-fidelity DNA
polymerase master mix (M0531). The opto-RhoA template plasmid was digested with
DpnI for one hour at 37°C before transformation. All genetic constructs were transformed
into competent E. coli (New England Biolabs, C2984H).
For filopodia quantification, the miRFP703-tagged LifeAct plasmid was acquired
from Addgene (plasmid 79993). For membrane localization kinetics, pCIBN(deltaNLS)pmGFP was acquired from Addgene (plasmid 26867). Photoactivatable Rac1 (pTriExmCherry-PA-Rac1) was acquired from Addgene (plasmid 22027).

4.4.2

Cell culture and transient transfection
HEK293T (ATCC, CRL-3216) cells were cultured in D10 media composed of

Dulbecco’s

Modified

Eagle

Medium

with

Glutamax

(Invitrogen,

10566016),

supplemented with 10% heat-inactivated fetal bovine serum (FBS) and penicillinstreptomycin at 100 U/mL. Cells were maintained in a 5% CO2 water-jacketed incubator
(Thermo/Forma, 3110) at 37°C. Cells were seeded onto poly-D-lysine-treated glass
bottom dishes (MatTek, P35GC-1.5-14-C) or into 24-well glass bottom plates (Cellvis,
P24-1.5H-N), treated in-house with type I collagen, at 15-20% confluency. Cells were
transfected at ~30-40% confluency 24 hours later using the TransIT-293 transfection
reagent (Mirus Bio, MIR2700) according to manufacturer instructions and Opti-MEM™
reduced serum media (Thermo Fisher, 3195062). Cells were imaged 24-48 h posttransfection. For experiments imaging actin polymerization, full media was replaced with
serum starvation media (2% heat-inactivated FBS) at transfection.
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For normal handling, cells were passage, transfected, incubated, and transported
under standard laboratory lighting conditions, and then microscopy-based assays were
conducted with room lights off after an initial 10-minute dark-adaptation period. All data
reported were acquired under the normal handling conditions. Under “stringent”
conditions for Rac1 comparison studies, the cells were handled during all steps as
prescribed by others for PA-Rac1 to reduce basal optogenetic activity (263). Cell culture
was performed under red safe-light conditions. Cells were transferred in completely
opaque carriers. Assays were performed in dark rooms with all light-sources tuned off or
baffled, including electronic displays and monitors (263).
Cell viability for opto-Rac1 versus PA-Rac was determined by Trypan blue
staining. 24 hours after transfection, cells were washed with PBS and incubated with
0.2% Trypan Blue solution (diluted 1:1 with PBS from 0.4% stock solution) for one
minute. Trypan Blue solution was then aspirated, and cells were fixed with 4%
paraformaldehyde for 10 minutes at room temperature. After fixation, plates were rinsed
three times with PBS with agitation for five minutes per wash. Cells were then imaged at
20× magnification with brightfield illumination for three FOV per plate, two plates per
condition, to count the number of stained vs. unstained cells for each construct.

4.4.3

Fluorescence microscopy and hardware
Fluorescence microscopy was performed on an automated Leica DMI6000B

fluorescence microscope under Leica MetaMorph control, with a sCMOS camera
(pco.edge), an LED illuminator (Lumencor Spectra-X), and a 63× oil immersion
objective. Excitation illumination was filtered at the LED source (mCherry imaging λ =
575/25 nm; GFP imaging or widefield BcLOV4 stimulation λ = 470/24 nm; miRFP
imaging λ = 632/22 nm). Fluorescent proteins were imaged with Chroma filters: mCherry
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(T585lpxr dichroic, ET630/75 nm emission filter, 0.2–0.5 s exposure), GFP (T495lpxr
dichroic, ET 525/50 nm emission filter, 0.2 s exposure), miRFP703 (AT655dc dichroic,
ET655 nm emission, 0.5 s exposure). Cells were imaged at room temperature in CO2independent media (phenol-free HBSS supplemented with 1% l-glutamine, 1% penicillinstreptomycin, 2% essential amino acids, 1% nonessential amino acids, 2.5% HEPES pH
7.0, and 10% serum); LifeAct and lamellipodia imaging were performed in CO2independent media without serum. The spatially patterned illuminator was customconstructed from a digital light processor (DLP, Digital Light Innovations CEL5500), as
described in section 3.4.3.

4.4.4

Expression level and membrane:cytosol ratio measurement
HEK293T cells were co-transfected with a GFP membrane marker and mCherry-

tagged tool construct in a 1:10 ratio. Cells were imaged at 63× magnification for 3-5
fields of view per construct. mCherry fluorescence was imaged with a 0.5 s exposure
time, followed by GFP fluorescence imaging (0.2 s exposure). mCherry fluorescence
was the imaged again after 5 seconds of blue light stimulation.
To assess expression level, cells were manually segmented using the pmGFP
micrograph to identify cell boundaries, and background-subtracted fluorescence was
recorded for N = 25-31 cells per condition. Cell fluorescence was normalized to BcLOV4mCherry mean fluorescence. To measure membrane:cytosol fluorescence ratio, the
plasma membrane and cytosol were manually segmented using pmGFP localization as
a guide. The ratio of mean membrane to cytosol fluorescence was calculated for darkadapted and post-illumination states for N = 25-75 cells per condition.
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4.4.5

DMD stimulation assays
For assays using spatially patterned illumination, mCherry fluorescence was

imaged every 15 seconds for up to 10 minutes. During this time, cells were periodically
stimulated with DLP-patterned illumination (typically 25 m-wide squares, ~25% cell
area illuminated) with a 0.8 – 5% duty ratio range (or 0.25-1.5 s-long pulses once every
15-30 s). For actin polymerization visualization, miRFP fluorescence was imaged every
1 minute for up to 10 minutes. In the cases of mechanistic controls: for actin
polymerization inhibition, cytochalasin D (Cayman Chemical, 11330) was added to cell
media for a final concentration of 10 µM, 1 hour prior to imaging. For Rac1-GEF
inhibition, NSC 23766 (Cayman Chemical, 13196) was added to cell media for a final
concentration of 50 M, 24 hours prior to imaging. For Cdc42-GEF inhibition, ZCL 278
(Cayman Chemical, 14849), was added to cell media for a final concentration 7.5 µM, 2
hours prior to imaging. For Arp2/3 inhibition, CK 666 (Millipore-Sigma, SML0006), was
added to cell media for a final concentration of 500 µM, 6 hours prior to imaging.
Equimolar concentrations of inhibitors were also added to CO2 independent media for
imaging.

4.4.6

Tool function quantification
For all tools, each data point was derived from an independent video. The

researcher was blinded during cell segmentation to experimental condition to prevent
bias. Statistical significance was assessed by the non-parametric Mann-Whitney U test,
uncorrected for multiple comparisons.
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4.4.6.1 opto-Rac1
For each video (N = 19-37), a cell within the DMD-illuminated region was
selected and segmented in ImageJ from the frame imaged at 0 seconds postillumination and 120 seconds post-illumination. To compute the distance the cell had
moved between the two timepoints, the average distance between segmented cell
borders was calculated via a custom analysis Python script.

4.4.6.2 opto-Tiam1
Contours of cell boundaries at initial (pre-illumination) and final timepoints of the
DMD-stimulation region were manually drawn, and binary masks of the cell region inside
(the overlap) and outside (the non-overlap) the stimulation region were created using the
Python OpenCV bitwise operation functions “and” and “xor”, respectively. Percent
change in cellular area within the overlap region between initial and final timepoints was
calculated. For identification of a viable fusion tool construct, N = 6 independent videos
per condition. For comparison between serum-starved and serum-fed cells, N = 12
independent videos per condition. For comparison to BcLOV4, N = 9 independent videos
per condition.

4.4.6.3 opto-Cdc42
Contours of cell boundaries were drawn and masks were created as described in
(4.4.6.2). For opto-Cdc42 experiments, LifeAct fluorescence intensity was calculated
within the overlap region, normalized to the non-overlap region, for each timepoint. The
change in this normalized LifeAct fluorescence between initial and final timepoints was
calculated for each video. For screening, N = 6 independent videos per condition. For
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comparison to BcLOV4, N = 18 independent videos per condition. For inhibitor
characterization, N = 30 independent videos per condition.

4.4.7

Membrane localization kinetics
For membrane recruitment quantification, prenylated GFP was co-transfected as

a membrane marker with the BcLOV4 fusions as previously described in (4.4.4). Briefly,
an mCherry fluorescence image (500 ms exposure) was captured to assess protein
expression level and subcellular distribution. Cells were then illuminated with a 5 s-long
blue light pulse to stimulate BcLOV4, during which time mCherry fluorescence images
were also captured every 200 ms to monitor subcellular localization changes. The GFP
membrane marker was imaged immediately after blue light stimulation for correlation
analysis. For membrane dissociation via thermal reversion of the photoactivated protein
in the dark, mCherry was visualized every 5 seconds for 10-15 minutes in the absence
of blue light stimulation. Membrane localization and dissociation were measured by line
section analysis and correlation with prenylated GFP in ImageJ and MATLAB as
previously described (69).
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CHAPTER FIVE: Optogenetic tools for termination of GTPase signaling

5.1

Introduction
Much of our work to this point has revolved around engineering optogenetic tools

for spatiotemporally precise activation of signaling using GTPases and GEFs. True
bidirectional control of cytoskeletal signaling requires the ability to activate as well as
terminate pathways of interest. We sought to engineer a new class of optogenetic tools
to terminate RhoA signaling by antagonism (using dominant negative RhoA GTPase)
and enzymatic hydrolysis (using RhoA GAP domains). Development of these
optogenetic termination tools will complete the RhoA optogenetic toolbox and greatly
enhance our ability to study processes like cell migration and mechanotransduction.

5.1.1

Rho GTPase biosensors
In creating optogenetic tools to control GTPase signaling termination,

quantification of tool function may not be as simple as observing changes in cell shape
or actin polymerization. Induced termination of GTPase signaling events which exist at a
low basal level in the cell may not result in pronounced morphological changes; thus, the
ability to differentiate between inactive, GDP-bound GTPase and active, GTP-bound
GTPase is useful in determining tool efficacy. Biosensors are proteins allowing for the
quantification of intracellular concentrations and localizations of molecules or proteins
using fluorescence readout (123). For optogenetic signaling termination tools, we are
interested in using a GTPase biosensor to measure whether recruitment of a terminating
protein results in less GTP-loaded GTPase at the membrane.
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For Rho GTPase signaling, two main classes of biosensors exist: FRET-based
and localization-based (186). FRET-based biosensors can be bimolecular or
unimolecular. For bimolecular sensors (Figure 5.1a), two constructs are expressed in
the cell: the GTPase fused to a FRET acceptor (e.g., YFP) and a downstream effectorbinding protein domain (EBD) is fused to a FRET donor (e.g., CFP). In the off state, the
GTPase is GDP-bound and does not interact with its downstream effector. In the on
state, activated GTPase interacts with the effector and the EBD binds the active effector.
This brings the FRET pair in close proximity and FRET is observed (128).
An obvious downside of the bimolecular biosensor is the requirement that two plasmids
be expressed, in addition to the optogenetic tool of interest, requiring stoichiometric
tuning of the system components and a higher genetic payload for the cell. In contrast,
unimolecular FRET biosensors (Figure 5.1b) consist of one protein component: GTPase
and FRET donor are fused to FRET acceptor and a GTPase binding domain (GBD) by a
long linker. The GBD preferentially binds the GTPase only in its active GTP-bound state.
Thus, in the off state, no FRET is observed. GTPase activation induces GBD-GTPase
binding, resulting in FRET between the fluorescent proteins (109, 270). Variations on the
unimolecular FRET-based biosensor also exist: fluorophores can be positioned inside
the clamshell fold created by activation (187), or endogenous GTPase activation can be
visualized by fusing the GTPase binding domain between FRET donor and acceptor. In
this configuration, FRET is observed in the inactive state and disrupted when the GBD
binds activated GTPase. This variation alleviates the need to express multiple proteins in
the cell and allows for visualization of endogenous rather than overexpressed GTPase
activity (270).
However, issues with FRET-based biosensors still exist, particularly when used
in conjunction with optogenetic tools. For example, the commonly used CFP-YFP FRET
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pair is incompatible with spatially confined illumination of a blue light-excited LOV-based
optogenetic tool as visualizing the FRET pair would result in activation of the LOV. Also,

Figure 5.1

Types of biosensors for GTPase signaling interrogation
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a. In bimolecular FRET systems, the GTPase is fused to a FRET donor, while an effector binding
domain (EBD) are fused to a FRET acceptor. GTPase activation results in EBD-effector binding,
bringing the fluorescent proteins together and resulting in FRET. b. In unimolecular FRET
systems, the FRET donor and acceptor are separated by the GTPase, a GTPase binding domain
(GBD) and a long linker. GTP loading results in GBD binding the activated GTPase and colocalization of the FRET pair. c. Localization-based biosensors fuse a GBD to a fluorescent
protein. Changes in fluorescence localization and intensity reflect changes in GTPase activation.

more generally, FRET systems take up valuable visualization channel bandwidth,
limiting the number of fluorescent proteins available for observing other cellular
phenomena. This bandwidth issue is compounded with optogenetic tools, which also
limit the number of available optical channels.
A solution to the FRET biosensor issue is the use of localization-based
biosensors. In these systems, a GBD with preference for the GTP-bound GTPase is
fused to a fluorescent protein; when the GTPase is activated, a change in fluorescence
intensity and localization is observed (14). For example, for a GTPase signaling at the
membrane, we expect high cytosolic fluorescence when GTPase signaling is in the off
state, and high membrane fluorescence in the on state. This system uses one protein
and one optical channel to visualize endogenous GTPase activation. While this system
is associated with high background signal because the fluorescent protein does not “turn
on” in response to signaling, it is more compatible with optogenetic tools than FRETbased systems. Notably, a major addition to the localization-based biosensor class was
recently reported (151). From a starting point of GFP-bound Rhotekin GBD (14), a
second GBD was added each sensor to increase signal, and monomeric GFP or
mNeonGreen was replaced with a dimeric fluorescent protein (dTomato) to improve tool
resolution. This biosensor is also specific to RhoA, unlike other biosensors which can
bind multiple GTPases (199).
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5.1.2

Strategies for terminating Rho GTPase signaling
As discussed in Chapter 1, GAPs inactivate GTPases by catalyzing hydrolysis of

GTP to form GDP. Similar to optogenetic recruitment of GEF proteins to activate
endogenous GTPase at the membrane, we hypothesize that spatiotemporally precise
GAP recruitment will result in GTPase inactivation. This strategy was successfully
implemented in a Drosophila tool, recruiting the RhoA-specific GAP RhoGAP71E to alter
embryogenesis (132). To our knowledge, this approach has not been applied in
mammalian cell systems. Activating GEFs can also be sequestered to the mitochondria,
resulting in a decrease in pathway activation, as described with a cryptochrome
heterodimerization tool (249). Another strategy for inactivation of GTPase signaling in
the cell is through the use of dominant negative GTPase mutants (Figure 5.2). These
mutants bind and sequester GTPase-activating GEFs, resulting in inactivation of the
GTPase (59) and have long been used to inhibit signaling and identify cell processes
that are affected. A dominant negative RhoA mutant (T19N) has been used to implicate
RhoA in stem cell differentiation and proliferation (66). However, this strategy for
signaling perturbation has only been used in an overexpression context rather than as a
POI in optogenetic tool development. We hypothesize that by recruiting a dominant
negative GTPase to the membrane, we can inhibit GTPase signaling through GEF
sequestration and engineer a new class of optogenetic inactivation tools.
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Figure 5.2

Mechanism of dominant negative GTPase inhibition

a. For wildtype GTPases, activation is catalyzed by GEF proteins, which exchange the bound
GDP for GTP. The GTP-bound GTPase can then interact with downstream effectors and catalyze
signaling events. b. Dominant negative GTPase mutants bind and sequester GEFs, preventing
them from activating their partner GTPases. As a result, GTPase signaling remains in the inactive
state.

5.1.3

Problem statement
To understand complex cell signaling feedback loops and processes involved in

migration, we need to be able to perturb both signaling activation and termination. To
accomplish this larger goal, a new class of optogenetic tools is needed which use light to
recruit proteins to the membrane for inhibition of GTPase signaling. To accomplish this
goal, we will use two parallel strategies: recruiting GAPs to catalyze GTP hydrolysis and
GTPase inactivation, and recruiting dominant negative GTPase mutants to sequester
activating GEFs and prevent activation from occurring. In addition to measuring changes
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in cell morphology, we will use the new dTomato-2xrGBD biosensor to quantify RhoAGTP levels before and after membrane recruitment as a means of assessing tool
function.

5.2

Results and discussion

5.2.1

Selection of candidate GAP domains
We decided to focus our initial GAP engineering work on the RhoA pathway

because of the availability of a single-chain GBD-based biosensor for RhoA-GTP
(dTomato-2xrGBD). To our knowledge, comparable sensors for Rac1- and Cdc42- GTP
do not yet exist. Twenty-seven GAP domains are known to inactivate RhoA (170); in
choosing GAPs to fuse to BcLOV4, we focused on RhoA GAPs known to localize to the
plasma membrane which showed evidence of controlling RhoA-mediated cell
contractility and stress fiber formation. Using these criteria, we selected two initial
candidates: ARHGAP1 and ARHGAP29. ARHGAP1, also known as p50RhoGAP, has
been shown to translocate between the cytosol and the inner leaflet when it is activated
(44, 223). ARHGAP29 is implicated in a RhoA-YAP mechanotransductive feedback loop.
Activation of RhoA drives YAP nuclear import, where it activates transcription factors to
increase ARHGAP29 transcription. ARHGAP29 is thought to turn off RhoA signaling and
prevent cytoskeletal over-maturation, which would otherwise inhibit persistent cell
motility (157).

5.2.2

Screening method for GAP tool functionality
Observing light-induced signaling with BcLOV4-GAP constructs requires a

different experimental and analysis workflow than those used for GTPase or GEF tools.
With activation tools, the cell is starting from a “resting state” in which signaling occurs at
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a low basal level. Membrane recruitment of the GTPase or GEF results in an increase in
signaling above the baseline, which is readily observable in the case of cytoskeletal
signaling pathways. In contrast, membrane recruitment of a GAP tool would theoretically
result in a decrease in signaling events below the already low baseline, resulting in lower
contrast between on- and off-states than observed with activation tools. For example, in
the case of RhoA signaling, we observed that the resting state cell does not show
extensive stress fibers or cytoskeletal tension. Membrane recruitment of a RhoA GAP,
then, may not result in appreciable change in stress fiber formation from the basal state.
Thus, for initial characterization of GAP tools, our strategy was to first
pharmacologically activate RhoA signaling with lysophosphatidic acid (LPA), which binds
to cell receptors LPA1 and LPA2. The C-termini of these receptors interact with the PDZ
domains of RhoA-activating ARHGEF11 and ARHGEF12, resulting in increased stress
fiber formation (265). Then, from a state of elevated RhoA signaling, we will then recruit
the GAP tool to the membrane with blue light, ideally allowing for more contrast between
on and off tool state.

5.2.3

Initial screening of GAP tool constructs
Our first RhoA GAP tool engineering attempt used the full ARHGAP1 gene in the

standard BcLOV4 screening workflow. In addition to its GTPase-interacting GAP
domain, ARHGAP1 also contains a CRAL-TRIO (183) (cellular retinaldehyde-binding
protein and TRIO-GEF) domain, which allows the protein to bind lipids of the plasma
membrane. Because of previous successful engineering by us and others using both the
catalytic and the lipid-binding domains (i.e., DH and PH domains) in GEF tool
engineering, we did not initially remove the non-catalytic domain from ARHGAP1 for
BcLOV4 fusion screening.
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From the initial six-construct screening workflow, only one construct (ARHGAP1BcLOV4-mCherry) expressed in HEK293T cells. Interestingly, rather than localizing to
the membrane, this construct formed a multi-micron aggregate in the cytosol in response
to blue light stimulation, suggesting localization to an organelle. We analyzed illuminated
ARHGAP1 localization by co-transfecting organelle markers and saw good alignment of
lit-state protein with the Golgi apparatus (Figure 5.3). This result suggests that the fulllength ARHGAP1-BcLOV4 fusion exhibits lipid binding with some specificity to the Golgi
membrane, either due to specific lipid head group composition or larger membrane
characteristics like curvature or disorder.
For subsequent engineering attempts with both ARHGAP1 and ARHGAP29, we
truncated the fused protein to contain only the GAP domains as predicted by the
PROSITE ExPASy database. For ARHGAP1, we saw no viable, healthy cells for
mCherry-BcLOV4-ARHGAP1, and cells for BcLOV4-ARHGAP1-mCherry were very dim.
The remaining constructs exhibited high expression; two of these (ARHGAP1-mCherryBcLOV4-3xFLAG and mCherry-ARHGAP1-BcLOV4-3xFLAG) bound the membrane in
response to blue light stimulation. For ARHGAP29, only BcLOV4-ARHGAP29-mCherry,
BcLOV4-mCherry-ARHGAP29, and ARHGAP29-BcLOV4-mCherry expressed in HEK
cells; BcLOV4-mCherry-ARHGAP29 did not associate with the membrane but the other
two constructs did. These ARHGAP1 and ARHGAP29 fusion constructs will be starting
points for further characterization to determine if light-induced GAP signaling occurs at
the membrane.
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Figure 5.3

Light-induced Golgi association of full-length ARHGAP1-BcLOV4

a. Following a 5 second pulse of blue light, a large protein aggregate gradually appeared in the
cytosol. b. This protein aggregate overlaps with an mCitrine-tagged Golgi tag. Scale = 10 µm.
Yellow arrows = aggregated protein.
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Figure 5.4

Molecular engineering of ARHGAP1-BcLOV4 fusions

a. Domain arrangement combinations of BcLOV4, ARHGAP1, and mCherry visualization tag.
Domains were separated by flexible (GGGS)2 linkers. b. Fluorescence micrographs showing
representative expression patterns of the soluble domain arrangements in the dark-adapted state
in HEK293T cells. Scale = 10 μm. c. Relative expression level of genetic constructs versus
BcLOV4-mCherry control with no effector. N = 30 cells per condition. Center line, median; “X”,
mean; box limits, upper and lower quartiles; whiskers, 1.5x interquartile ranges d. Representative
membrane localization of cytosolic-expressing constructs following blue light stimulation. (Top)
Fluorescence micrograph; scale = 10 μm. (Bottom) Line section pixel intensity.
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Figure 5.5

Molecular engineering of ARHGAP29-BcLOV4 fusions

a. Domain arrangement combinations of BcLOV4, ARHGAP29, and mCherry visualization tag.
Domains were separated by flexible (GGGS)2 linkers. b. Fluorescence micrographs showing
representative expression patterns of the soluble domain arrangements in the dark-adapted state
in HEK293T cells. Scale = 10 μm. c. Relative expression level of genetic constructs versus
BcLOV4-mCherry control with no effector. N = 30 cells per condition. Center line, median; “X”,
mean; box limits, upper and lower quartiles; whiskers, 1.5x interquartile ranges. d. Representative
membrane localization of cytosolic-expressing constructs following blue light stimulation. (Top)
Fluorescence micrograph; scale = 10 μm. (Bottom) Line section pixel intensity.
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5.2.4

RhoA-GTP biosensor characterization
The most straightforward method for basic functional characterization of GAP

tool constructs is through the use of a GTPase biosensor. This approach gives
quantitative readout indicating whether the tool in its activated state is altering the
amount of active GTPase with subcellular spatial precision. For our tool engineering, we
used the dTomato-2xrGBD RhoA-GTP biosensor, which binds GTP-bound RhoA with
higher affinity than RhoA-GDP. Thus, RhoA signaling activation at the membrane will
correspond with a decrease in cytosolic biosensor fluorescence and an increase in
fluorescence in the periphery of the membrane. As previously described (130),
measuring membrane fluorescence intensity from widefield micrographs can lead to
numerical confounds due to convolution and imaging artifacts, so we will use cytosolic
fluorescence intensity to quantify changes in biosensor localization
In the basal state, the biosensor expresses in the cytosol of HEK293T cells.
Following the addition of LPA at a final concentration 10 µM, we observed a decrease in
cytosolic biosensor and an increase in biosensor localized to the membrane. The extent
of the cytosolic intensity decrease ranges between 30 and 50 percent of the prestimulation baseline with variance from cell to cell; the decrease stops about three
minutes after LPA addition (Figure 5.6). Notably, in our hands, significant
photobleaching of the dTomato fluor occurred throughout the imaging time course,
underscoring the importance of using sparse biosensor imaging paradigms when
possible and correcting for bleaching by calculating fluorescence decrease in nontreated cells subjected to the same excitation pulse sequence.
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Figure 5.6

RhoA biosensor and LPA stimulation

a. Representative images of dTomato-2xrGBD in HEK293T cells. b. Fluorescence micrographs of
biosensor-expressing cells before and after LPA stimulation. c. Quantification of cytosolic
biosensor intensity for cells shown in (b), normalized to initial fluorescence readout prior to LPA
stimulation. Scale = 10 µm.

Next, we sought to test the RhoA biosensor compatibility with BcLOV4-based
tools. We co-expressed a Clover-tagged opto-RhoA with the dTomato-tagged biosensor
and observed decrease in cytosolic biosensor similar to that caused by LPA stimulation
147

(Figure 5.7a-b). This result demonstrates that RhoA-GTP readout is compatible with the
BcLOV4 system. The increased biosensor intensity at the membrane following blue light
stimulation also provides further evidence that opto-RhoA is GDP-bound prior to
recruitment to the membrane, where it is activated by endogenous RhoGEFs. For
spatially confined illumination, biosensor localization remained the same in the cytosol
outside of the stimulated region and increased at the membrane within the illumination
boundary (Figure 5.7c). We also tested the biosensor with the co-expression of either
3xFLAG-tagged BcLOV4 or 3xFLAG-tagged opto-RhoA (Figure 5.8). Over a 10-minute
time course, we observed a ~15% drop in cytosolic biosensor signal for BcLOV4,
compared to ~40% for opto-RhoA, underscoring the need for photobleaching correction
in these assays.

5.2.5

Preliminary characterization of ARHGAP tool activity
We used the biosensor transfection and imaging conditions determined above to

test the viability of BcLOV4-RhoA GAP fusions. In this assay, FLAG-tagged ARHGAP1BcLOV4 or ARHGAP29-BcLOV4 were co-transfected with the biosensor. BcLOV43xFLAG was used as a negative control. Cells were treated cells with LPA for three
minutes, then subjected to blue light stimulation with a 1.6% duty cycle for ten minutes.
LPA treatment resulted in an initial decrease in cytosolic biosensor signal and an
increase in biosensor at the membrane. However, for the ARHGAP1-BcLOV4-3xFLAG
condition, recovery of the cytosolic fluorescence intensity was observed within 30
seconds of blue light stimulation, eventually plateauing above the baseline observed
prior to LPA addition. In contrast, BcLOV4-3xFLAG trace remained flat following the
initial decrease caused by LPA treatment (Figure 5.9). These data suggest that
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ARHGAP1-BcLOV4 may be a functional starting point for light-inducible GTPase
signaling termination.
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Figure 5.7

RhoA biosensor with opto-RhoA-Clover

a. RhoA biosensor (dTomato-2xrGBD) and opto-RhoA-Clover expressing cells stimulated with
whole-field blue light with a 1.6% stimulation duty cycle. Dark state opto-RhoA image via Clover
visualization tag could not be captured without stimulating the LOV. b. Quantification of cytosolic
biosensor fluorescence with whole-field stimulation, normalized to fluorescence at time 0. c.
RhoA biosensor and opto-RhoA-Clover expressing cells stimulated with spatially confined blue
light with a 1.6% stimulation duty cycle. Top, micrographs visualized on dTomato (biosensor)
channel. Bottom, line section profile intensity plots. White box = stimulated region. Scale = 10 µm.
Red line = line section.
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Figure 5.8

Biosensor visualization of widefield opto-RhoA stimulation

BcLOV4-3xFLAG and opto-RhoA-3xFLAG were co-expressed with dTomato-2xrGBD. a.
Fluorescence micrographs of cells stimulated with widefield blue light with a 1.6% stimulation duty
cycle. Scale = 10 µm. b. Cytosolic biosensor intensity over 10 minutes of stimulation, normalized
to initial fluorescence at time 0. Mean ± SEM.
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Figure 5.9

Characterization of opto-GAP tool function

BcLOV4-3xFLAG and ARHGAP1-3xFLAG were co-expressed with dTomato-2xrGBD. LPA
stimulation (10 µM) was applied at time 0; whole-field blue light was applied with a 1.6%
stimulation duty cycle beginning at 3 minutes. a. Representative images of biosensor in cells over
the course of the experiment. Scale = 10 µm. b. Quantification of cytosolic biosensor, normalized
to initial value at time 0.

5.2.6

Characterization of opto-RhoA-DN activity
In addition to GAP tool engineering, we also made some progress in the use of

the BcLOV4-fused dominant negative RhoA GTPase as a new optogenetic tool. We
expected recruitment of this protein to bind endogenous RhoA GEFs and prevent RhoA
activation at the membrane. Early data shows that spatially confined illumination of optoRhoA-T19N-mCherry-expressing HEK293T cells results in membrane protrusion
formation within the stimulated zone (Figure 5.10a). Whole-field stimulation also showed
some membrane ruffling and the appearance of an increase in cell area (Figure 5.10b).
These results may suggest that RhoA signaling inhibition by the dominant negative tool
results in disinhibition and apparent activation of the Rac1 GTPase. Further experiments
are necessary to understand these protrusions better: a first step lies in determining
whether the observed protrusions are a result of actin disassembly or concerted Rac1
activation. Interestingly, Rac1 and RhoA are typically active at different poles of the cell;
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that we are observing possible Rac1 activation in the same region as RhoA inactivation
may reveal new insight into RhoA-Rac1 feedback and spatial signal integration (35).

Figure 5.10

Characterization of opto-RhoA-DN

HEK293T cells expressing opto-RhoA-DN were visualized by mCherry tag with (a) spatially
confined stimulation and (b) widefield stimulation at a 1.6% duty cycle. White box = stimulated
region. Yellow dotted line = initial cell boundary at time 0. Scale = 10 µm.

5.3

Conclusions and future directions

5.3.1

Conclusions
Here, we report initial progress in the creation of RhoA GAP and RhoA dominant

negative tools. For GAP perturbation, we observed a decrease in pharmacologically
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elevated RhoA-GTP levels following light-induced activation of an ARHGAP1-BcLOV4
fusion in HEK293T cells. For dominant negative RhoA, we observe protrusion formation
following tool stimulation, suggesting either disassembly of RhoA-polymerized actin or
the disinhibition of Rac1, resulting in lamellipodia formation. We plan to carry out more
extensive characterization and application of these tools as described below.

5.3.2

Further characterization of GAP and DN tools
Several experiments are necessary to characterize the RhoA GAP tools. First,

we will repeat the biosensor assay in which RhoA signaling is initially stimulated with
LPA and then terminated by BcLOV4-GAP membrane recruitment. In addition to
increasing sample size allowing for statistical comparison to dark-state controls, we also
seek to understand the timescale and extent of GAP inactivation that can be achieved in
this setup. Of particular interest is whether the increase in cytosolic biosensor above preLPA treatment baseline observed in the pilot GAP study is reproducible; if so, it may
suggest that pharmacological RhoA stimulation is not necessary to observe GAP
activation with the RhoA biosensor. In addition, we will conduct the same experiment
with DMD stimulation to determine how cell polarization and angle of blue light
stimulation affect GAP tool activity, as well as morphological changes which may occur
to the rest of the cell following increased local concentration of RhoA GAP.
We also plan to characterize the effect of the GAP tools on cell polarization and
investigate whether they can be used to delay or inhibit cell polarization and actin cap
formation. We will compare the proportion of GAP tool-expressing cells exhibiting wellformed actin caps (visualized by phalloidin staining) following trypsinization and plating
in lit versus dark state conditions compared to BcLOV4 control cells. We hypothesize
that membrane recruitment of the GAP will prevent cell polarization, resulting in more
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rounded cells without actin caps in the lit state. Finally, we plan to use opto-GAP tools to
characterize the timescales of RhoA activation and inactivation. Specifically, we will use
genetically encoded biosensors and fluorescently tagged proteins to compare how long
it takes to observe changes in downstream proteins like ROCK and myosin light chain,
as well as cytoskeletal changes like actin organization and focal adhesions following
signaling activation or termination.
For dominant negative GTPase tools, the most pressing question is to determine
what is underlying the light-induced protrusion formation we have observed. To
determine whether the phenomenon is due to Rac1 activation or simply actin
disassembly, we will visualize polymerized actin in either live cells using LifeAct or fixed
cells using phalloidin. A decrease in polymerized actin in the lit state suggests
disassembly, while an increase suggests a GTPase-mediated event. We can also use
pharmacological inhibitors of Rac1 signaling like GEF inhibitor NSC 23766 and Arp2/3
inhibitor CK 666 to confirm that Rac1 mediates the protrusions we observe. Identification
of a suitable Rac1 biosensor would provide further confirmation that membrane
recruitment of dominant negative RhoA results in disinhibition of Rac1. Identification of
the mechanism of protrusion formation will enable us to use the dominant negative tool
to investigate RhoA-Rac1 feedback.

5.3.3

Investigating RhoA-YAP mechanotransduction
A major motivation of the creation of the BcLOV4 Rho GTPase optogenetic

toolbox was the ability to answer interesting biological questions which previously could
not be explored in such depth. An example of this kind of question is the RhoA-YAP
mechanotransductive feedback loop (157) which drives persistent cell migration.
Creation of opto-RhoA, including wildtype, dominant negative, and constitutively active
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mutants, as well as opto-RhoGAP and opto-RhoGEF will allow us to systematically
perturb each node in the feedback loop and measure the changes they effect on YAP
nuclear localization through visualization of fluorescently tagged or immunolabeled YAP,
on transcription through qPCR, and cell migration through long-timescale microscopy
assays.
Specifically, we can compare the effects of RhoA activation using opto-RhoA and
opto-RhoGEF and measure the effects of local GAP:GEF balance on downstream YAP
signaling. Because RhoA signaling leads to RhoGAP transcriptional upregulation, an
interesting question is whether the constitutively active opto-RhoA leads to a similar
increase in RhoGAP expression. The G17V mutation in the constitutively active RhoA
mutant renders it insensitive to GAP-mediated hydrolysis, leading us to question whether
its GAP insensitivity would change the nature of the GAP upregulation feedback loop.
Finally, we will compare signaling turn-off mechanisms using opto-RhoGAP and optoRhoA-DN to determine their effects on cytoskeletal tension and the timescale of GTPase
inactivation. Characterizing this feedback loop using the tools described in this thesis
would allow us to uncover new biological insights into persistent cell migration and
deepen our understanding of how cells integrate transcription, signaling, and mechanics.

5.3.4

Investigating RhoA-Rac1 feedback
An important aspect of Rho GTPase signaling which is not fully understood is the

ability of GTPases to regulate each other. An example of this inter-pathway crosstalk is
the RhoA-Rac1 feedback loop. RhoA and Rac1 activation events are often localized to
opposite ends of the migrating cell, with RhoA initiating contraction at the trailing edge
while Rac1 induces protrusions to drive the leading edge forward(35). RhoA and Rac1
have been demonstrated to inhibit each other, though many questions remain. Adding
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the RhoA dominant negative tool to our signaling toolbox will allow us to investigate the
mechanism of RhoA-Rac1 crosstalk by selectively inhibiting RhoA signaling and
comparing subsequent Rac1 signaling to direct pathway activation using opto-Rac1 or
opto-Tiam1. We will also use pharmacological inhibitors of Rac1 signaling to learn about
the mechanism through which RhoA inhibition activates Rac1.
In parallel, we will also create a dominant negative form of opto-Rac1 through the
T17N mutant (40) and determine whether parallel inhibition and activation can be
observed, i.e., cell contraction following Rac1 inhibition implying disinhibition of RhoA.
Using biosensors in conjunction with dominant negative tools, we will investigate how
local concentrations of GTPases and GEFs as well as underlying cell polarity affects
crosstalk. Specifically, we will co-express wildtype GTPase (i.e., opto-RhoA and optoRac1) or dominant negative GTPase (i.e., opto-RhoA-DN and opto-Rac1-DN) tools and
recruit both tools simultaneously to the membrane using DMD-patterned illumination,
thus activating or inhibiting both players in the feedback loop. We will measure the
effects of this dual inhibition using a RhoA or Rac1 biosensor and observed changes in
cell morphology to uncover the relative magnitudes of RhoA and Rac1 inhibition and
uncover the spatial integration dynamics of the feedback loop.
GEF and GAP tools can also be used to inform mechanism of RhoA-Rac1
feedback, as some proposed mechanisms of inhibition include RhoA activating a Rac1inhibiting GAP (182) and Rac1 inhibiting a RhoA-activating GEF (176). Using the
expanded BcLOV4 toolbox, we can test these proposed mechanisms: for example, we
can locally activate a Rac1 GAP to determine whether RhoA activity increases, or
inactivate RhoA GEFs using dominant negative Rac1. In conjunction with experiments
with pharmacological GEF and GAP inhibitors, we can gain new mechanistic insight into
RhoA-Rac1 interaction. Overall, expanding the BcLOV4 toolbox to include dominant
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negative GTPases will allow for more thorough investigation of the mechanisms behind
Rho GTPase crosstalk and regulation.

5.4

Materials and methods

5.4.1

Genetic constructs
Domain arrangement combinations of BcLOV4, mCherry, and the ARHGAP1 or

ARHGAP29 effector (with a flexible (GGGS)2 linker between each pair) were assembled
into the pcDNA3.1 mammalian expression vector under a CMV promoter by Gibson
cloning with NEB HiFi DNA Assembly Master Mix (E2621). BcLOV4 and mCherry were
amplified from their previously reported mammalian codon-optimized fusion (Addgene
plasmid 114595) (69). The DNA sequences of ARHGAP1 (Genbank ID NP_004299.1)
and ARHGAP29 (Genbank ID AAH93741.1) were human codon-optimized using the
Integrated DNA Technologies (IDT) Codon Optimization Tool and ordered as a gBlock®
from IDT or as a synthesized gene without adapters from Twist Biosciences. The GAP
domain of each protein was identified using the PROSITE ExPASy database and
amplified from the full-length gene. All genetic constructs were transformed into
competent E. coli (New England Biolabs, C2984H). All sequences were verified by
Sanger sequencing.
The RhoA dominant negative (T19N) mutant was generated by QuikChange sitedirected mutagenesis according to manufacturer’s instructions. Briefly, overlapping
primers encoding the mutation with melting temperatures ≥ 78°C were designed using
Agilent’s

online

primer

design

tool

(https://www.agilent.com/store/primerDesignProgram.jsp). The mutation was introduced
over 18 PCR cycles with 8-minute elongation time using the Phusion® high-fidelity DNA
polymerase master mix (New England Biolabs, M0531). The opto-RhoA-mCherry
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template plasmid was digested with DpnI for one hour at 37°C before transformation into
Turbo competent cells.
For co-localization experiments, GFP membrane marker (pCIBN(deltaNLS)pmGFP, #26867) and Golgi marker (mCitrine-SiT-N-15, # 56318) were acquired from
Addgene. The RhoA-GTP biosensor was acquired from Addgene (dTomato-2xrGBD,
#129625).

5.4.2

Cell culture and transient transfection
All mammalian cells were maintained in a 5% CO2 water-jacketed incubator

(Thermo/Forma ,3110) at 37°C. For imaging experiments, cells were seeded onto polyD-lysine-treated glass bottom dishes (MatTek, P35GC-1.5-14-C) or into 24-well glass
bottom plates (Cellvis, P24-1.5H-N), treated in-house with type I collagen, at 15-20%
confluency. Cells were transfected 24 hours after seeding at ~30-40% confluency, then
imaged 24-48 hours after transfection. All transfections were performed with OptiMEM™ reduced serum media (Thermo Fisher, 3195062).
HEK293T (ATCC, CRL-3216) were cultured in D10 media composed of
Dulbecco’s

Modified

Eagle

Medium

with

GlutaMAX

(Invitrogen,

10566016),

supplemented with 10% heat-inactivated fetal bovine serum (FBS) and penicillinstreptomycin at 100 U/mL. HEK cells were transfected using the TransIT-293
transfection reagent (Mirus Bio, MIR2700) according to manufacturer instructions.

5.4.3

Fluorescence microscopy and hardware
Fluorescence microscopy was performed on an automated Leica DMI6000B

fluorescence microscope under Leica MetaMorph control, with a sCMOS camera
(pco.edge), an LED illuminator (Lumencor Spectra-X), and a 63× oil immersion
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objective. Excitation source illumination was filtered at the LED source (mCherry imaging
λ = 575/25 nm; GFP or Alexa Fluor 488 imaging or widefield BcLOV4 stimulation λ =
470/24 nm; mCitrine imaging λ = 513/17 nm). Fluorescent proteins were imaged with
Chroma filters: mCherry (T585lpxr dichroic, ET 630/75 nm emission filter, 0.2-0.5 s
exposure), GFP (T495lpxr dichroic, ET 525/50 nm emission filter, 0.2 s exposure),
mCitrine (T520lpxr dichroic, ET 535/30 nm emission filter, 0.5 s exposure). Digital
micromirror device (DMD) was constructed as described in Chapter 3.
Cells were imaged at room temperature in CO2-independent media (phenol-free
HBSS supplemented with 1% l-glutamine, 1% penicillin-streptomycin, 2% essential
amino acids, 1% nonessential amino acids, 2.5% HEPES pH 7.0, and 10% serum).

5.4.4

Expression level measurement
HEK293T cells were co-transfected with a GFP membrane marker and mCherry-

tagged tool construct in a 1:10 ratio. Cells were imaged at 63× magnification for 3-5
fields of view per construct. mCherry fluorescence was imaged with a 0.5 s exposure
time, followed by GFP fluorescence imaging (0.2 s exposure). mCherry fluorescence
was the imaged again after 5 seconds of blue light stimulation.

N = 30 cells per

condition.

5.4.5

Widefield and DMD stimulation assays
For widefield stimulation assays, mCherry fluorescence was imaged before a 5-

second pulse of blue light. mCherry fluorescence was then imaged every 15-30s for 10
min following stimulation. For data analysis, each cell was treated as a separate data
point, with N = 30 cells per condition. For DMD stimulation assays, mCherry
fluorescence was imaged every 15 seconds for 10 minutes. During this time, cells were
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stimulated for one second per minute (1.6% duty cycle) patterned illumination (25 μmwide square encompassing ∼25% of cell area). For widefield and DMD stimulation
assays, statistical significance was assessed by the two-sided non-parametric MannWhitney U test, uncorrected for multiple comparisons.

5.4.6

Biosensor and stimulation experiments
The RhoA-GTP biosensor was co-transfected with the tool plasmid of interest at

a 1:1 ratio. The biosensor was imaged using mCherry settings (FIM 100, 0.5 s
exposure). Biosensor localization changes were measured by defining a cytosolic region
of interest and measuring fluorescence intensity in that region over time. For RhoA
activation, lysophosphatidic acid (18:1 LPA, Avanti Polar Lipids, 857130P) was prepared
as a 1 mM stock in a 1:1 mixture of ethanol and water. Aliquots were stored at -20 °C in
glass vials with Teflon caps. Prior to use, aliquots were warmed on a 50 °C heat block
for 10 minutes, then homogenized in a water bath sonicator for 2-5 minutes. For
stimulation, cells were treated with LPA for a final concentration of 10 mM, either by
adding the lipid mixture directly to cells using a Hamilton syringe or by perfusing serumfree CO2 independent media pre-mixed with LPA over cells using a syringe pump at a
rate of 0.5 mL/min.
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CHAPTER SIX: Design principles governing BcLOV4 tool engineering

This chapter adapts work from the following publication:

Berlew, E. E.; Yamada, K.; Kuznetsov, I. A.; Rand, E. A.; Ochs, C. C.; Jaber, Z.;
Gardner, K. H.; Chow, B. Y., Designing single-component optogenetic membrane
recruitment systems: the Rho-family GTPase signaling toolbox. ACS Syn Biol 2022.

Author contributions: EEB and KY designed genetic constructs, designed experiments,
conducted experiments, and analyzed data. IAK constructed the patterned illumination
system, conducted the FRAP measurement, and contributed to automated data analysis
development. EAR and CO assisted with genetic construct design, engineering, and
assays. BYC coordinated all research. All authors contributed to data analysis and
manuscript preparation.

6.1

Introduction

6.1.1

BcLOV4 structure-function
Optogenetic tools made from different photosensory proteins differ in signal

transduction mechanism from sensor to effector. In membrane recruitment systems, the
structural basis of this mechanism determines the design rules for how the tool platform
can be engineered to bring proteins of interest to the plasma membrane. To our
knowledge, BcLOV4 is the first characterized RGS-LOV protein; while its individual
protein domains bear sequence homology to known RGS and LOV proteins and its
photocycle kinetics are in line with previously reported LOVs, structural insight into
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BcLOV4 and other RGS-LOVs is still emerging. Elucidation of the structure-function
underlying BcLOV4’s light-induced conformational change and lipid binding will support
its use as an optogenetic tool platform.
As discussed in chapter 2, BcLOV4 is a multi-domain protein: RGS, LOV, and
PAS-like domain of unknown function (DUF) domains are preceded by a 98-residue
disordered N-terminus. Attempts to remove non-LOV domains have yielded mixed
results, suggesting that the protein may be sensitive to the placement and size of
effector proteins when engineering optogenetic fusion tools. The disordered N-terminus
can be removed without issue in bacterial overexpression systems, though yield was
significantly decreased for the same truncation in mammalian cells. Removal of the Nterminus preceding the LOV domain (i.e., the first 242 residues of the protein) results in
lipid binding in the dark state, suggesting that the RGS domain is important for shielding
the amphipathic helix prior to blue light exposure. C-terminal truncation after the helix
abolished lipid binding in mammalian cells. The sensitivity of BcLOV4 to removal or
alteration of its termini suggests that addition of additional protein domains may alter
BcLOV4 expression and signal transduction in cells. In light of these results, we wanted
to explore the design rules governing BcLOV4 tool fusions to gain insight into RGS-LOV
structure-function and guide future engineering of BcLOV4 optogenetic fusion tools.

6.1.2

Problem statement
In screening the expression of domain arrangements during the construction of

GEF and GTPase fusion tools, we observed that arrangements with mCherry and the
effector at the N-terminus of BcLOV4 were consistently disfavored (Figure 6.1). Instead
of expressing in the cytosol and translocating to the membrane in response to blue light
exposure, these constructs exhibited a permanently lit-like phenotype, with protein
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bound to the membrane and/or aggregated in puncta throughout the cytosol even prior
to light stimulation. These disfavored domain arrangements share two features:
increased steric bulk of both mCherry and the effector protein at the BcLOV4’s Nterminus and a solvent-exposed BcLOV4 C-terminus. We sought to uncover the
BcLOV4 structure-function underlying this phenotype and engineer the protein to make
viable these previously disfavored arrangements.

Figure 6.1

Disfavored BcLOV4 domain arrangements
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Published tools for Rho-family GTPases and GEFs compared to the same effectors’ disfavored
domain arrangements. Scale = 10 µm.

6.2

Results and discussion

6.2.1

The effects of terminal fluorescent protein bulk on BcLOV4 localization
To determine whether the phenotype of the disfavored BcLOV4 tool domain

arrangements was the result of BcLOV4 folding, we expressed constructs with effector
bulk replaced with additional fluorescent protein (FP) tags in cells and observed their
localization (Figure 6.2). Interestingly, we found that BcLOV4 constructs were
permanently membrane-localized if one, two, or three FPs were fused to its N-terminus
without any tag on the C-terminus. Unlike the lit-like (FP)n-BcLOV4 fusions, constructs
with at least one FP fused to the C-terminus of BcLOV4 were cytosolic in the dark state
and reversibly bound the plasma membrane in response to blue light stimulation,
regardless of N-terminal bulk. These expression patterns suggested that the prestimulation membrane binding observed in disfavored tool constructs was due to
interactions between BcLOV4’s amphipathic helix and inner leaflet phospholipid head
groups, rather than an interaction between the fused effector and its membranelocalized interaction partner.
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Figure 6.2

The effect of fluorescent protein bulk on BcLOV4 protein localization

mCherry fluorescence was visualized for dark-adapted HEK293T cells. Scale = 10 µm.

6.2.2

Immunochemical investigations into the BcLOV4 C-terminus
Across pathways, effectors, and FPs, the lit-like constructs shared two

characteristics: an exposed BcLOV4 C-terminus and at least one protein domain at its
N-terminus. We next sought to determine whether the exposed C-terminus alone was
responsible for this phenotype and the N-terminal bulk was merely a confound of our
experimental need to visualize the proteins in the cell, or whether the combination of
bulk and terminus exposure caused pre-stimulation membrane binding. To differentiate
between these possibilities, we replaced FP-based visualization with immunostaining
fixed cells expressing epitope-tagged BcLOV4. This substitution allowed us to reduce
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drastically the steric bulk required to image BcLOV4 in cells and better explore the role
of the uncapped C-terminus.
We first imaged BcLOV4 tagged with 3xFLAG at its N-terminus, reducing the Nterminal bulk from several hundred amino acids to 24, and observed that 3xFLAGBcLOV4 was membrane-localized even in its dark state (Figure 6.3a). Previous
experiments showed that BcLOV4-3xFLAG (i.e., tagged at its C-terminus) was cytosolic
in its dark state and membrane-localized under blue light. We tested a smaller epitope,
His6, and observed similar lit-like expression for His6-BcLOV4 (Figure 6.3b). These
results suggest that exposure of BcLOV4’s C-terminus is responsible for the lit-like
phenotype we observed in these disfavored constructs, though it should be noted that
without an antibody to immunostain and image BcLOV4 itself, we cannot rule out that
any N-terminal bulk, even a few amino acids, is disruptive to BcLOV4 folding without a
C-terminal protein domain.

Figure 6.3

Visualization of BcLOV4 localization with N-terminal epitope tags

HEK293T cells expressing (a) 3xFLAG-BcLOV4 and (b) His6-BcLOV4 were fixed in the dark and
protein localization was visualized by anti-FLAG (a) or anti-His (b) immunostaining.

6.2.3

Partial

rescue

of

light-induced

membrane

association

with

C-terminal

mutagenesis
Based on the consistently lit-like expression pattern of two domain arrangements
in our tool screening workflow, these arrangements were not suitable for dynamic
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signaling induction and the possible constructs for each tool were reduced from six to
four. For most effectors, one of these four remaining effectors was found to be a
functional membrane recruitment tool, but Cdc42 proved to be an exception: we
observed leakiness and some off-target filopodia formation with the potentially viable
constructs identified in the screening workflow. To accommodate the diverse structures
of proteins of interest for membrane recruitment, we sought to engineer BcLOV4 to
tolerate being at the C-terminus of the fusion protein and make viable these previously
disfavored arrangements.
The final residue of untagged BcLOV4 is phenylalanine; due to its bulk and
aromaticity, we hypothesized that solvent exposure of this amino acid could disrupt
protein folding and result in dark-state exposure of the lipid-binding amphipathic helix.
We created several mutants of the F594 residue spanning the chemical diversity of
amino acids and imaged HEK cells expressing these mutants fused to an N-terminal
mCherry tag (Figure 6.4a-b). None of the point mutants screened (F594del, F594A,
F594E, F594G, F594K, F594S) fully rescued the dark-state cytosolic expression
observed for BcLOV4-mCherry, though the F594A mutant exhibited higher cytosolic
fluorescence and some enhanced blue light-driven membrane association (Figure 6.4c).
All screened constructs exhibited a dark-state membrane:cytosol fluorescence ratio
greater than one, meaning more protein was localized to the membrane than for
BcLOV4-mCherry (ratio ~ 0.8). Thus, point mutations of the C-terminus of BcLOV4 were
not sufficient to inhibit dark-state membrane binding and operationalize previously
disfavored domain arrangements.
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6.2.4

FLAG capping of BcLOV4’s C-terminus
In some tool characterization studies, we replaced the mCherry visualization tag

with a 3xFLAG peptide tag to increase the number of optical channels available to us in
the experiment. Interestingly, we observed that FLAG-tagged opto-RhoA (RhoABcLOV4-3xFLAG) exhibited an expression profile similar to that of BcLOV4-mCherry
(i.e., cytosolic in its dark state and membrane-localized under blue light, as confirmed by
anti-FLAG immunostaining). This observation suggested that the 3xFLAG peptide
(GGGS linker followed by DYKDHDG-DYKDHDI-DYKDDDDK) was sufficient to recover
BcLOV4’s light-inducible membrane binding (Figure 6.5a).
To test the generality of this observation, we expressed mCherry-BcLOV4 in
HEK cells with and without a C-terminal FLAG tag and imaged cells before and after
blue light exposure. Uncapped mCherry-BcLOV4 appeared permanently membranelocalized, while mCherry-BcLOV4-3xFLAG was cytosolic in the dark and bound the
membrane in response to blue light stimulation (Figure 6.5b). To quantify this
phenomenon and assess its statistical significance, we measured the membrane:cytosol
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Figure 6.4

BcLOV4 C-terminal mutagenesis

a. Representative images mCherry-BcLOV4 with final F594 residue mutated. b. Quantification of
dark-state membrane:cytosol protein ratio for C-terminal mutants. N = 20 cells per condition. c.
Dark-adapted and post-illumination images of mCherry-BcLOV4-F594A. Scale = 10 µm.

fluorescence ratio in each light condition for N = 30 cells per construct and applied a
non-parametric Mann-Whitney U test comparing dark- and lit-state cells for each
construct (Figure 6.5c). For uncapped mCherry-BcLOV4, the ratio was greater than one
in both conditions, reflecting the higher protein concentration at the membrane
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compared to the cytosol, and no significant difference was observed between dark and
lit states (mean ± SEM, dark ratio = 1.62 ± 0.132, lit ratio = 1.66 ± 0.134, p = 0.43).
FLAG-capped mCherry-BcLOV4 more closely mirrored the localization pattern observed
for BcLOV4-mCherry, with a ratio less than one for dark-state protein and greater than
one following blue light stimulation (mean ± SEM, dark ratio = 0.867 ± 0.031, lit ratio =
1.08 ± 0.039, p < 0.001).
We also tested the FLAG cap’s ability to rescue cytosolic expression in
constructs with greater N-terminal bulk and observed light-inducible translocation for 3xmCherry-BcLOV4-3xFLAG, a construct with ~85 kDa of protein at BcLOV4’s N-terminus,
while the uncapped version of this construct was permanently membrane-bound. This
finding suggested that FLAG capping the C-terminus of BcLOV4 is a valid strategy to
make viable the previously disfavored domain arrangements with two protein domains
N-terminal to BcLOV4.

6.2.5

Membrane translocation kinetics of FLAG-capped BcLOV4
Membrane association kinetics for mCherry-BcLOV4-3xFLAG were similar to

those of BcLOV4-mCherry, with τon = 1.17 s (95% CI 1.05-1.29 s), demonstrating that
FLAG capping has no significant effect on the rapid light-induced membrane
translocation of BcLOV4 which makes it suitable for optogenetic tool development
(Figure 6.6a). Membrane dissociation for this FLAG-capped variant is slower, with τoff =
126.2 s (95% CI = 118.8-133.7 s) (Figure 6.6b). This lengthened residence time
suggests that adding steric bulk at the termini of BcLOV4 can affect the speed of thermal
reversion and release of the membrane by the amphipathic helix.
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Figure 6.5

FLAG capping rescues constitutively active phenotype

a. Schematic of C-terminal FLAG cap-mediated rescue of dark-state cytosolic expression for
previously unviable domain arrangements. b. Dark-adapted and post-illumination expression
patterns for uncapped vs. 3xFLAG-capped mCherry-BcLOV4. Scale = 10 µm. c. Quantification of
3xFLAG rescue of dark-state cytosolic expression via membrane:cytosol protein ratio, measured
by mCherry fluorescence. N = 30 cells per condition. Mann-Whitney U test, uncorrected for
multiple comparisons. (***) p < 0.001, (n.s.) not significant.
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6.2.6

Rescue of membrane recruitment and effector function in previously disfavored

tool constructs
Following the finding that a 3xFLAG cap on the C-terminus of BcLOV4 was
sufficient to rescue the abnormal expression caused by solvent exposure of its Cterminus, we next sought to use the strategy of FLAG-capping to make viable tools from
previously disfavored domain arrangements with mCherry and the protein of interest
(POI) at the N-terminus of BcLOV4. We screened the expression of POI-mCherryBcLOV4-3xFLAG and mCherry-POI-BcLOV4-3xFLAG for effectors Rac1, Tiam1, RhoA,
ARHGEF11 (RhoGEF), and Intersectin1 (Cdc42-GEF). It should be noted that
engineering opto-Cdc42 (see Chapter 4) was only possible when FLAG-capping was
included in our screening workflow; the only construct producing robust filopodia in
response to blue light without dark-state leakiness was mCherry-Cdc42-BcLOV43xFLAG.

Figure 6.6
Membrane translocation kinetics of mCherry-BcLOV4-3xFLAG in
HEK293T cells
Time constants were determined by correlation analysis between a membrane marker (pmGFP)
and line section profiles of the mCherry tag. N = 30 cells. a. Membrane association: τon = 1.17 s,
95% CI, 1.05-1.29 s. b. Membrane dissociation: τoff = 126.2 s, 95% CI, 118.8-133.7 s.

For each of the effectors we screened, at least one FLAG-tagged construct was
capable of initiating pathway signaling following membrane recruitment of the effector.
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Figure 6.7 shows the best-performing construct for each effector. mCherry-Rac1BcLOV4-3xFLAG and Tiam1-mCherry-BcLOV4-3xFLAG both produced lamellipod-like
protrusions following DMD stimulation. RhoA-mCherry-BcLOV4-3xFLAG and RhoGEFmCherry-BcLOV4-3xFLAG induced cell contraction in the stimulated region. Activation of
mCherry-Intersectin1-BcLOV4-3xFLAG produced spiky filopodia in response to blue light
stimulation. We also observed rescue of dark-state cytosolic expression for disfavored
arrangements with Ras pathway effectors iSH and the catalytic domain of SOS (Figure
6.8). These results further demonstrate that the addition of FLAG caps to disfavored
domain arrangements in our tool screening workflow will expand the possible viable tool
constructs and enable the engineering of membrane recruitment tools with structurally
diverse effector domains.

6.2.7

Development of a cloning and screening workflow for BcLOV4 tool development
To aid others in creating BcLOV4 fusion tools for optogenetic membrane

recruitment, we created a plasmid set and workflow for screening domain arrangements
of BcLOV4, mCherry and proteins of interest (Figure 6.9). The plasmid set consists of
two constructs: BcLOV4-mCherry and mCherry-BcLOV4-3xFLAG. Each plasmid can be
digested with three restriction enzymes with different cut sites, resulting in six total
backbones for Gibson assembly with the protein of interest. For example, plasmid A
contains an EcoRI restriction site before the (GGGS)2 linker separating BcLOV4 from
mCherry. Restriction digest followed by phosphatase treatment results in a backbone
that can be assembled with (GGGS)2-POI to yield domain arrangement 1, BcLOV4-POImCherry. Following cloning, plasmids can be transfected into a cell line of interest and
mCherry fluorescence can be visualized to determine which constructs express in the
cytosol and translocate to the membrane in response to blue light stimulation. Further
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testing of successful constructs can then be performed to measure signaling activation
following membrane recruitment. The plasmid set is available from Addgene (plasmids
174511 and 174512).

Figure 6.7
Recovered fusions created with previously reported effectors and
BcLOV4 C-terminal 3xFLAG tags
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mCherry tag was imaged with pulsatile patterned stimulation (1.6% duty ratio). White box =
illumination field. Dotted yellow line = cell boundary mask in the dark-adapted state. Scale = 10
µm.

Figure 6.8

Rescue of disfavored Ras pathway effector domain arrangements

Rescued constructs = mCherry-iSH-BcLOV4-3xFLAG and SOScat-mCherry-BcLOV4-3xFLAG.
Scale = 10 µm.
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Figure 6.9

6.3

Engineering workflow for BcLOV4 optogenetic tools

Conclusions and future directions
In summary, we created a plasmid set and screening workflow to enable other

labs to engineer BcLOV4 optogenetic tools with relative simplicity. As observed in
developing GTPase and GEF tools, there is no one-size-fits-all approach to identifying
the optimal protein domain arrangement for BcLOV4, the visualization tag, and the
protein of interest: RhoA. Cdc42 and Rac1 tools each used different domain
arrangements, and GEFs and GTPases from the same pathways did not share
orderings. Thus, the ability to screen all possible domain orderings with two plasmids is
particularly important to accommodate diverse effector structures. The plasma
membrane is a signaling hub for many cellular activities; BcLOV4 has great potential for
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single-component optogenetic targeting pathways beyond small GTPases, including
Ras-Erk and lipid synthesis pathways.
In developing this tool design workflow, we also uncovered an interesting feature
of the BcLOV4 C-terminus: the requirement for a peptide cap to shield its terminal
residues from exposure and prevent pre-illumination lipid binding. In the future, an
interesting avenue would be to explore whether this C-terminal cap is necessary in other
RGS-LOV proteins or whether BcLOV4 is an outlier. The exact role of the C- and Ntermini in dark-state inhibition of lipid binding and the potential generality of the
uncapped C-terminal phenotype can be further explored when the crystal structure of
BcLOV4 is solved at higher resolution. Despite remaining structure-function questions,
we have created a tool engineering pipeline and demonstrated the utility of BcLOV4 as a
single-component optogenetic tool platform for activation of membrane signaling
pathways. Ongoing cryo-EM and mass spectrometry studies may enhance our
understanding of BcLOV4 structure-function.

6.4

Materials and methods

6.4.1

Genetic constructs
Fluorescent protein-tagged BcLOV4 constructs, 3xFLAG-tagged constructs, and

toolbox plasmids were assembled into the pcDNA3.1 mammalian vector under a CMV
promoter by Gibson cloning with HiFi DNA Assembly Master Mix (New England Biolabs,
E2621). BcLOV4 and mCherry were amplified from their previously reported mammalian
codon-optimized fusion (Addgene plasmid 114595) (69). The DNA sequences of BFP,
mNeonGreen, and mKo-kappa were human codon-optimized using the Integrated DNA
Technologies (IDT) Codon Optimization Tool and ordered as gBlocks®. GTPase and
GEF effectors were amplified from previous domain arrangements discussed in
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Chapters 3 and 4. Mutagenesis of BcLOV4’s C-terminus was generated by QuikChange
site-directed mutagenesis. Briefly, overlapping primers encoding the mutation with
melting temperatures ≥ 78°C were designed using Agilent’s online primer design tool
(https://www.agilent.com/store/primerDesignProgram.jsp). The mutation was introduced
over 18 PCR cycles with 8-minute elongation time using the Phusion® high-fidelity DNA
polymerase master mix (New England Biolabs, M0531). The template plasmid was
digested with DpnI for one hour at 37°C before transformation. All genetic constructs
were transformed into competent E. coli (New England Biolabs, C2984H). All sequences
were verified by Sanger sequencing.

6.4.2

Cell culture and transient transfection
HEK293T (ATCC, CRL-3216) cells were cultured in D10 media composed of

Dulbecco’s

Modified

Eagle

Medium

with

Glutamax

(Invitrogen,

10566016),

supplemented with 10% heat-inactivated fetal bovine serum (FBS) and penicillinstreptomycin at 100 U/mL. Cells were maintained in a 5% CO2 water-jacketed incubator
(Thermo/Forma 3110) at 37°C. Cells were seeded onto poly-D-lysine-treated glass
bottom dishes (MatTek, P35GC-1.5-14-C) or into 24-well glass bottom plates (Cellvis,
P24-1.5H-N), treated in-house with type I collagen, at 15-20% confluency. Cells were
transfected at ~30-40% confluency 24 hours later using the TransIT-293 transfection
reagent (Mirus Bio, MIR2700) according to manufacturer instructions and Opti-MEM™
reduced serum media (Thermo Fisher, 3195062). Cells were imaged 24-48 h posttransfection.
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6.4.3

Fluorescence microscopy and hardware
Fluorescence microscopy was performed on an automated Leica DMI6000B

fluorescence microscope under Leica MetaMorph control, with a sCMOS camera
(pco.edge), an LED illuminator (Lumencor Spectra-X), and a 63× oil immersion
objective. Excitation illumination was filtered at the LED source (mCherry imaging λ =
575/25 nm; GFP imaging or widefield BcLOV4 stimulation λ = 470/24 nm; miRFP
imaging λ = 632/22 nm). Fluorescent proteins were imaged with Chroma filters: mCherry
(T585lpxr dichroic, ET630/75 nm emission filter, 0.2–0.5 s exposure), GFP/Alexa Fluor
488 (T495lpxr dichroic, ET 525/50 nm emission filter, 0.2 s exposure). Cells were
imaged

at

room

temperature

in

CO2-independent

media

(phenol-free

HBSS

supplemented with 1% l-glutamine, 1% penicillin-streptomycin, 2% essential amino
acids, 1% nonessential amino acids, 2.5% HEPES pH 7.0, and 10% serum). The
spatially patterned illuminator was custom-constructed from a digital light processor
(DLP, Digital Light Innovations CEL5500), as described in section 3.4.3.

6.4.4

Expression level and membrane:cytosol ratio measurement
HEK293T cells were co-transfected with a GFP membrane marker and mCherry-

tagged tool construct in a 1:10 ratio. Cells were imaged at 63× magnification for 3-5
fields of view per construct. mCherry fluorescence was imaged with a 0.5 s exposure
time, followed by GFP fluorescence imaging (0.2 s exposure). mCherry fluorescence
was the imaged again after 5 seconds of blue light stimulation.
To assess expression level, cells were manually segmented using the pmGFP
micrograph to identify cell boundaries, and background-subtracted fluorescence was
recorded for N = 25-31 cells per condition. Cell fluorescence was normalized to BcLOV4mCherry mean fluorescence. To measure membrane:cytosol fluorescence ratio, the
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plasma membrane and cytosol were manually segmented using pmGFP localization as
a guide. The ratio of mean membrane to cytosol fluorescence was calculated for darkadapted and post-illumination states for N = 30 cells per condition. Statistical
significance was assessed by the two-sided non-parametric Mann-Whitney U test,
uncorrected for multiple comparisons.

6.4.5

Anti-His and anti-FLAG immunostaining
Cells were plated in pre-treated 35 mm glass bottom dishes and transfected as

described in (5.4.2). 24 hours after transfection, cells were washed once with PBS. Darkadapted condition plates were placed in an opaque container. Lit-state plates were
placed under a strobing blue LED (Mightex, BLS-LCS-0455-03-22, λ = 455 nm, light
intensity 15 mW/cm2) strobing at a 1.6% stimulation duty cycle. After five minutes, media
was removed and cells were fixed with 4% paraformaldehyde in PBS at room
temperature for 15 minutes, then washed twice with 0.1 M glycine in PBS (hereafter
referred to as “PBS-glycine”) for 5 minutes per wash. Cells were blocked in 5% BSA /
1% normal goat serum / 0.4% saponin in PBS (hereafter referred to as “blocking buffer”)
at room temperature for 30 minutes. For anti-His immunostaining, cells were incubated
with His-Tag Mouse mAb (Cell Signaling Technology, 2366) diluted 1:400 in blocking
buffer for 3 hours at room temperature. For anti-FLAG immunostaining, cells were
incubated with DYKDDDK Tag Mouse mAb (Cell Signaling Technology, 8146) diluted
1:250 in blocking buffer. Following primary antibody incubation, plates were washed with
PBS-glycine three times. Plates were incubated with Anti-Mouse IgG F(ab’)2 Alexa Fluor
488 (Cell Signaling Technology, 440) diluted 1:500 in blocking buffer for 90 minutes at
room temperature. Cells were then washed three times in PBS-glycine and imaged
plates in PBS.
181

6.4.6

Membrane localization kinetics
For membrane recruitment quantification, prenylated GFP was co-transfected as

a membrane marker with the BcLOV4 fusions as previously described in (3.4.4). Briefly,
an mCherry fluorescence image (500 ms exposure) was captured to assess protein
expression level and subcellular distribution. Cells were then illuminated with a 5 s-long
blue light pulse to stimulate BcLOV4, during which time mCherry fluorescence images
were also captured every 200 ms to monitor subcellular localization changes. The GFP
membrane marker was imaged immediately after blue light stimulation for correlation
analysis. For membrane dissociation via thermal reversion of the photoactivated protein
in the dark, mCherry was visualized every 5 seconds for 10-15 minutes in the absence
of blue light stimulation. Membrane localization and dissociation were measured by line
section analysis and correlation with prenylated GFP in ImageJ and MATLAB as
previously described (69).

6.4.7

Microscopy assays
For DMD stimulation assays, mCherry fluorescence was imaged every 15

seconds for 10 minutes. During this time, cells were stimulated for one second per
minute (1.6% duty cycle) patterned illumination (25 μm-wide square encompassing
∼25% of cell area). The stimulation angle was defined as the angle defined by the
polarization axis and the line segment between the cell centroid and the centroid of the
stimulated cell area.
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CHAPTER SEVEN: Conclusions and future directions

7.1

Conclusions

7.1.1

BcLOV4 as a novel photoreceptor and optogenetic platform
Optogenetic tool engineering to recruit proteins of interest to the membrane has

long been an approach to perturb cell physiology and to study the plethora of signaling
events at the plasma membrane with spatiotemporal precision. Most existing
optogenetic tools for controlling membrane recruitment rely on heterodimerization pairs,
which require careful stoichiometric tuning and the use of multiple optical channels for
their implementation. Single-chain photoswitching systems can also be associated with
high dark-state activity resulting from pathway activation occurring as a result of diffusive
contact with the membrane. These issues demonstrated the importance of discovering
and characterizing new signaling mechanisms from natural photoreceptors, which may
enable the development of new, more broadly applicable optogenetic tool platforms.
Following the 2016 discovery of BcLOV4, a novel fungal photoreceptor which
directly binds membrane lipids in its blue light-illuminated state across cell types, we
sought to understand the biophysical basis of this light response. We established that
the C-terminal amphipathic helix (AH1) is responsible for membrane binding; mutating
the acidic amino acids in this helix resulted in a protein that did not bind lipid. Protein
characterization showed that the BcLOV4 N-terminal disordered region is not required
for protein folding or lipid binding as truncation of residues 1-98 did not change the
protein photocycle or in-cell light response. The RGS domain, while apparently nonfunctional in GPCR signaling in mammalian cells, appears to play a role in dark-state
inhibition, as removing this domain resulted in permanently lit-like protein. The C183

terminus following the LOV domain of BcLOV4 also appears to be crucial to
chromophore incorporation and protein binding as soluble C-terminal truncations could
not be produced. In characterizing in vitro and cellular behavior of CeRGS, we
demonstrated that light-induced lipid binding may be general to all RGS-LOV proteins,
which is bolstered by multiple sequence alignment data of RGS-LOVs showing
conservation of the lipid-binding alpha helix. These findings shed light on this new class
of photoreceptor, and we used this knowledge of BcLOV4 structure-function to develop
single-component optogenetic tools in the remainder of this work.

7.1.2

Development of a Rho-family optogenetic toolbox
The Rho GTPase pathways are localized to the plasma membrane and underly

processes like cell migration and mechanotransduction. The ability to perturb these
cascades with single-component optogenetic tools will enable the study of these events
with a minimal genetic payload and most other optical channels available for visualizing
other cellular structures or proteins. In this work, we created GTPase and GEF tools for
the RhoA, Rac1, and Cdc42 pathways. For all tools, we observed robust, spatially
confined cytoskeletal rearrangements: RhoA and ARHGEF11 recruitment led to cell
contraction, Rac1 and Tiam1 recruitment induced sheet-like lamellipodia formation, and
Cdc42 and Intersectin1 recruitment formed spiky filopodial protrusions. Beyond these
easily observed changes in cell shape, we also characterized tool activity using
pharmacological inhibitors to confirm the mechanism underlying these rearrangements
and by measuring change in cell area (RhoA, ARHGEF11, Rac1, Tiam1), change in cell
dimensions (RhoA, ARHGEF11), actin polymerization (RhoA, ARHGEF11, Cdc42), and
downstream signaling events (RhoA). These tools will benefit the Rho GTPase field in
that they can be used to induce robust pathway activation and will allow for comparison
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studies within (e.g., GTPase versus GEF) and between (e.g., Cdc42 versus Rac1)
signaling pathways without the confounds associated with using optogenetic tools from
different platforms.

7.1.3

Recruitment of wildtype GTPase is sufficient for pathway activation
Up to this point, most optogenetic tools for GTPase signaling activation rely on

the recruitment of a Rho family GEF to the membrane to catalyze activation of
endogenous GTPase. While this approach works, it is inherently limited by the
concentration of GTPase at the membrane location to which the tool is recruited. We
used the less common method of recruiting the GTPase itself to the membrane—while
this approach is technically limited by endogenous GEF concentration to activate the
overexpressed GTPase in the tool, the rapidity of GEF turnover suggested that it would
result in more robust pathway activation than recruiting the GEF itself.
To our initial surprise, recruitment of the wildtype (i.e., not constitutively active)
GTPase was sufficient to induce pronounced cytoskeletal changes, suggesting that
mutations to inhibit GDI interaction or lock the GTPase in the active state are not
necessary for pathway activation in optogenetic tool fusions. In fact, tool functions
worsened when we made these mutations: for the Rac1 and RhoA GTPases,
constitutively active mutations resulted in leakier tools with lower contrast ratios for dark
versus illuminated cells. This finding suggests that wildtype GTPase tools have lower
dark-state activity because pathway activation requires both membrane localization of
the tool and interaction with a nearby GEF. In placing GTPase activation under these
two layers of control, we achieved tighter control over unwanted dark-state activity
without sacrificing activation speed once recruitment occurs. This method allowed us to

185

create powerful GTPase optogenetic tools and will help guide the future of optogenetic
GTPase tool engineering.

7.1.4

Creation of optogenetic tools for signaling pathway termination
Much of the optogenetic tool development in the Rho GTPase field has focused

on tools for activating signaling. While the ability to induce pathway activation is
important, terminating proteins cannot be ignored for the roles they play in shaping cell
signaling and behavior. For example, RhoA signaling termination has been implicated in
persistent cell motility (157) and in controlling the timing of neuronal axon elongation
(62). We demonstrated that BcLOV4-mediated recruitment of a RhoA GAP domain in
cells with elevated basal RhoA signaling resulted in signaling termination measured by a
RhoA biosensor. This tool furthers existing termination tool progress, including optoGAP, which uses using another RhoA GAP in Drosophila embryogenesis (96); and optoRGS, which can be used to terminate GPCR signaling (86). As more non-FRET-based
biosensors are developed to enable visualization of active GTPase in conjunction with
changes in the cytoskeleton, further GAP tool engineering can occur to control the
termination of Rac1 and Cdc42 signaling with spatiotemporal precision.

7.1.5

Elucidation of design principles governing BcLOV4 tool design
In creating BcLOV4-based optogenetic tools, we observed that (1) optimal

protein domain arrangements varied from effector to effector, and (2) domain
arrangements with BcLOV4 at the C-terminus of the protein were consistently
disfavored, resulting in lit-like protein expression patterns. This phenomenon was
recapitulated in BcLOV4 constructs in which N-terminal protein bulk was replaced with a
small epitope visualization tag, suggesting that the exposed C-terminus of BcLOV4
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mediates this dark-state membrane binding. By adding a C-terminal 3xFLAG peptide
cap to BcLOV4, we were able to rescue normal dark-state cytosolic expression in these
previously disfavored domain arrangements. This simple C-terminal engineering resulted
in at least one functional FLAG-tagged construct for each Rho family GTPase or GEF,
and, notably, the creation of a Cdc42 tool when all other domain arrangements were not
suitable. These design principles, in conjunction with the plasmid set and cloning
scheme we reported, will allow others to create their own membrane recruitment tools
for signaling pathways of interest.

7.2

Future directions

7.2.1

Solving the BcLOV4 crystal structure
Biophysical and cellular characterization of BcLOV4 have revealed key

information about RGS-LOV lipid binding. Notably, the amphipathic helix at the Cterminus of the protein is responsible for binding anionic phospholipids on the inner
leaflet of the plasma membrane. While the N-terminus of the protein is expendable in
terms of maintaining light-induced membrane binding, the RGS appears to function as a
steric occlusion domain, preventing the amphipathic helix from interacting with the
membrane when the protein is in its dark state. Efforts toward solving the BcLOV4
protein structure would provide additional information on how the amphipathic helix
binds acidic membrane phospholipids and clarify the role of the RGS domain, which to
date has not been shown to be functional in terminating GPCR signaling in cells.
Structural characterization will also inform future tool engineering with BcLOV4, such as
suggesting ways to tune the BcLOV4 lipid binding affinity and specificity for customizable
recruitment profiles. It will also provide biophysical data to inform the existing finite
element model of BcLOV4 membrane association.
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7.2.2

Development of new tools on the BcLOV4 platform
As demonstrated by the wide variety of effectors with which optogenetic

membrane recruitment tools have been reported, the plasma membrane contains many
biologically interesting and clinically relevant signaling pathways. The workflow we
developed to engineer and test BcLOV4 optogenetic tools can be applied to signaling
pathways beyond Rho family GTPases, as demonstrated by our collaboration with
others to engineer iSH and SOS tools (15). Also of great interest is the creation of
additional GAP or dominant negative tools for the Cdc42 and Rac1 signaling pathways.
Currently, a challenge of pursuing this research avenue is the lack of non-FRET-based
biosensors for these signaling pathways; because signaling termination can be harder to
visualize than activation, a biosensor is necessary to quantify changes in GTP-bound
GTPase levels following tool activation. For the Cdc42 pathway, we will use Cdc42GAP,
a 25 kDa protein previously shown to be localized to the leading edge of filopodiaforming cells (222). Rac1 GAP β2-Chimaerin (30 kDa) has similarly been found at the
edge of Rac1-mediated lamellipodia formation (47). Like other chimaerin family proteins,
β2-Chimaerin is regulated by membrane-bound receptor tyrosine kinases, particularly
the epidermal growth factor receptor (EGFR) (82), further supporting the possibility that
its recruitment to the membrane will result in Rac1 GTPase inactivation. The expansion
of the BcLOV4 optogenetic pathway will enable others to use blue light to control
membrane signaling with a single protein tool.
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7.2.3

Using BcLOV4 tools to study signaling pathway integration
An advantage of having tools for the Rho GTPase pathways on the same

optogenetic platform is the ability to drastically reduce presence of experimental
confounds associated with pooling data from optogenetic tools on different platforms.
For example, if a Cry2-GTPase and Phy/PIF-GEF tool are used in an experiment to
compare the timescales of GTPase versus GEF activity, a number of differences
between the platforms must be accounted for, including normalizing stimulation intensity
across two colors of light, determining heterodimer stoichiometric titrations, accounting
for the exogenous cofactor requirement of the Phy/PIF system, and comparing
expression levels of tools which may use different fluorescent proteins for visualization.
When the BcLOV4 platform is used, only a single plasmid must be transfected,
making determining expression conditions easier. Since all tools are activated with the
same light wavelength, stimulation paradigms and visualization fluorescent proteins can
be shared across conditions. The BcLOV4 Rho GTPase toolbox can thus be used to
study questions of signaling integration and inter-pathway comparison. Examples
include studying Rho GTPase crosstalk, as the GTPases are known to regulate each
other (150, 186), as well as comparing GTPase and GEF recruitment to infer the spatial
distribution of GEFs and GAPs in the cell. The BcLOV4 toolbox will make more
straightforward the nodal dissection of cell signaling networks.

7.2.4

Using RhoA tools to explore feedback loops in mechanotransduction
Beyond its roles in cell polarity and contraction, RhoA has also been recently

identified as a key player in a mechanotransductive feedback loop. As discussed in
Chapter 3, RhoA activation leads to an increase in cytoskeletal tension and the
maturation of focal adhesions through ROCK and myosin. This increase in tension
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drives the nuclear translocation of transcriptional co-activators YAP and TAZ, which
upregulate the transcription of RhoA-inactivating GAPs including ARHGAP29 (157).
Thus, RhoA activation also includes a mechanism by which over-maturation of the
cytoskeleton can be prevented by increasing the presence of RhoA-specific inactivators
in the cell. This feedback loop represents an interesting link between the cell’s
cytoskeletal state and transcriptional activity and is required for cell motility and wound
healing.
The optogenetic tools engineered in this thesis will enable the nodal dissection of
this feedback loop without experimental confounds due to multiple activation/repression
methods using different optogenetic platforms. Having optogenetic tools to control both
endogenous RhoA activation (via opto-RhoGEF) and RhoA signaling activation by
overexpression of the wildtype GTPase (via opto-RhoA) will allow us to study the effects
of local GTPase and GEF concentrations on observed pathway activation. In addition,
the creation of a RhoA-terminating optogenetic tools in opto-ARHGAP29 and optoRhoA-DN enable the comparison of induced vs. endogenous RhoA signaling termination
on cell migration.
Since all tools are BcLOV4 protein fusions, assays can be streamlined, using the
same stimulatory blue light duty cycle to induce tool activity and similar imaging
paradigms to observe tool localization. The advantage of single-component BcLOV4
tools is again apparent: in experiments designed to dissect the RhoA-YAP feedback
loop, the ability to conserve optical bandwidth required for tool imaging and maximize
the number of optical channels available to visualize RhoA-GTP, YAP, myosin, vinculin,
and other pathway components is a significant advantage. The RhoA tools presented in
this thesis will expand our ability to characterize this negative feedback loop and, more
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generally, to study crucial biological processes like cell migration and wound healing with
spatiotemporal precision.
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APPENDIX 1: Synthetic cell-like membrane interfaces for probing dynamic
protein-lipid interactions

This chapter adapts work from the following publication:
Glantz, S. T.*; Berlew, E. E.*; Chow, B. Y., Synthetic cell-like membrane interfaces for
probing dynamic protein-lipid interactions. Methods in enzymology 2019, 622, 249-270.
(*) denotes equal contributions.

A1.1 Introduction
Many key cellular signaling processes in environmental sensing, development,
and migration are mediated by dynamic protein-lipid interactions with the plasma
membrane, including the recruitment to and undocking from the inner leaflet. The ability
to rapidly probe the lipid interactions of these membrane-associated proteins in a highly
controlled manner on commoditized instrumentation would facilitate structure-function
analyses, inform their signaling mechanism and dynamics, and provide an assay
platform for engineering lipid-interacting protein tools.
Protein-lipid overlay (PLO) assays are a common high throughput methodology
for screening protein-lipid interactions (53, 114, 184), but these assays test for
headgroup interactions without recapitulating a membrane interface and are prone to
false positives (171, 271). Another protein-lipid binding assay that can be performed
without complex instrumentation is the liposome pulldown (138, 195, 234). Yet, this
assay requires the isolation of lipid-bound protein by ultra-centrifugation or solid-support
immobilization of protein (148, 276), making it challenging to study proteins that are
unstable in aqueous solution and liable to precipitate (as many lipid-interacting proteins
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are). Additionally, the assay is low-throughput because results must be resolved in gels.
Gold-standard techniques for determining protein affinity are often inaccessible or poorly
suited for widescale screening due to cost, such as surface plasmon resonance (SPR)
(20, 231), or due to large milliliter-scale protein volumes, such as isothermal titration
calorimetry (ITC) (218).
Fluorescence imaging of water-in-oil (w/o) emulsions with lipid-stabilized droplet
interfaces offers a complementary platform for screening protein-lipid interactions,
determining relative affinities, and monitoring interaction dynamics (69). In this system,
the droplet interior emulates the cytosol, while the lipid monolayer-stabilized droplet
interface emulates the plasma membrane inner leaflet (Figure A1.1). Lipid interfaces are
simple to produce as single-emulsions by brief agitation of lipid-containing decane oil
(the continuous phase of the emulsion) and a much lower volume of protein-containing
aqueous solution (the dispersed phase of the emulsion). Single-emulsions (typically,
without lipid stabilization) have long been used prevalently in clonal library preparation in
next-generation sequencing (92, 144) and emulsion & digital droplet PCR (188, 221).
However, they have also been adapted as synthetic cell-like structures for cell-free in
vitro compartmentalization for directed) and for size tuning in exploring the role of
cytoplasmic volume in development (74, 75).
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Figure A1.1 Probing dynamic interactions between proteins and membranes in
synthetic cell-like lipid-stabilized water-in-oil (w/o) emulsions
Preparation of (10−5 m-sized) synthetic cell-like droplets by emulsification, where the dispersed
aqueous phase emulates the cell cytosol, and the lipid-stabilized water/oil interface emulates the
plasma membrane inner leaflet. Protein : membrane lipid interactions can be screened by
automated fluorescence imaging in synthetic cell-like droplets in vitro. Quantitative analysis of
spatiotemporal interaction dynamics is facilitated by optical induction with purified recombinant
optogenetic tools or photochemical uncaging.

Several aspects of lipid-stabilized single-emulsions make them simple to
implement for protein-lipid screening applications and in-depth analyses alike. The
composition of the interface is easily tuned by adjusting the lipid mixture in the oil phase
prior to emulsification, which only requires pipetting or bath sonication to recapitulate the
membrane-like structure. Only a small amount of protein is required per experiment (~1
microliter per assay), which is helpful considering that lipid-interacting proteins are often
challenging to solubilize. Once formed, the relative lipid-binding of fluorescently labeled
proteins is imaged using an inverted epi-fluorescence microscope, one of the most
common instruments found in any biomedical laboratory.
The microscopy-based analysis is amenable to automation and customization in
medium-throughput assays in multi-well plate format, and temporally precise induction
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using light-responsive proteins (69) or photocaged ligands (30). Recently, we used this
platform to establish the relative lipid-binding selectivity and signaling structure-function
of BcLOV4, a natural photosensory protein that binds anionic membrane phospholipids
through a directly light-regulated electrostatic interaction (69); when expressed in cells,
this protein is also useful as a single-component system for optogenetic membrane
recruitment of fused proteins. In this report, we show further examples of
spatiotemporally resolved and quantitative analyses that can performed using the w/o
emulsion platform, such as determining membrane association and undocking/
dissociation kinetics of BcLOV4 and estimating its diffusional sampling distance.
Here, we provide protocols for droplet formation and automated fluorescence
imaging and analysis in MATLAB (including code). We also report the production of
BcLOV4 protein, which is particularly suitable as a control because it binds a wide range
of anionic lipids when optically induced with modest levels of blue light (69). Ultimately,
the synthetic cell-like membrane system is useful for (i) screening natural or engineered
protein variants to gain structural design insights into lipid-binding function, (ii) testing the
specificity of a lipid-binding protein for various lipid compositions, (iii) identifying
membrane interactions without the confounding presence of other proteins in cells, and
(iv) studying spatiotemporal dynamics of protein-membrane interactions through timeresolved imaging aided by conditional activation by optochemical and optogenetic tools.
Time-resolved and high-content analysis of single cells is one of the most
important uses of fluorescence microscopy. As described here, protein-membrane
dynamics in synthetic cell-like structures can mirror and/or inform cellular protein-lipid
interactions. For example, the post-illumination membrane association kinetics of our
BcLOV4 control protein, and its membrane dissociation/undocking kinetics in the dark,
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are similar in this in vitro system to the timescales observed in eukaryotic cells (Figure
A1.2).

Figure A1.2 Dynamic and photoinducible protein interactions with membrane
phospholipids in synthetic cell-like interfaces and eukaryotic cells
The positive control, BcLOV4, is recruited to membrane interfaces through a directly lightregulated electrostatic interaction with anionic phospholipids. Dissociation of photoactivated
BcLOV4-mCherry from phospholipid interfaces in the dark is on similar biologically relevant
timescales in vitro and in cellulo. a. Exemplar fluorescence micrographs of BcLOV4 in droplets
show it is in the aqueous phase in the dark and is strongly recruited to the phospholipid-stabilized
water/oil interface under blue light, only to revert to the water phase upon termination of
illumination. Radial line profiles for time-lapse images taken before, during, and long after
illumination may be used to quantitatively assess the ratio (R) of fluorescence signal at the
boundary “b” to the interior “i”. Scale bar = 20 µm. Blue light pulses: λ = 440/20 nm, 5 s, 15
mW/cm2. mCherry imaging (λex = 550/15 nm, λex = 630/75 nm). b. Calculating the “R” ratio for
droplets over time post-illumination reveals an exponentially decaying fluorescence intensity at
the water/oil boundary and measurable dissociation kinetics, τoff = 133s. c. HEK cells. [i] Blue
light-induced membrane recruitment (scale = 10 µm). [ii] Dissociation in the dark. d. S. cerevisiae
yeast. [i] Blue light-induced membrane recruitment (scale = 5 µm). [ii] Dissociation in the dark. All
panels: 5 sec. blue light pre-illumination at irradiance = 15 mW/cm2.

More spatiotemporally complex biophysical insights can be inferred in this cell
free-system, such as the diffusional sampling distance (137) of membrane-interacting
proteins (Figure A1.3). In the absence of an anionic membrane target or electrostatic
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stabilization, activated BcLOV4 in bulk solution in vitro will form large colloidal
aggregates (> 1 µm in size). In large droplets, the two simultaneous processes, of highaffinity membrane binding and the less preferred self-aggregation, result in a dark halo
between the droplet interface and an interior core of observable colloids (Figure A1.3a–
c). The size of this region of depleted protein is indicative of the sampling distance over
which the protein can encounter its high-affinity membrane sink, whereas beyond this
distance from an anionic membrane (or in the absence of one), the protein selfaggregates (Figure A1.3d–g). Photoactivated BcLOV4 has an observed sampling
distance of ~12 µm regardless of droplet size, which is larger than the typical eukaryotic
cell radius, thus informing why colloidal BcLOV4 photobodies are not formed in the
cytosol of cells.

Figure A1.3
distance

Droplet-based high-content analysis of protein diffusional sampling
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a. Fluorescence micrograph showing BcLOV4-mCherry is uniformly distributed in the dark. b.
Upon illumination, BcLOV4 binds anionic phospholipid-stabilized interfaces when the membrane
target is within the diffusional sampling distance of the protein, but forms colloidal protein
aggregates in an electrostatically driven process at large distances from the interface because it
is effectively in bulk solution unable to encounter its target. c. In large droplets, the distance
between the interface and the region of aggregates (highlighted in red) is consistent despite
droplet size variation, with d. a mean distance of 12.3 ± 1.3 µm as the empirically measured
effective diffusional sampling distance. e. Scheme of conditions under which BcLOV4 binds
anionic membrane interfaces and/or self-aggregates. f. Fluorescence micrograph of BcLOV4mCherry bound nearly exclusively at the membrane interface in a small droplet (yellow arrow)
devoid of aggregates, but with clear formation of aggregates in two large droplets (white arrows)
as schematized in panel e. g. BcLOV4-mCherry aggregates form uniformly throughout 100%
phosphotidylcholine droplets that lack negatively charged phospholipids at the water/oil interface.

A1.2 Methods development
A1.2.1 Generation of phospholipid-stabilized emulsion droplets
The method reported here for creating synthetic cell-like emulsion droplets
(Figure A1.4) is adapted from work by others in cell-free signaling (30, 74, 75). We first
solubilize the lipids in chloroform to facilitate dispensing, and then the organic solvent is
evaporated to generate a lipid film that is subsequently resuspended in decane oil and
blended with other lipids to the desired relative composition. Separately, fluorescently
labeled protein is prepared in aqueous buffer. Vigorous mixing of the aqueous and
decane solutions results in a uniform emulsion, where the aqueous solution is the
droplet interior or emulsion dispersed phase when its volume is much lower than the oil
volume, which will be the droplet exterior or continuous phase.
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Figure A1.4

Step-by-step preparation of the water-in-oil emulsions

a. Schematic. b. Optical images of 2mL glass vials through the process, corresponding to the
steps in panel a [i-v]. Note that multiple samples have been pooled for the turbid emulsion in
image v. for increased volume for visual clarity.

This protocol describes the generation of phospholipid-stabilized water-in-oil
emulsion droplets that have a lipid composition of 80% phosphatidylcholine (PC) and
20% phosphatidylserine (PS), but these lipids may be substituted for alternative lipids.
Qualitative interaction screening is possible with phosphatidyl-inositol phosphates
(PIPs), based on our results with BcLOV4 and GFP-tagged pleckstrin homology (PH)
domains (of design created by others (229)) (Figure A1.5). However, we do not
recommend quantitative analyses with long-chain PIPs because they distribute non199

uniformly into two populations of droplets, one of high PIP-concentration and one with no
PIPs, presumably due to micellar formation in decane to shield the highly hydrophilic
headgroups.

Figure A1. 5 Non-uniform distribution of phosphatidylinositol 4,5-bisphosphate (PIP2)
in lipid-stabilized water-in-oil emulsions
Fluorescence micrographs of PIP2 distribution visualized with PLCδ1 pleckstrin homology domain
fused to GFP (PLCδ1-GFP). a. PLCδ1-GFP in purely PC-stabilized droplets are only found in the
droplet interior. b-c. Emulsions prepared with PIP2 result show two populations of droplets, one
subset with no apparent PIP2, and another subset (yellow arrows) with patches of PIP2 at the
interface. Scale bar: (a-b) 25 µm, (c) 50 µm.

A1.2.1.1 Materials
1. Hamilton 1000 series Gastight glass syringe with removeable needle: 1 mL
and 100 µL sizes, with 22-gauge needles (Hamilton, p/n 81365)
2. 2 mL glass vials with Teflon-lined caps (Thomas Scientific 1234R80)
3. Glass Pasteur pipette
4. Phospholipids of choice: e.g. phosphatidylcholine (PC; Avanti Polar Lipids
840051C), phosphatidylserine (PS; Sigma Aldrich P7769), phosphatidyl glycerol
(PG; Sigma Aldrich, P8318), and phosphatidic acid (PA; Sigma Aldrich P9511)
5. Chloroform
6. Decane
7. Nitrogen/Argon gas, connected to a low-pressure airbrush or nitrogen spray
gun
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8. Fluorescently labeled candidate lipid-binding protein of interest (5-10 µM) in 1X
phosphate buffered saline (PBS)
9. Vacuum desiccator
10. Chemical fume hood
11. Water bath sonicator
12. Hotplate, preferably with sand or oil bath

A1.2.1.2 Protocol
All work with chloroform and lipids should be performed in glass vials with Teflonlined caps, and volume transfer should be performed with Hamilton syringes unless
otherwise specified. Chloroform should be handled in a working fume hood.
1. Using Hamilton syringes, prepare phospholipid stock solutions in chloroform:
a. 32.6 mM PC (25 mg PC in 1 mL chloroform)
b. b. 19 mM PS (15 mg PS in 1 mL chloroform)
2. Direct a stream of dry argon or nitrogen gas at the lipid solutions to evaporate the
chloroform solvent. The chloroform should be gently agitated by the gas flow,
and should not be splashing violently in the vial. When the organic solvent has
been evaporated, a hazy lipid film should be visible at the bottom of the vial. Note
that the glass vial will get very cold as the chloroform vaporizes. Throughout the
vaporization process, rotating the vial in your gloved hand to warm it will increase
the rate of evaporation and generate a more even lipid film on the bottom walls of
the vial.
3. Completely dry the film of trace solvent by placing the vials in a vacuum
desiccator chamber for 30 minutes at room temperature. Generally, “house
vacuum” systems should be sufficient for this purpose. Alternative to steps 2 and
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3 above, the vial can be heated in a fume hood in a sand or oil bath, first at 4050°C to gently evaporate most the solvent, and then completely drying the film in
vacuum or heating it above the chloroform boiling point (> 62 °C).
4. Using Hamilton syringes, re-suspend the lipid film in decane. The following
concentrations are appropriately soluble for PC and PS.
a. 32.6 mM PC (25 mg PC in 1 mL decane)
b. 19 mM PS (15 mg PS in 1 mL decane)
5. Solubilize the lipids in decane by water bath sonication for 2 minutes at room
temperature. Then, heat the decane lipid stocks at 50°C for 1-3 hours. The
stocks should be uniformly clear with no visible lipid films or clumps. These lipid
stocks may be stored at −20°C if not used immediately.
6. Blend phospholipids in decane to generate a desired lipid composition in the oil
phase such that the total phospholipid concentration is 20 mM. Store the oil
phase at −20°C until ready for use.
7. Prepare the aqueous phase solution of fluorescently labeled protein in 1X PBS
(suggested protein concentration of 5-10 µM).
Steps 8-10 can be performed with adjustable non-glass pipettes.
8. Prepare water-in-oil emulsion droplets immediately prior to imaging them, by first
transferring 30 µL of the lipid stock in decane to an Eppendorf tube If the lipid
stock has been previously frozen, warm the stock to at least room temperature to
ensure accurate volume transfer of the viscous solutions in a pipette. Lipid-indecane solutions can be heated to 37-42°C if needed prior to handling.
9. Pipette 1.3 µL of the protein solution into the 30 µL decane mixture. The water
phase should immediately sink to the bottom of the decane as a discrete
aqueous phase.
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10. Set a pipette to 20 µL volume. Place the pipette tip at the very bottom of the
Eppendorf tube to access the aqueous phase and gently pipette up-and-down
until the phase separation is noticeably disrupted. Then, pipette up-and-down
vigorously (~30 seconds) until a uniformly cloudy suspension is visible (but, avoid
foaming). This phospholipid-stabilized water-in-oil emulsion is ready for image
analysis.

A1.2.2 Automated fluorescence imaging plates
Standard multi-well microplates for imaging are typically made from plastics like
polystyrene that strongly bind phospholipids, leading to droplet instability and rapid
accumulation at the microplate wall. However, plates made of acrylic and/or glass do not
present such confounds. This section describes the fabrication of custom microwell
plates that are defined by holes cut into an acrylic sheet, fused to cover glass as the
plate bottom. (Figure A1.6)
The 25 µL assay volume in the following section has been optimized for the
microwell plate geometry described here in this section, resulting in a monolayer of
droplets that are spaced with minimal overlap. However, this combination of microwell
plate dimensions and sample volume is not prescribed, and alternative combinations are
possible.

Figure A1.6

Design and assembly of the imaging plate
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An acrylic plate is required to avoid lipid interactions with the plastics of standard multiwell plate.
a. Dimensions of the acrylic cutout from the top down. b. Top-down schematic and image of
uncured optical adhesive droplet placement (drawn in blue), prior to placement of the coverglass.
c. Cross-sectional schematic of the imaging plate sandwich and optical adhesive curing process.
d. Top-down schematic and image of the cured imaging plate. The adhesive seals the crossroads
of the grid, but should minimally seep into the circular wells so that imaging is entirely through the
coverglass.

A1.2.2.1 Materials
1. Laser cutter (or outsourced to machine shop)
2. ≥ 1/8”-thick clear acrylic
3. Microscope cover glass, 25 x 25 mm, No. 1
4. Norland Optical Adhesive (#81)
5. UV lamp/LED

A1.2.2.2 Protocol
1. Laser-cut plates from > 1/8” clear acrylic, with dimensions described in Figure
A1.6a. To keep the piece clean, keep the adhesive paper-backing on when
cutting, and cut the piece with the paper facing down on the stage.
2. Remove the paper backing from the acrylic plates.
3. Apply a drop of Norland Optical Adhesive (#81) at each crossroad of the array of
holes (dots as shown in Figure A1.6b), using the applicator of the adhesive
bottle. The adhesive droplets should be ~ 1 mm-diameter.
4. Cover the holes of the acrylic plate with the glass coverslip (one coverslip per
acrylic plate) to form the bottom of the microwells. Ensure that a seal is formed
around the circumference of each well, without excess adhesive oozing into the
wells.
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5. Cure the plates under a UV floodlight, with cover glass facing the light source.
The duration will depend on the wavelength and irradiance of the light source;
general guidelines and light source-specific protocols for curing are provided by
the manufacturer. We use an IntelliRay 400 Shuttered UV Floodlight with Rayven
curing chamber for 15 minutes (λ = 365 nm, irradiance = 175 mW/cm2).
6. Store microwell plates in a clean and covered container to prevent dust
accumulation.

A1.2.3 Imaging dynamic membrane recruitment
For imaging analysis, droplets should be stable and not dynamically merge or
coalesce into larger droplets. Monolayers of droplets spaced with minimal overlap
provide suitably stable imaging conditions for most applications, with enough droplets
per field-of-view for error analysis using 20-40x objective lenses. At 20×, 25-75 droplets
should be in the field of view, with a mean droplet diameter ~ 20-50 µm.
The protocols below describe assays on an inverted epi-fluorescence
microscope, which is suitable for screening and dynamic analyses on the timescale of a
few minutes. However, if a confocal microscope is available, confocal microscopy is
beneficial when imaging droplets that vary widely in diameter and thus have dissimilar
midplanes across a single field-of-view, and also when imaging over extended time
periods to account for droplet movement.
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A1.2.3.1 Materials
1. Inverted fluorescence microscope, equipped with automation software such as
Micromanager or MetaMorph.
2. Additionally, for optogenetic induction with BcLOV4-mCherry, the microscope will
require:
a. Co-aligned and individually controlled LED light sources for BcLOV4
stimulation, (blue, λ ~ 450 nm) and mCherry imaging (yellow/amber, λ ~
570 nm)
b. Filter set that permits simultaneous imaging and optogenetic stimulation.
For example: λ > 585 nm (long-pass) dichroic mirror, λ = 630 ± 37.5 nm
(bandpass) emission filter, with excitation wavelength controlled at the
light source
3. Optical power meter
4. Microscope size standard

A1.2.3.2 Protocol
General:
1. Immediately prior to imaging, transfer 25-30 µL of freshly generated emulsion
droplets to a new microwell.
2. Focus on the glass bottom of the microwell plate at 20× magnification in
brightfield mode, and raise the focal plane until droplets are clearly visible.
3. Use fine focus control to find the droplet top and bottom, and then, set the focus
at the droplet midplane prior to fluorescence imaging.
Optical induction of the BcLOV4 control:
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4. Determine excitation source settings for BcLOV4 photo-stimulation with 15
mW/cm2 blue light through a 20× objective lens. Stimulation at this irradiance,
which is the in vitro saturation value for BcLOV4, will limit cofactor
photobleaching.
a. Measure the beam power (in W or mW) with an optical power meter. The
beam should be smaller than the detector area. If your power meter
measures an irradiance (power / area), then multiply the reading by the
detector area.
b. Use a microscope size standard to determine the field-of-view of your
objective lens (and approximate beam diameter), and then divide the
measured power by this area.
5. Collect four mCherry fluorescence images, each separated by 15 seconds, to
capture the “dark-state” images of the blue-light inducible system.
6. If only testing for droplet quality, skip this step and move on to step 7. To capture
association dynamics, capture a 5 Hz-framerate movie with simultaneous
excitation of BcLOV4 and mCherry.
7. Photo-stimulate BcLOV4 for 5 seconds with 15 mW/cm2 blue light, and then
image the mCherry tag. The protein should be membrane interface-localized. For
determining undocking time constants by thermal reversion in the dark, image
the droplets every 15 seconds for 5 minutes, without any further blue light
stimulation. An exponential fit should yield a time constant of ~ 0.5-2 minutes.

A1.2.4 Image analysis and segmentation
While the distribution of the protein within each droplet can be manually
assessed (for example, using tools in ImageJ), such analysis becomes highly rate207

limiting for the medium-to-high throughput assays possible. However, because the
droplets are perfectly spherical such that they appear circular when imaged at their
midplane, the individual droplets and their respective phase/compartment boundaries
are easy to segment computationally. This section describes an automated analysis
pipeline (Figure A1.7) that finds circles of a given diameter range, and subsequently
segments these circles further to distinguish the phospholipid boundary layer from the
aqueous interior, and to quantify protein in each compartment. Note that some proteins
are beyond a diffusional sampling distance from the membrane-like interface in large
droplets (>> 25 µm diameter), and thus, will not find the phospholipid monolayer
accessible. Therefore, in this protocol, we have defined an interior “core” region for each
droplet that eliminates any protein beyond the sampling distance from the interface.
Here, we provide code in MATLAB (available in online supplementary material) for
analyzing BcLOV4, but the general approach described in the workflow of Figure A1.7
and pseudocode in the protocol below should apply to other image analysis programs
and proteins of interest.
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Figure A1.7

Segmentation of the emulsion dispersed phase and droplet interface

a. Schematic of a droplet with robust phospholipid-stabilized water/oil interface recruitment of
activated BcLOV4 in the presence of negatively charged phospholipids, and internal aggregation
beyond the diffusional sampling length from the droplet exterior. “Outer,” “inner” and “core” masks
are generated from boundary segmentation as described in the pseudocode. b. Example
MATLAB analysis of a fluorescence micrograph of phospholipid bound BcLOV4 in 80% PC/ 20%
PS droplets in the illuminated state. Automated segmentation identifies the outer boundary
(orange), the inner boundary (red) and the interior diffusional sampling length (green). c. Droplets
vary in radius where d. the mean droplet radius is 19.9 µm (red dotted line) and the droplet Rdispersion is 0.42 for 957 droplets identified by MATLAB automated analysis that was set to find
droplets ranging from 10 - 60 µm (solid red lines). e. Common errors in droplet generation that
compromise the segmentation and analysis include: [i] oversized droplets caused by poor
emulsification due to insufficient vigor applied when by mixing by pipette. [ii] internal protein
aggregates from poor protein stability under the given buffer conditions, [iii] difficult to resolve,
overlapping droplets due to overloading of the microwell plate during imaging, [a-e] scale bar = 50
µm.

A1.2.4.1 Materials
1. Image analysis software (MATLAB)

A1.2.4.2 Protocol
1. Input file: Stack of fluorescence micrographs showing the localization of a
fluorescently tagged protein in emulsion droplets, with each image corresponding
to a different timepoint.
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2. Save the input image file as a variable name (in MATLAB, use “imread” function).
3. Identify the outermost boundary for all droplets with a given diameter range (in
MATLAB, use “imfindcircles” function) and record each object’s centroid
coordinate and radius. This is the outer water/oil (w/o) interface boundary. When
finding circles, it is optimal to use a relatively narrow diameter range to improve
detection speed and accuracy. Software programs will measure the circle
diameter in pixels. Use a micron-scale size reference to convert image pixels to
an experiment-relevant size range in microns. For example, at 3.14
pixels/micron, a 20-50 µm droplet diameter range corresponds to a diameter
range of 63-157 pixels.
4. For each pair of outermost boundary radius and centroid, generate a virtual inner
water/oil (w/o) interface boundary description by subtracting 3 microns in length
from the radius.
5. For each pair of outermost boundary radius and centroid, generate a virtual
dispersed phase diffusion boundary by subtracting the calculated diffusion length
from the radius (for BcLOV4, 12 µm).
6. Generate three masks for each droplet: a mask that extends from the centroid to
the (i) outermost boundary (“outer”), (ii) to the inner water/oil interface boundary
(“inner”), and (iii) to the diffusion boundary (“core”).
7. For each of the masked regions, calculate the area and sum the fluorescence
intensity over all pixels.
8. Quantify the phospholipid boundary protein level as:
Normalized boundary intensity=

Intensity ("outer" - "inner")
Area("outer" - "inner")

9. Quantify the dispersed phase protein level as:
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Normalized dispersed phase intensity=

Intensity ("inner" - "core")
Area("inner" - "core")

10. To visualize the segmentation by image processing, draw circles on the image
using the identified coordinates. In MATLAB, use “imshow” to display the original
image and “viscircles” to display the found objects.
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APPENDIX 2: An iLID variant with light-inducible Golgi binding

A2.1 Introduction
In collaboration with the Jared Toettcher lab (Princeton University), we became
interested in an iLID truncation which exhibits rapid, reversible, blue light-induced
binding to the Golgi apparatus in mammalian cells (Figure A2.1). This truncation,
hereafter referred to as iLID*, has six N- and C-terminal amino acids removed from the
original reported iLID construct (81); the full protein sequence is listed in Figure A2.2.
Binding to the Golgi apparatus was confirmed by the Toettcher lab by measuring protein
co-localization with a fluorescent Golgi apparatus label. Golgi association occurs within
100 msec of blue light stimulation and disappears within 250 msec when the light
stimulus is withdrawn. Notably, iLID* binding occurs without the co-expression of an
SspB binding partner, which enables wildtype iLID subcellular localization through lightinduced heterodimerization. The lack of binding partner requirement suggests that in
mammalian cells, iLID* undergoes a blue light-induced conformational change, allowing
it to bind a Golgi-associated lipid or protein.
Because different endomembrane organelles have different lipid compositions
(111), we hypothesized that iLID*-Golgi association could be the result of a high-affinity
interaction with a lipid which is enriched on Golgi membranes. Identifying the protein and
lipid interaction occurring in this system is of interest because, to our knowledge, a
single protein selectively binding the Golgi in response to light has not been reported.
Understanding the protein and lipid structures underlying this light response may
suggest new ways to engineer Golgi-targeting optogenetic tools, either by fusing
effectors of interest to iLID* or by introducing iLID* moieties to other photoreceptors. To
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work toward understanding iLID*-Golgi association, we worked with purified protein and
previously described protein-lipid interaction screens (67, 69) to determine whether this
interaction could be recapitulated in vitro and identify potential binding partners.

Figure A2.1

An iLID truncation binds the Golgi apparatus in its illuminated state

iLID*-mCherry was expressed in HEK293T cells. Cells were illuminated for 250 msec for the right
panel.

Figure A2.2

iLID* protein sequence

Residues removed from the original iLID sequence are shown in red.

A2.2 Results and discussion
A2.2.1 Biophysical characterization of purified protein
To study iLID*-lipid interactions, we initially overexpressed and purified two
constructs from E. coli: mCherry-iLID* and iLID*-mCherry, with a GGGGA linker
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separating the proteins in each construct. Purified protein ran as expected on an SDSPAGE gel, and flavin binding was confirmed with UV-vis spectroscopy, which showed a
triplet peak centered at 447 nm. LOV photocycle was observed by measuring
absorbance at 447 nm before and after exposure to blue light (Figure A2.3). We
proceeded with iLID*-mCherry due to its higher yield and greater drop in A450 following
blue light stimulation.

Figure A2.3

Biophysical characterization of iLID truncations

a. UV-vis spectra of purified protein. b. Recovery of absorbance at 447 nm following 30 seconds
of 15 mW/cm2 blue light stimulation. Absorbance values are normalized to pre-illumination values.

A2.2.2 Identification of lipid interaction partners
In disentangling the structural basis of iLID*-Golgi association, we considered
two main possibilities: (1) that iLID* is binding to a particular lipid headgroup, or (2) that
iLID* is associating with the Golgi because of a larger property of the Golgi membrane,
like disorder or low curvature radius. Because testing interactions with specific lipids is
more straightforward than creating membranes with specific meta-properties, we first
used commercially available lipid panel strips to identify any headgroups to which iLID*
bound more strongly. In this assay, His6-tagged purified protein is incubated with strips
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spotted with a panel of lipid headgroups; immunostaining is used to obtain colorimetric
readout indicating binding. Binding is correlated to spot intensity above the local
background reading of the strip. We tested iLID* binding to lipids on three panels:
membrane lipids, PIP lipids, and sphingolipids. iLID* did not bind to any of the lipids on
the sphingolipid strips. For membrane and PIP lipid strips, we saw enriched signal for
several lipids (Figure A2.4), demonstrating a preference for lipids with -1 net charge.
Interestingly, phosphatidic acid (PA) showed up as a hit on both panels on which it was
presented and is known to provide disorder and curvature to Golgi membranes (124,
272).

Figure A2.4

Protein-lipid overlay data for iLID*-mCherry
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a. Spot intensity for membrane lipid panel for headgroups above background. PE,
phosphatidylethanolamine; PA, phosphatidic acid. b. Spot intensity for PIP lipid panel for
headgroups above background. c. Intensity versus headgroup net charge for lipids with intensity
above background.

A2.2.3 Demonstration of protein-lipid interaction in water-in-oil emulsions
Since the lipid strip assay involve the presentation of a lipid headgroup in a nonmembrane context, we next wanted to demonstrate binding to PA in a more natural
context using water-in-oil emulsions (protocells). However, we ran into serious technical
issues in attempting to incorporate long- or short-chain PA into the phosphatidylcholine
(PC)-containing lipid phase of the protocell mixture. PA appeared to separate within the
protocell membrane, indicated by bright protein patches along the membrane even at
concentrations as low as 1%, though incorporation appeared to increase as PA
concentration was increased to 15%. This non-homogenous lipid phase contrasts with
the evenly distributed mixtures of PC and phosphatidyl serine (PS) we observed in
BcLOV4 lipid binding characterization.
We next tested whether adding phosphatidylserine to the lipid mixture could be
used to help solubilize PA and result in more evenly distributed lipid monolayers. In
mixing equimolar amounts of phosphatidylserine and PA with PC solvent; we saw some
improved incorporation, especially at the higher end of PS and PA concentrations tested.
However, monolayers were still non-uniform, with some protocells showing bright rings
at the perimeter from lipid-bound protein and others containing non-membrane-bound
protein. Increasing PA concentration to 20% without the use of PS led to well-mixed
protocells. iLID*-mCherry bound the lipid phase even in the dark-adapted state and at
protein concentrations as low as 0.5 µM (one-tenth the normal protein concentration).
Both these findings suggest a high-affinity interaction between iLID* and PA. The protein
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also bound phosphatidylserine in the dark state when PS was present at concentrations
greater than 15%.

Figure A2.5

Protocells data for iLID*-mCherry

a. Dark-state protocells with increasing PA concentrations and 5 µM protein. b. Dark-state
protocells with increasing PA and PS concentrations; 5 µM protein. c. Dark-state protocells with
20% PA and increasing protein concentrations. d. PC- and PS-containing dark-state protocells.
(a-d) PC, phosphatidylcholine; PA, phosphatidic acid; PS, phosphatidylserine. Scale = 20 µM.

A2.3 Conclusions and future directions
Through these preliminary studies, we found evidence for iLID*-mCherry binding
to phosphatidic acid, a component of Golgi membranes. More generally, the protein
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exhibits a preference for lipid headgroups with a -1 net charge. Solidifying this interaction
as the basis for the light-inducible iLID*-Golgi binding shown in mammalian cells next
requires identification of the protein substructures responsible for this interaction through
examination of the iLID* crystal structure and screening of blue light response of iLID*
mutants of candidate residues. In parallel, iLID* interactions with phosphatidic acid in
more realistic liposomal membranes through microscale thermophoresis or surface
plasmon resonance can be explored.
From a tool development perspective, iLID* could potentially be used as a
mechanism for light-inducible recruitment of signaling proteins to the Golgi. One
potential application is in the recruitment of ARHGAP1, a GAP domain which inhibits
RhoA signaling at the plasma membrane and Cdc42 signaling at the Golgi(159). In cells,
the GTPase Arf1 binds ARHGAP21 and recruits it to the Golgi, where it controls Arp2/3
and filamentous actin. Fusing this GAP domain to iLID* could be a useful strategy for
light-inducible termination of Cdc42 Golgi signaling.

A2.4 Methods
A2.4.1 Protein expression and purification
iLID*-mCherry and mCherry-iLID* genes were cloned into a plasmid with a pBAD
backbone in frame with an N-terminal His6 tag. Plasmids were transformed into One
Shot TOP10 competent E. coli (Thermo Fisher C404010) and plated on LB/ampicillin. A
single colony was used to inoculate a 10 mL culture of YT media supplemented with
ampicillin and grown at 37 °C with 250 r.p.m. shaking overnight. The following day, the
overnight culture was diluted 1:200 into YT media supplemented with ampicillin and
grown at 37 °C with 250 r.p.m. shaking until mid-log phase was reached (OD600 = 1.0).
Protein production was induced with 0.2% arabinose, and cells were grown for 18-22
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hours at 18 ºC with 250 r.p.m. shaking in a refrigerated incubator. Cells were then
harvested in 250 mL centrifuge bottles by spinning at 3000 x g for 20 minutes, and
subsequently frozen at -20 ºC for < 2 weeks prior to cell lysis and purification.
Frozen cells were thawed at room temperature for 5-10 minutes and then
resuspended in 50 mL lysis buffer (50 mM Tris pH 8.0, 150 mM NaCl, 0.4 mM
phenylmethanesulfphonylfluoride (PMSF), 14 μL of β-mercapthoethanol, and a tablet of
cOmplete Mini protease inhibitor (Roche)) per liter of harvested cell culture. Resuspended cells were homogenized with 3 passes through a 21-gauge syringe needle.
10 mL aliquots of lysate were each sonicated 5 times with a duty cycle of 15 seconds
ON, 30 seconds OFF with a Fisher Scientific Series 60 Sonic Dismembranator at 100%
power (60W). Individual aliquots were pooled and transferred to a 50 mL polycarbonate
conical tube and clarified by centrifugation at 25,000 x g for 30 minutes at 4 ºC to
remove insoluble fractions. The supernatant was decanted and kept at 4 ºC prior to
further purification. Flavin mononucleotide was added to the supernatant at a final
concentration of 25 mg/mL and incubated at 4 °C for 20 minutes.
Ni-NTA superflow resin (3-4 mL) (Qiagen) was loaded onto a column and
equilibrated with resuspension buffer. The supernatant was loaded onto the column
followed by three 100 mL washes of resuspension buffer with increasing concentrations
of imidazole (10 mM, 20 mM, 30 mM). Protein was eluted in resuspension buffer with
250 mM imidazole and buffer exchanged into 1x PBS using PD-10 desalting columns
with Sephadex G-25 resin (GE 17085101). Buffer exchanged material was centrifuged at
4 ºC at 25,000 x g for 30 minutes to pellet insoluble protein debris. Buffer exchange was
repeated twice more, and the column was re-equilibrated with 1x PBS prior to each
usage. Purified protein was stored for < 2 weeks at 4 ºC.
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A2.4.2 UV-vis spectroscopy
Absorbance

scans

were

measured

on

an

Ocean

optics

USB2000+

spectrophotometer with a deuterium/halogen light source. Full spectrum (λ = 250-700
nm range) absorbance scans were measured in quartz cuvettes (Starna Cells 16.100FQ-10/Z15). Photocycle kinetics were measured by monitoring the absorbance at 447 nm
(A447). After baseline measurements were made for 15 seconds at room temperature,
the samples were stimulated with blue-light (10 s, λ = 455 nm, 15 mW/cm2) delivered by
a collimated LED (Mightex), and then dark-state recovery was monitored every 0.5
seconds for an additional 2 minutes.

A2.4.3 Protein-lipid overlay assay
Lipid strips were purchased from Echelon Biosciences (Sphingo strips, P-6000;
PIP strips, P-6001; Membrane lipid strips, P-6002). Strips were blocked for 1-4 hours in
PBS containing 3% BSA without detergent. 0.5 μM of His6-iLID*-mCherry was then
added to PBS / 3% BSA and this solution was incubated with a blocked lipid strip for 1
hour at room temperature. Membranes were washed 4 times with PBS-T (PBS + 0.1%
Tween20) and then probed with mouse anti-His primary antibody at 1:2000 dilution (Cell
Signaling Technology, 2366) in PBS + 3% BSA for either 1 hour at room temperature or
overnight at 4 °C. After an additional 4 washes with PBS-T, membranes were probed
with IRDye 680RD Goat (polyclonal) Anti-Mouse IgG (Licor 925-68070) at 1:15000
dilution in PBS-T + 3% BSA for 1 hour at room temperature. Blots were washed an
additional 4 times in PBS-T and then in 1x PBS. Blots were imaged on an Odyssey
Infrared Imaging System in the λ = 700 nm channel at Intensity 5.
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A2.4.4 Protocells assay
Lipids

(phosphatidylcholine,

P3556;

phosphatidic

acid,

P9511;

phosphatidylserine, P7769; all from Millipore-Sigma) were resuspended in chloroform in
a glass test tube or round-bottom flask. Chloroform was evaporated under a stream of
nitrogen and the remaining lipid film was dissolved into decane (Aldrich D901) at 2.5-25
mg/mL, based on the solubility of each individual phospholipid. To facilitate suspension
in decane and to remove excess chloroform, solutions were heated at 50 ºC for 3 hours
and sonicated in a water bath for 30 minutes. Lipids were stored in glass vials with
Teflon caps (Thomas Scientific 1234R80) at -20 ºC. In experiments, 30 µL of 20 mM
lipids (total molarity) was mixed vigorously with 1.28 µL of purified mCherry-tagged
protein in PBS (5 µM, unless otherwise specified) by pipetting up and down until a
cloudy suspension formed. 20 µL of the water-oil emulsion was transferred to microwells
and imaged at 20×.
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APPENDIX 3: Toward the characterization of bioinformatically predicted
lipase-LOV proteins

A3.1 Introduction
The 2016 bioinformatics study (71) reporting all computationally predicted LOVeffector pairs identified two previously uncharacterized LOV classes: RGS-LOVs, to
which BcLOV4 belongs; and lipase-LOVs. Lipase-LOV proteins, if biochemically
validated, would represent a new sensor-effector pair and potentially link light inputs to
cellular lipid cleavage. One of these lipase-LOVs, from the green algae Dolichomastix
tenuilepis, was able to be produced recombinantly in E. coli at modest yield for
investigations into its lipase and LOV protein activities. It should be noted that protein
solubility was greatly improved by the inclusion of an N-terminal NusA solubility tag. In
addition, four mutations were made to the LOV domain to stabilize flavin binding and
blue light photocycle (M352I, S353R, C302V, C304T). We sought to identify what, if
any, lipid substrates this predicted lipase cleaves.
Initially, three substrate classes for the Dolichomastix tenuilepis lipase (DtLipase)
were identified based on functional, structural, and physiological hypotheses. From a
functional standpoint, many lipases exhibit broad esterase-like activity (51), so testing
DtLipase activity on p-nitrophenyl derivatives with varying chain lengths could be
informative. Structurally, alignment of the DtLipase sequence with other lipases showed
some homology with PAF-acetylhydrolase-like lipases (7); this type of activity can be
tested with a commercially available PAF cleavage endpoint kit (Cayman Chemical).
Physiologically, when expressed in Chinese Hamster Ovary cells, DtLipase appears to
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localize to a crystalloid endoplasmic reticulum, suggesting it may cleave ester bonds in
polysaccharides (158).
Preliminary data showed that DtLipase may exhibit weak cleavage activity on a
p-nitrophenyl palmitate substrate (chain length 16), measured by p-nitrophenol
absorbance increase at 400 nm over several hours. However, since lipids may selfcleave in solution over time, a non-protein-containing control must be included to
determine whether lipase-catalyzed cleavage is occurring. Minimal activity was also
observed on phospholipase A2 substrate DBPC, but this assay was conducted without
consistent protein concentrations across experimental conditions. Our screening of
these substrate classes involved the use of liposomes and lipids in solution to account
for the possibility that the lipase has higher activity on lipid interfaces; normalizing the
amount of protein across conditions in the same experiment; and the inclusion of nonprotein-containing conditions to control for lipid self-cleavage.

A3.2 Results and discussion
A3.2.1 P-nitrophenyl butyrate cleavage assay
We tested the activity of purified DtLipase on liposomes made of p-nitrophenyl
butyrate (chain length 4). In this assay, cleavage of the lipid substrate releases pnitrophenol, which absorbs at 400 nm. Thus, to monitor lipid cleavage, we varied
substrate concentration from 5 to 20 µM and incubated with no protein, NusA only,
NusA-DtLipase, or the positive control wheat germ lipase. As shown in Figure A3.1,
wheat germ lipase cleaved all substrate concentrations tested above 5 µM, with pnitrophenol concentrations increasing at rates of 2-4 µM per minute. NusA and NusADtLipase showed similar weak increases of less than 0.5 µM p-nitrophenol per minute,
suggesting that no significant cleavage is occurring. This result suggests that if DtLipase
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activity is in fact able to cleave p-nitrophenyl butyrate substrates, higher protein
concentrations may be required for observable lipase activity.

Figure A3.1

DtLipase incubation with p-nitrophenyl butyrate liposomes

Liposomes made of p-nitrophenyl butyrate were incubated with no protein, NusA, NusA-DtLipase,
or positive control wheat germ lipase. Lipase-mediated cleavage was monitored by recording the
solution’s absorbance at 400 nm, which corresponds to the release of p-nitrophenol from the
liposome substrate.

A3.2.2 DBPC cleavage assay
We next tested the possibility that DtLipase cleaves a phospholipase A2-type
substrate using DBPC. Cleavage is monitored by the release of a fluorescent molecule,
which emits at 525 nm. Over a time course of 30 minutes, we observed minimal
fluorescence changes from the substrate only. Little difference was observed for
DtLipase samples with and without DBPC substrate, suggesting that if DtLipase is
exhibiting phospholipase A2-like activity, it is too weak to detect in this assay.

Figure A3.2

DtLipase-LOV incubation with DBPC substrate

DBPC substrate was incubated with or without NusA-DtLipase-LOV. Lipase-mediated cleavage
was monitored by recording the solution’s fluorescence emission at 525 nm, which corresponds
to DBPC cleavage.
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A3.3 Conclusions and future directions
In addition to DBPC and p-nitrophenyl butyrate, we also tested DtLipase with a
PAF acetylhydrolase activity kit but saw no cleavage with the positive control; thus, that
assay would need to be repeated with working standards to assess whether DtLipase is
an acetylhydrolase. Together, these results underscore the need to work on DtLipase
and lipase-LOV protein expression and purification conditions so that protein can be
produced in high enough concentration for meaningful assay results. Another avenue in
determining the biochemical validity of lipase-LOV proteins is to investigate the other
lipase-LOV proteins identified in the bioinformatics screen, which may be more
amenable to bacterial overexpression.

A3.4 Methods
A3.4.1 Protein expression and purification
Bacterial expression plasmids were transformed into BL21(DE3) E. coli cells by
mixing 10 ng of purified plasmid DNA into 10 µL of chemically competent cells (NEB
C2527H), incubating at 4 ºC for 30 minutes, heat-shocking cells in a 42 ºC water bath for
30 seconds, placing heat shocked cells on ice for 2 minutes, and then incubating for 1
hour at 37 ºC in 100 µL S.O.C. media. Transformed cells were grown on Luria Broth (LB)
plates with 50 µg/mL kanamycin overnight at 37 ºC, and single colonies were picked and
grown overnight to saturation in LB media with 50 µg/mL kanamycin. Cultures for protein
production were initiated by diluting saturated overnight cultures 1:200 into fresh LBkanamycin media in 1-2 L baffled flasks, and subsequently grown at 37 ºC with 250
r.p.m. shaking to a mid-log phase of OD600 = 0.5-0.8. Protein production was induced
with 0.5 mM isopropyl-beta-D-thiogalactopyranoside (IPTG), and cells were grown for
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18-22 hours at 18 ºC with 250 r.p.m. shaking in a refrigerated incubator. Cells were then
harvested in 250 mL centrifuge bottles by spinning at 3000 x g for 20 minutes, and
subsequently frozen at -20 ºC for < 2 weeks prior to cell lysis and purification.
Frozen cells were thawed at room temperature for 5-10 minutes and then
resuspended in 50 mL ice-cold lysis buffer (50 mM sodium phosphate, 500 mM NaCl,
0.5% Triton-X-100, pH 6.5) per liter of harvested cell culture. All subsequent steps were
carried out on ice or in a 4 ºC cold room. Re-suspended cells were homogenized with 3
passes through a 21-gauge syringe needle. 10 mL aliquots of lysate were each
sonicated 5 times with a duty cycle of 15 seconds ON, 30 seconds OFF with a Fisher
Scientific Series 60 Sonic Dismembranator at 100% power (60W). Individual aliquots
were pooled and transferred to a 50 mL polycarbonate conical tube and clarified by
centrifugation at 25,000 x g for 30 minutes at 4 ºC to remove insoluble fractions. The
supernatant was decanted and kept at 4 ºC prior to further purification.
His6-tagged proteins were affinity-purified by fast protein liquid chromatogphy
(FPLC, AKTA Basic) on Ni-NTA (GE HisTrap FF) columns. All exposed samplecontaining FPLC segments were covered with aluminum foil to maintain darkness. After
sample loading onto a 5 mL column at 1mL/min, the column was washed with 20 mM
imidazole in buffer (50 mM sodium phosphate, 500 mM NaCl, 10% glycerol, pH 6.5) for
15 column volumes, followed by a linear gradient, from 20 to 250 mM imidazole, over 15
column volumes at 5 mL/minute. Proteins were eluted with 500 mL imidazole, and
collected in 10 x 2 mL fractions. Samples were pooled based on purity assessed by
SDS-PAGE and concentration assessed by absorbance spectroscopy (A280), and then
buffer exchanged into 1x PBS using PD-10 desalting columns with Sephadex G-25 resin
(GE 17085101). Buffer exchanged material was centrifuged at 4 ºC at 25,000 x g for 30
minutes to pellet insoluble protein debris. Buffer exchange was repeated twice more,
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and the column was re-equilibrated with 1x PBS prior to each usage. Purified protein
was stored for < 2 weeks at 4 ºC.

A3.4.2 P-nitrophenyl butyrate cleavage assay
P-nitrophenylbutyrate (pNPB) was purchased from Millipore-Sigma (P9876). To
make 10 mg/mL liposomes, 8.4 µL pNPB was diluted in 1 mL 1X PBS. The mixture was
hydrated by heating at 50 °C on a heat block with intermittent vortexing for 30
minutes.The mixture was then sonicated in a water bath sonicator for twominutes and
placed on ice. The mixture was then extruded for ten passes with an Avanti Lipid
extruder with a 0.05 µm membrane; 5 µL liposomes was used per well of a 96 well plate
of this assay. Wheat germ lipase (WGL) positive control was purchased from MilliporeSigma (L3001) and is listed as containing between 5 and 15 lipase units per mg. For
calculations, we assumed a potency of 10 lipase units per mg. WGL (30 mg, 300 units)
was dissolved in 500 µL 1X PBS. This solution was then diluted tenfold in DPBS, and 33
µL was used for two units per well in this assay. Protein (either NusA only or NusALipase) was buffer-exchanged into 1x PBS and diluted to a final concentration of 20 µM;
150 µL protein was used per well. Absorbance at 400 nm was measured every 30
seconds for one hour in a Tecan M200 plate reader set to 37 °C with 1 mm amplitude
shaking for 1 second between measurements.

A3.4.3 DBPC cleavage assay
Full-length DtLipase-LOV was buffer exchanged into 1x PBS and diluted to 20
µM. DBPC substrate (Echelon Biosciences, L-3000) was dissolved in PBS for a final
concentration of 10 µM. Substrate cleavage was measured in a black 96-well plate in a
Tecan M200 spectrophotometer, with 200 µL sample volumes. Protein-only condition
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used 10 µL protein diluted to 200 µL with PBS. Substrate-only condition used 10 µL
substrate diluted to 200 µL with PBS. Protein plus substrate condition used 10 µL of
each protein and substrate, diluted to 200 µL with PBS. The plate was exposed to 15
mW/cm2 blue light for three seconds per minute. Emission was measured at 525 nm
using 495 nm excitation and a gain setting of 50.
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